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ii. Abstract 
 
Fingermark examination is one of the most common forensic techniques used by 
the police and forensic examiners. Many methods for developing fingermarks on 
countless different surfaces exist, and various analytical methods are utilised to 
extract further information from fingermarks once visualised. However, there are 
still several areas of fingermark identification and examination that can be 
optimised. 
 
The need to dark adapt the eyes prior to fingermark examination in low light 
environments was investigated. It was discovered that participants could 
visualise an average of 16 % more fluorescent patterns when allowing their eyes 
time to adapt to their darkened environment.  This large increase in the amount 
visualised by participants suggests that crime scene officers should be allowing 
their eyes time to dark adapt prior to conducting examinations in the dark. 
 
Following on from this result, a study investigating the possible link between 
uptake of docosahexaenoic acid and dark adaptation ability was performed. After 
taking fish oil supplements containing docosahexaenoic acid for four weeks, dark 
adaptation ability was shown to improve in the majority of participants. Following 
this, after a washout period of six weeks with no fish oil supplementation, dark 
adaptation ability reverted back to its original level or partially worsened. This 
result suggests that docosahexaenoic acid levels can affect the ability of an 
individual to dark adapt, and confirms that any changes caused by the fatty acid 
are reversible when levels are returned to normal. 
 
To improve the usefulness of fingermarks not suitable for identification, the 
possibility of a relationship existing between fingerprint size, and physical stature 
was examined. The area, circumference, width and length of 200 donor’s 
fingermarks was measured and statistically compared to their height. Whilst a 
positive relationship was found, the usefulness of this relationship to forensic 
examiners would likely be minimal due to the large error (± 15 cm) associated 
with the results. Forensic officers confirmed that whilst interesting, the results 
would have limited use in the field. 
iv 
 
 
This research was also supplemented with an investigation into how developing 
fingermarks via cyanoacrylate fuming would affect the ability to then gain any 
useful information from LCMS analysis. Whilst this work needs further 
investigation, the preliminary results show that cyanoacrylate fuming the 
fingermarks did not remove the ability to analyse paracetamol, ibuprofen and 
caffeine present in the fingermark using LCMS. 
 
This collection of research has shown that both fingermark development and 
collection can be optimised and the physiological aspects of both the size of the 
fingerprint, and the residue deposited with the fingermark can be used for 
analysis beyond simply pattern matching. 
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DESI Desorption electrospray ionisation 
DFO 1,8-dizafluoren-9-one 
DHA Docosahexaenoic acid 
DHAME cis-4, 7, 10, 13, 16, 19-Docosahexaenoic acid methyl ester 
DIP Distal interphalangeal 
DNA Deoxyribonucleic acid 
DSTL The Defence Science and Technology Laboratory 
EPA Eicosapentaenoic acid 
EPAME cis-5,8,11,14,17-Eicosapentaenoic acid methyl ester 
FAME Fatty acid methyl ester 
FTIR Frustrated total internal reflection 
GCMS Gas chromatography mass spectrometry 
HFA Humphrey Field Analyser 
IBM, SPSS International Business Machines Corporation, Statistical 
Package for the Social Sciences 
Ind/1,2-Ind 1,2-indanedione 
IR Infra-red 
LCMS Liquid chromatography mass spectrometry 
MALDI Matrix assisted laser desorption ionisation 
MP Metacarpophalangeal 
MRI Magnetic Resonance Imaging 
MS Mass Spectrometry 
NMR Nuclear Magnetic Resonance 
NSAID Nonsteroidal anti-inflammatory drug 
PFDA Portable Field Dark Adaptometer 
PIP Proximal Interphalangeal 
PUFA Polyunsaturated Fatty Acid 
RH Relative humidity 
RRF Relative response factor 
ROS Rod outer segments 
rpm Revolutions per minute 
THC Tetrahydrocannabinol 
UPLC Ultra-performance liquid chromatography 
UV Ultraviolet 
VMD Vacuum metal deposition 
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1 Introduction 
 
 Hands 
 
The hand consists of 27 bones. There are 8 carpal bones which make up the 
wrist, 5 metacarpal bones in the palm, and 14 phalangeal bones that make up 
the fingers.1 From the tip of the finger, the 3 bones that make up the digit are 
known as the distal, middle and proximal phalanx respectively. The thumb 
consists of only a distal and proximal phalanx. These are all shown in  
Figure 1. Each finger has 3 joints between the bones, the metacarpophalangeal 
(MP), the proximal interphalangeal (PIP) and the distal interphalangeal (DIP) 
joints.1 There are approximately 1.6 – 4.0 million eccrine sweat glands over the 
entire surface of the human body and the highest density of these is on the palms 
of the hands and the soles of the feet.2 The skin on either side of the hand is 
different. The skin over the palm and the fingertips (the volar surface of the hand) 
is described as glabrous1 compared to the hairy skin on the dorsum of the hand.  
 
Figure 1 – The Bones of the Human Hand.3 
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The epidermis is the outermost layer of skin with the dermis below. These are 
connected by a series of papillary folds, which form the recognisable fingerprint 
structure.1 
 
1.1.1 The Fingertip 
 
Beneath the skin in the fingertips is subcutaneous tissue composed of elastic 
adipose cells enfolded in a fibrous tissue network.4 The fingertip pulp is 
comprised of these fatty tissues and the skin surrounding the fingertip. The digital 
pulp is thought to have several purposes: to protect the underlying tendons, 
muscles and nerves when gripping objects, to stabilise the skin and pulp whilst 
gripping and also to maintain the shape of the digit.5  
 
 Fingerprints 
 
Fingerprints are essentially the pattern of the friction ridges formed on the tips of 
the fingers. Every person’s fingerprints are different, even identical twins possess 
unique fingerprints from each other.6 An individual’s fingerprints do not change 
throughout their lifetime, even during wound healing; the friction ridges are only 
altered if there is injury to the basal layer of the epidermis.7 The fingerprint 
patterns begin to become established in the womb at 10-16 weeks, but 
fingerprints are not fully formed until about 7 months into pregnancy.8 Any scars 
which form over the fingerprint due to injury will possess the same level of 
uniqueness as the fingerprint itself, as the chance events that occur during 
formation will be different for every individual.7 Whilst the theory that fingerprints 
improve grip has been disproved,9 other theories for the practical use of 
fingerprints have been suggested, such as increasing touch sensitivity in the 
fingertips and allowing the skin to deform and stretch more easily, acting as 
protection against damage. The point at which ridges join, separate or split 
(bifurcation) are known as minutia and were originally examined by Galton.10 
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1.2.1 Fingerprint Classification 
 
The shapes that the ridges in the fingerprints form can be characterised as 
patterns. Fingerprint patterns can be classified into three basic groups by the 
Henry Classification; arches, whorls and loops,11 each of which can be seen in  
Figure 2. Other patterns can also be seen, such as composites, which contain a 
combination of the arch, whorl or loop in the same print. Arches can be simple or 
tented and loops can be formed facing either towards the centre of the body, or 
away from it, these are named radial loops and ulnar loops, respectively.12 Loops 
are the most common fingerprint pattern seen, but both loops and whorls are 
much more common than arches. These patterns form the first level of 
classification when analysing fingerprints. The second level of classification is the 
minutia, observed at the ridge endings and bifurcations. It is thought that 
bifurcations are formed as ridges separate as the finger grows, and that new 
ridges pull away from the primary ridges to fill the gaps that are created.13 The 
third level refers to both the pores present within the ridges, and the length and 
width of the ridges seen. The analysis of each of these levels can be performed 
using an algorithm, which compares fingerprints.8 
 
Figure 2 – Fingerprints with red arrows to indicate the right loop (a), left loop (b), 
whorl (c), tented arch (d) and the simple arch (e) patterns.14 
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1.2.2 Fingermark Deposition 
 
When a finger comes into contact with a surface, a fingermark is deposited. 
Depending on the properties of the finger and the surface at the time of 
deposition, both the quality of the mark and the ability to collect or image it can 
vary.15 There are 3 types of marks that can be deposited;15 impression marks are 
left when a fingerprint is pressed into a soft substrate, such as wax or wet paint.  
Negative marks are found when a fingerprint has picked up some of a loose 
substrate, leaving a reverse mark in the substrate. Examples include fingerprints 
in dust. However, both negative and impression marks are less common than 
positive marks, which are formed through a substrate present on the finger being 
deposited on a surface. The substrate on the finger may be a contaminant picked 
up through use of the hands, or the substrate may simply be sweat secreted by 
the eccrine sweat glands on the palmar surface of the hand. Fingermarks left in 
sweat are not usually visible and are known as latent fingermarks. Latent 
fingermarks are the most common form of fingerprint evidence but can be the 
most difficult prints to locate.16 It is mainly for these difficult to locate and visualise 
latent fingerprints that development techniques are used. 
 
1.2.3 Latent Fingermark Composition 
 
Latent fingermarks are composed of the sweat secreted on the fingers, along with 
contaminants picked up by the fingertips. The composition of a specific 
fingermark is by definition, unknown.17 However, the general composition of 
fingermark residue has been heavily researched and reviewed.18 Whilst the 
sweat secreted on the palmar skin on the fingers is from eccrine glands, 
sebaceous sweat can also be collected by the fingers when touching the face. 
Natural fingermarks will contain a mixture of these sweats and therefore a 
collection of various components in the residue. Latent fingermark residue may 
also contain contaminants that are present from touching other surfaces. A 
comparison of the compositions of fingermark residue from different sources is 
shown in Table 1. 
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As shown in Table 1, there are several different glands that contribute to the 
sweat present in fingermark residue. There are 3–4x106 sweat glands across the 
human body,19 and three types of sweat glands that contribute to latent 
fingermark residue, eccrine, sebaceous and apocrine. Eccrine sweat glands are 
found all over the body, but in highest concentration on the palms of the hands 
and the soles of the feet, therefore eccrine sweat is a predominant component of 
fingerprint residue.20 Sebaceous glands however are found predominantly on the 
face and back and not found at all on the palms of the hand. Sebaceous material 
is transferred to the palms and fingers through touching the face and other body 
parts.21 Sweat from the apocrine glands can also be transferred onto the fingers 
and therefore into fingerprint residue through touching of body parts containing 
apocrine glands.20  
 
Latent fingerprint residue is a complex mixture of chemical components, unique 
to each person, and even to each fingermark, as the contribution of each 
component is based on many different variables, such as physiological and 
psychological state.20 The components that together form fingerprint residue are 
very important for several reasons; primarily because it is these components of 
the residue that react with or give the optimal conditions, which allows various 
visualisation techniques to work. 
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Table 1 – A summary of the constituents of fingermark residue and their 
sources.20 
Source Location Constituents 
Eccrine sweat Eccrine glands Water, urea, uric acid, creatinine, 
amino acids, ammonia, choline, 
glucose and other reducing sugars, 
lactic acid and lactate, sodium, 
chloride, potassium, sulphate, 
calcium, trace metal ions, 
phosphate, sulphate, enzymes, 
peptides, proteins, vitamins 
Sebum Sebaceous glands Free fatty acids (saturated and 
unsaturated), cholesterol esters, 
mono-, di- and triacylglycerides, wax 
esters, cholesterol, squalene and 
other hydrocarbons 
Apocrine sweat Apocrine sweat 
glands 
Ammonia, androgenic steroids, 
cholesterol, glycogen, iron, proteins, 
water 
Epidermal Epidermis Free fatty acids, glycerides, 
proteins, sterols, sterol esters 
External 
contaminants 
From touching other 
objects and 
surfaces 
Drugs, cosmetics, explosives, food, 
dust, grease 
  
The amino acids present in eccrine sweat are responsible for the reaction with 
several fingermark visualisation techniques and for this reason, they have been 
thoroughly studied using several different analytical techniques.18  
 
1.2.4 Amino Acids in Fingerprints 
 
As outlined in Table 2, there are many different amino acids present at various 
concentrations in fingerprint residue. 
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Table 2 – Amino acids identified in fingermark residue.18 
Amino acids Serine ratio (%) 
Serine 100 
Glycine 54-67 
Ornithine 32-45 
Alanine 22-35 
Aspartic acid 11-24 
Threonine 9-18 
Histidine 13-17 
Valine 7-12 
Glutamic acid 3-12 
Lysine 5-10 
Leucine 7-10 
Isoleucine 6-8 
Phenylalanine 5-7 
Tyrosine 3-6 
Proline - 
Cysteine - 
 
There are currently three reagents in operational use worldwide that react with 
amino acids to produce a compound which allows the visualisation of 
fingermarks, these are ninhydrin, 1,8-diazafluoren-9-one (DFO) and 1,2-
indanedione (1,2-Ind).20 Several different amino acids are present in fingermark 
residue, in varying concentrations, which also vary between individuals. It has 
also been established that sex can be determined from the differences in amino 
acid concentrations in fingermark residue.22 Chemical composition has also been 
found to vary depending on the age of the donor, this has been established using 
a combination of attenuated total reflection, Fourier transform infra-red (ATR-
FTIR), IR micro-spectroscopy and mathematical modelling.23–25 
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 Protocols in Fingerprint Research 
 
Whilst the previously mentioned Fingermark Visualisation Manual gives current 
forensic examiners a detailed and thorough description of current methodologies 
suitable to enhance and develop latent fingermarks,15 new methods are 
constantly being discovered and tested, alongside changes to current well known 
and used methods. As forensic evidence is necessary for criminal investigation 
cases, forensic methodologies are likely to be discussed in court, and it is 
therefore vital that all forensic evidence enhancement research is conducted and 
reported accurately and leaves no room for errors. Similarly, particularly in the 
UK, new fingermark enhancement techniques need to be validated and reported 
in the Fingermark Visualisation Manual, prior to operational use.15 Whilst this is 
well known, and taken into account when developing or testing new 
methodologies, fingermark enhancement is particularly hard to test consistently, 
due to the natural differences between deposited fingermarks discussed in 
Section 1.2.3. There are documents available presenting the best practise 
guidelines for the evaluation of fingermark enhancement techniques.26 Several 
different attempts have been suggested in order to create consistent research 
fingermarks. These range from physical devices used to control the pressure and 
place of fingermark deposition,27,28 to replacing natural prints deposited by donors 
with pseudo prints comprised of the standard compounds present in fingerprint 
sweat.29 However usually, fingermark enhancement techniques are simply tested 
using as many donors as possible, and include casework exhibits that have been 
touched incidentally leaving natural fingermarks, rather than those placed 
purposely by donors. Further methodology used throughout fingermark 
enhancement research is outlined below, some of these techniques were utilised 
throughout this research. 
 
1.3.1 Terminology 
 
Throughout fingerprint literature, the terms fingermark and fingerprint are used. 
Generally, a fingerprint can refer to both the physical pattern on the fingertip, but 
also to the impression collected via inking or a similar controlled setting. However, 
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latent impressions deposited incidentally, which usually require development to 
be visualised, can be referred to as fingermarks. When describing fingermarks 
deposited intentionally, but for research into development of latent fingermarks, 
both terms could be used interchangeably, as the prints are collected in a 
controlled manner, but they are collected to be used as latent marks, such as 
those found at a crime scene. Throughout this report, both terms will be used 
when appropriate.  
 
1.3.2 Split and Depletion Prints 
 
When multiple fingermark development techniques need comparing, it is 
impossible to obtain two identical fingermarks, even from the same donor, due to 
the amount of variation found in fingermark residue as explained in Section 1.2.3. 
The method of split printing can be utilised to directly compare multiple 
techniques using the same fingermark. A schematic explaining the method of split 
printing is shown in Figure 3.  
 
 
Figure 3 – Schematic showing the process of using split prints to test and 
compare multiple fingermark development techniques. 
 
This technique is used regularly when comparing new and current development 
methods,30–32 and it is often used alongside a depletion series. A depletion print 
can be used to show how well a technique performs on fingermarks that have 
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been weakened via touching other surfaces a number of times prior to depositing 
the fingermark that will be tested. A depletion series is produced when a single 
finger is used to deposit a large number of prints, and all are developed, showing 
how the development technique works with weaker fingermarks, as less sweat 
will be deposited with each touch. The change in how well the fingermarks 
develop can be monitored visually, or through the use of a grading scale.  
 
1.3.3 Grading Fingermarks 
 
As many individuals involved in fingermark research are not expert fingermark 
examiners, it can be difficult for them to accurately judge the quality of a 
fingermark. Similarly, comparing the effectiveness of different techniques or the 
successfulness of the same technique on different surfaces can be difficult. A 
scale was devised by CAST that allowed the success of a fingermark to be 
quantified using a scale from 0-4.33 This is sometimes known as the ‘Bandey 
scale’, and is outlined in Table 3. 
 
Table 3 – Bandey/CAST scale for assessment of developed marks.34 
Score Level of Detail 
0 No evidence of mark 
1 Weak development: evidence of contact but no ridge details 
2 Limited development: about 1/3 of ridge details are present but 
probably cannot be used for identification purposes 
3 Strong development: between 1/3 and 2/3 of ridge details: 
identifiable finger mark 
4 Very strong development: full ridge details: identifiable finger mark 
 
This scale can be very useful to give a quantifiable ‘result’ to the quality of 
fingermarks developed using different techniques, and the number of marks 
receiving a 3 or 4, therefore being classed as identifiable, can be reported. Other 
similar absolute scales have been proposed, alongside a comparative scale.26 
The comparative scale outlined below in Table 4 was developed at the University 
of Canberra, and can be used to directly compare two halves of a split 
fingermark.35 
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Table 4 – The University of Canberra comparative scale used to assess the 
performance of two detection methods, A and B, applied to a split fingermark 
impression.35 
Score Definition 
+2 
Half-impression developed by method A exhibits far greater ridge 
detail and/or contrast than the corresponding half-impression 
developed by method B 
+1 
Half-impression developed by method A exhibits slightly greater 
ridge detail and/or contrast than the corresponding half-
impression developed by method B 
0 No significant difference between the corresponding half-
impressions 
-1 
Half-impression developed by method B exhibits slightly greater 
ridge detail and/or contrast than the corresponding half-
impression developed by method A 
-2 
Half-impression developed by method B exhibits far greater ridge 
detail and/or contrast than the corresponding half-impression 
developed by method A 
 
These grading scales allow fingermark development results to be quantified, and 
assessed so that they can be progressed through to operational trials and if 
successful, routine use. 
 
 Visualising Fingermarks 
 
As outlined in Section 1.2.2, negative or positive fingermarks can be deposited 
when touching a surface, depending on the materials present on the finger and 
present on the surface being touched. If an impression or negative fingermark is 
left, it is possible to identify it with the naked eye as it will be prominent in whatever 
substrate was touched. However when looking for positive fingermarks, 
processes may be needed to make the fingerprint visible. Many processes can 
be used to visualise latent fingermarks, these processes are grouped into 3 
categories; optical, chemical or physical treatments.15,16 Whilst many different 
techniques exist, the Fingermark Visualisation Manual categorises these 
techniques based on the level of evaluation of the technique that has been 
performed and also the results of this evaluation.15 Category A processes have 
12 
 
been evaluated extensively by the Home Office and are considered suitably 
effective for routine police work, these processes should be used preferentially to 
other categories where possible.15 These known processes along with new 
techniques are constantly been tested and evaluated so that the police are 
equipped with the best possible tools for varying surfaces and scenarios.  
 
Whilst there are many different techniques, the techniques that were vital to the 
studies performed during this research, which are described throughout this 
thesis, are outlined below. 
 
1.4.1 Dusting Powders 
 
Powders are one of the oldest reported techniques for latent fingermark 
detection.32 The process of dusting for powders is also simple and non-
hazardous, so can be performed easily and cheaply. Powders adhere directly to 
the material present in the fingermark residue. Several different powder types 
exist, varying in particle size, colour, fluorescence and other characteristics. More 
recently powders have been developed that are visible in the near infra-red 
spectrum, allowing for fingerprints to be photographed with high contrast even on 
highly detailed backgrounds.31 Powders are most effective on non-porous or 
semi-porous surfaces as the powder sticks to fingerprint ridges with a higher 
affinity than to the background surface. However, there is a broad variety of 
fingerprinting powders for which a significant proportion of potential surfaces are 
suitable. It is the lipid content of the fingermark that powders are able to adhere 
to, meaning that powders rely on a certain level of sebaceous content in residue. 
However, powders can also adhere to the water content in recently deposited 
fingermarks. Several different powders are recommended by the Home Office, 
but specifically for glass, aluminium powder is recommended as the most 
effective powder.32 Typical particle diameter of aluminium powder falls between 
4 -10 µm.15 As smaller powders adhere more easily to fine fingermark detail, flake 
powders such as aluminium powder are usually under 10 µm in diameter.36 
Magnetic powders are also used, these can be applied using a magnetic wand 
which removes any contact between the fingerprint and a brush, which can cause 
damage to a mark.20 Whilst powders are very suitable for lots of cases when 
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looking for latent fingerprints, on larger objects it can be difficult and time 
consuming to dust for every possible print. Cyanoacrylate fuming is a process, 
which is also highly effective on non-porous surfaces, and can develop all latent 
fingermarks on an object during one run. 
 
1.4.2 Cyanoacrylate Fuming 
 
Superglue fuming is a process used to develop latent fingerprints on non-porous 
and semi-porous surfaces. Ethyl cyanoacrylate is fumed within a closed system 
containing the object or objects that suspected fingerprints may be present on 
developing white fingerprints. The white deposits are polycyanoacrylate, the 
polymer formed through the polymerisation of cyanoacrylate.32 Whilst heat is 
needed to fume the cyanoacrylate, 80 % relative humidity (RH) is also needed to 
develop fingerprints with good contrast. It has been shown using electron 
microscopy that at 80 % RH long fibrous deposits of polycyanoacrylate grow, 
which cannot be seen at lower humidity.32 The polymerisation of cyanoacrylate is 
shown in Figure 4. The polymerisation process is base initiated, and even weak 
bases such as water will initiate the polymerisation. It was thought that it was the 
water component of fingermark residue that was responsible for the 
polymerisation and the importance of moisture in a fingermark has been 
confirmed.37 However, fingermark residue contains many bases that could initiate 
the polymerisation of ethyl cyanoacrylate. 
 
Superglue is known to give better results than powdering on textured surfaces, 
as the powder can get stuck within the ridges of the surface.32 Fingermarks fumed 
with cyanoacrylate can be post treated with fluorescent reagents to improve the 
contrast on different surfaces, and certain one-step fuming compounds exist that 
produce a fluorescent compound as part of the polymerisation process. 
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Figure 4 – The initiation, propagation and termination steps of the 
polymerisation reaction of ethyl cyanoacrylate adapted from Bleay, Croxton and 
de Puit.20 
 
1.4.3 Ninhydrin 
 
Ninhydrin is a Category A chemical fingerprint development process, it is 
commonly used on paper evidence and is suitable for porous and semi-porous 
surfaces.15 Ninhydrin was developed in 1910, but was not used for developing 
fingerprints until 1954.32 Ninhydrin reacts with the various amino acids present in 
fingermark residue to give the product Ruhemann’s purple,16 this is shown in  
Figure 5. 
Initiation 
Multiple 
propagation 
steps 
Termination 
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Figure 5 – The accepted reaction scheme between ninhydrin and the amine 
group of amino acids to form Ruhemann’s purple, adapted from the Fingerprint 
Source Book.32 
 
Fingerprints developed using ninhydrin are purple and are visible under white 
light to the naked eye, however, these marks can also appear dark red depending 
on the compounds that are present in the fingermark residue. As outlined in 
Section 1.2.4, several different amino acids along with other compounds are 
present in fingermark residue. Whilst ninhydrin produces marks visible under 
white light, the marks can be post treated with zinc salts to produce a fluorescent 
metal complex38. Several ninhydrin analogues have been evaluated, the most 
well used being 1,2-indanedione, shown in  
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Figure 6, which produces  a Ruhemann’s purple analogue,39 known as Joullie’s 
pink, fluoresces yellow-orange under green light. Whilst 1,2-indanedione is 
currently still classified as Category B fingermark development technique,15 
recent research has shown that when used in combination with zinc chloride, 1,2-
ind is the most effective single use technique, as the zinc allows stable, 
fluorescent complexes to form, and 1,2-ind/zinc followed by ninhydrin produced 
the most combination marks.40–42 
 
 
 
Figure 6 – The structure of 1,2-Indanedione. 
 
 
1.4.4 1,8-Diazafluoren-9-one (DFO) 
 
1,8-Diazafluoren-9-one (DFO) is a Category A chemical fingerprint development 
process, also commonly used on paper evidence and suitable for porous and 
semi-porous surfaces.15 DFO also reacts with the amino acids present in 
fingermark residue, similar to ninhydrin. The main difference between ninhydrin 
and DFO is that through the reaction with amino acids present in fingerprint 
residue, DFO produces a product that is fluorescent under green light. The 
accepted reaction scheme between DFO and amino acids is shown in Figure 7. 
DFO, whilst reacting with amino acids present in fingermark residue, has been 
shown not to consume all amino acids present in the fingermark.43 Due to this, 
ninhydrin can be used to treat a fingermark as a post-treatment after DFO. DFO 
solutions often contain methanol, as this helps to form the hemiketal that is the 
reactive species.44,45 
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Figure 7 – The accepted reaction scheme between DFO and the amine group 
of amino acids to form the fluorescent product, adapted from the Fingerprint 
Source Book.32 
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 Fluorescence 
 
The fluorescence of fingerprint reagents was vital to many parts of the research 
outlined in this thesis, however, the fluorescence methods utilised specifically do 
not add to the novelty of this work. The following is a brief introduction into 
fluorescence, fluorescence spectroscopy, and its uses specifically in fingerprint 
examination. 
 
Fluorescence occurs with certain molecules, known as fluorophores. When 
fluorescence occurs, a photon is absorbed by the molecule, creating an excited 
singlet state. This excited singlet state has a short lifetime, usually 1-10 
nanoseconds. During this excited state lifetime, some energy is lost, creating a 
relaxed singlet state. A photon is emitted from the molecule, returning the 
fluorophore to its ground state.46 The photon emitted is of a lower energy, and 
therefore, has a longer wavelength, due to the energy lost in the excited state 
lifetime.32,46 This process is shown by a Jablonski diagram, an example of which 
is shown in Figure 8.  
 
 
 
The energy of emission is usually lower than the absorption,47 as shown by the 
Jablonski diagram in Figure 8. This phenomenon is known as the Stokes shift/ 
Fluorescence occurs naturally, but also has many uses, such as in dyes, 
Figure 8 – A basic Jablonski diagram. 
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fluorescent labelling, chemical sensors and fluorescent lamps. Typical 
fluorescence lifetime is near 10 ns.47 To measure fluorescence, a fluorescence 
spectrometer can be used. 
 
1.5.1 Fluorescence Spectroscopy 
 
Fluorescence spectroscopy can be used to excite a compound with a specific 
wavelength of light, and measure the emission wavelength emitted. It is therefore 
a useful tool to measure changes to compounds based on their fluorescence 
properties. Most spectofluorometers can record both emission and excitation 
spectra.47 
 
 
 
Unlike an absorption spectrum, fluorescence spectra cannot be recorded relative 
to a blank, as a blank with no fluorescence would offer no signal. Instead, 
fluorescence intensity measurements are absolute, and therefore can be difficult 
to compare.47 
 
Light 
source 
Detector 
Emission filter/monochromator 
Excitation 
filter/monochromator 
Sample 
Figure 9 – Simple schematic of a fluorescence spectrometer. 
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1.5.2 Fluorescent Fingerprint Examination 
 
The use of fluorescence to enhance fingerprints was proposed and has been 
used since the 1930’s,32 where ultraviolet (UV) light was used to excite early 
fingerprint powders. Fluorescence examination is now commonly used for 
fingerprint examination and detection, and several fluorescent detection methods 
were originally recommended by the Centre for Applied Science and Technology 
(CAST)15,32 now integrated with The Defence Science and Technology 
Laboratory (DSTL). A filter is often required to visualise fluorescent fingerprints, 
as shown by Figure 10. The filter blocks reflected light so only the fluorescent 
mark is visible. However, another use of fluorescent examination is to view the 
fluorescence of a background surface whilst the fingermark adsorbs the 
illuminating wavelengths.20 Background fluorescence can be an issue when 
examining fluorescent fingermarks as this can interfere with the visibility of the 
fluorescence of the fingermark. The powders discussed in Section 1.4.1 utilise 
materials which are excited by IR-radiation,31 as very few naturally occurring 
materials possess this feature.20 However, IR-excited powders fluoresce in the 
IR range and so an IR sensitive viewing system is required to visualise the marks. 
 
 
 
 
 
Figure 10 – Schematic showing the viewing of a fluorescent fingermark 
through a filter, adapted from The Fingerprint Source Book.32 
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When looking for and visualising fluorescent evidence, it is recommended that 
the individual’s dark adaptation is maintained throughout the examination.15 
 
 Dark Adaptation 
 
1.6.1 Cones and Rods in the Retina 
 
The retina is a thin layer of tissue at the back of the eye located near the optic 
nerve. There are two types of photoreceptor present in the retina; rods and 
cones.48 All parts of the retina contain both rods and cones except the central 
region of the fovea centralis, which contains only cones.48 Whilst all other areas 
contain both photoreceptor cells, the proportions of each vary between areas. 
The rods and cones have different roles, specifically for light and dark adaptation 
of the eyes. The cones are responsible for perception of colour, whilst the rods 
allow for vision in dim light. The rods contain rhodopsin, the light sensitive 
receptor protein. The relationship between increase in sensitivity in the dark and 
increase in amount of rhodopsin present has been found to be logarithmic.49 
 
1.6.2 The Process of Dark and Light Adaptation 
 
Dark adaptation is defined as the adjustments, both chemical and physical, that 
occur in the eye when moving from a lit environment to one of much lower light 
levels.50 Light and dark adaptation of the eyes is a well-known phenomenon, 
initially described in 186551 and measured in 1903.52 Despite this, the dark 
adaptation process is still not fully understood.53 Dark adaptation occurs in two 
parts: the first is rapid and due to cone function, the second is slower and due to 
rod function.54 These two distinct functions form the classic dark adaptation 
curve, which remains similar between all individuals, with only slight differences.48 
The shape of this classic curve is shown in Figure 11, adapted from Hecht and 
Mandelbaum’s data. The shaded area in the original curve represented 80 % of 
measurements from participants, whilst the outline of the curve was made using 
the data from the participants who gave the highest and lowest values. The first 
part of cone adaptation takes approximately three mins to achieve and a large 
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decrease in threshold luminescence is observed, this decrease then slows before 
the rod function takes over; this point of transition is known as the cone-rod break. 
Once the rod function starts, there is a decrease in the curve again, before 
plateauing and reaching the absolute threshold. The absolute threshold for dark 
adaptation is the point where the retina has reached absolute photochemical 
reactivity. 
 
 
 
 
Whilst every person goes through the same process of dark adaptation, time 
taken to achieve dark adaptation varies between individuals.54 Many factors will 
affect time taken for the eyes to dark adapt, including eyesight, age and level of 
light adaptation prior to darkness.  
 
1.6.3 The Importance of Dark Adaptation 
 
There are many professions, and situations where it is best suited to be dark 
adapted, and able to find fine detail in the dark. One specific example of this is 
crime scene officers looking for fluorescent evidence in the dark, either at a crime 
scene, or once evidence has been moved to a laboratory. It is recommended that 
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Figure 11 – General shape of the dark adaptation curve. Based on Hecht and 
Mandelbaum’s data from Pirenne,48 not to scale. 
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crime scene officers attain a level of dark adaptation prior to looking for 
evidence,15 however, there is currently no standardised way of monitoring your 
dark adaptation or minimum level of dark adaptation that it is recommended to 
reach. To combat this, both CAST and Foster + Freeman have developed hand 
held devices, which can be used to monitor dark adaptation. The Crime-lite Eye™ 
developed by Foster and Freeman utilises an LED numerical display, whilst the 
Dark Adaptation Readiness Kit (DARK) developed by CAST, uses shapes and a 
percentage intensity.50 To maintain dark adaptation when moving between dark 
and light environments, red filter goggles have been suggested. It is also thought 
that red filter goggles can be used to begin dark adaptation prior to entering a 
darkened room, reducing the time needed in the dark to reach absolute threshold 
of dark adaptation.50 Light adaptation is very fast compared to dark adaptation, 
taking only a few minutes.48 For this reason, even short interruptions of light 
during dark adaptation will greatly affect the time taken to dark adapt, as the eyes 
will essentially have to begin the process of dark adaptation again. 
 
 Docosahexaenoic Acid 
 
1.7.1 Fatty Acids 
 
The term fatty acids encompasses several diverse molecules, which are 
characterised by their hydrophobic nature caused by their repeating methylene 
groups.55 In almost all naturally occurring unsaturated fatty acids, the double 
bonds are in cis formation, and a single methylene group usually occurs between 
each double bond.55 Fatty acids are often referred to in shorthand derived from 
their structure, or by historical names in order to avoid their lengthy IUPAC 
names. Shorthand names are often derived using the following form: C:Dn-x, 
where C is the number of carbon atoms, D is the number of double bonds, and x 
is the number of carbons between the methyl end of the carbon chain and the 
first double bond. This shorthand works for naturally occurring fatty acids as the 
double bonds are always in cis formation with the single methylene group 
separating each double bond.55 
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Figure 12 – The structure of docosahexaenoic acid (DHA) 22:6n-3. 
 
Docosahexaenoic acid (DHA, 22:6n-3) is a fatty acid with the structure shown in 
Figure 12. DHA is not synthesised in the body, it is only gained through the diet 
and through conversion from α-linolenic acid (ALA, 18:3n-3).56 DHA synthesis 
rates from ALA is considered low compared to dietary uptake in mammals.56 The 
synthesis pathway from ALA to DHA is shown in Figure 13. 
 
 
 
 
Figure 13 – The synthesis pathway from ALA to DHA, adapted from Calder.146 
α-Linolenic acid (ALA, 18:3n-3)  
Stearidonic acid (18:4n-3)  
Eicosatetraenoic acid (20:4n-3)  
Eicosapenatanoic acid (EPA, 20:5n-3)  
Docosapentaenoic acid (22:5n-3)  
Docosahexaenoic acid (DHA, 22:6n-3)  
Δ6-desaturase 
Elongase 
Δ5-desaturase 
Elongase 
Elongase 
Δ6-desaturase 
Β-oxidation 
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1.7.2 DHA and Dark Adaptation 
 
A deficiency of DHA can lead to abnormal retinal function.57 Whilst the 
mechanisms of DHA in the retina are unknown, its effects on visual ability is well 
known.58 As explained in Section 1.6, dark adaptation is due to the rod 
photoreceptor cells in the eyes. The fatty acid DHA is stored in high 
concentrations in the rod cells in the retina,59 and there is a suggested link 
between DHA and dark adaptation ability for this reason. Investigation into this 
link could benefit crime scene officers, alongside other individuals requiring a high 
level of dark adaptation. A link between dark adaptation and dyslexia has also 
been investigated in a small study and the effect of supplementation of fish oil 
containing DHA was considered.60 However, the small sample size used for this 
study, and lack of other research into this area leaves a need for further 
investigation into the links between dark adaptation, dyslexia and DHA. 
 
 Mass Spectrometry – Fingerprints in Forensics 
 
Throughout this research, mass spectrometry was vital to identify and quantify 
compounds present in both latent fingermarks, and in blood samples.  
 
Mass spectrometry is a common analytical technique used for the identification 
and quantification of ions in a complex mixture. All mass spectrometers have an 
ion source, a mass analyser and an ion detector, but there are different 
techniques that can be used in each of these components. The choice of which 
technique to use is based on the compounds being analysed.  
 
The ion source ionises the sample prior to analysis. Choice of technique for the 
ion source depends on the volatility of the compound being analysed and how 
much fragmentation is required. Electron ionization for example, works well for 
gas phase molecules and induces extensive fragmentation.61 
 
The mass analyser separates the ions produced by the ion source according to 
their masses. Mass analysers have different principles of separation and also 
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different resolving power; the ability of the mass analyser to distinguish between 
two ions with similar m/z.61 A quadrupole analyser separates ions based on their 
m/z, specifically on their trajectory stability in oscillating electric fields. A basic 
example of a quadrupole mass analyser is shown in Figure 14. 
 
 
 
 
Recently, desorption electrospray ionisation (DESI) and matrix-assisted laser 
desorption/ionisation (MALDI) have been used to chemically image latent 
fingermarks through the identification of specific ions present in the latent 
fingermark residue.62–64 
 
Mass spectrometry can be paired with both liquid chromatography (LC) and gas 
chromatography (GC), to separate different compounds present within a sample 
prior to identifying the ions present. Fatty acids can be measured in blood or 
plasma using GCMS, this has been studied extensively.65–69 
 
The use of MS for both fingermark and blood analysis is explained throughout 
this thesis, and previous literature behind both techniques is explored in the 
respective chapter’s literature reviews.  
 
 
 
 
 
Ions 
To detector 
Figure 14 – A basic diagram of a quadrupole mass analyser, where the red and 
blue lines indicate possible paths taken by ions. 
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 Other Fingerprint Methodology 
 
1.9.1 Frustrated Total Internal Reflection 
 
For both fingerprints in security and in crime investigation, fingerprint scanning is 
becoming more common, as the components needed have become cheaper. The 
oldest and most commonly used live-scan fingerprinting technique is Frustrated 
Total Internal Reflection (FTIR).70 Total internal reflection occurs when light 
passes from a medium with a higher refractive index to a medium with a lower 
refractive index and the angle it reaches the second medium at is higher than the 
critical angle.71 FTIR however, occurs when another material is present at the 
interface between two mediums (‘frustrating’ the total internal reflection) causing 
light to escape there instead.72 This method has been used for fingerprinting 
since the 1960’s.73 The contrast of the ridges can be seen clearly using this 
technique as they appear bright, and the valleys of the print appear dark due to 
FTIR.70 This is shown below in Figure 15. Reflection occurs at the air/glass 
interface, and transmission occurs at the skin/glass interface. However, newer 
examples of FTIR’s uses in both forensics and fingerprinting are still being 
published. More recently, FTIR has been investigated for the collection of shoe 
prints.74 
 
Figure 15 – An example of an FTIR-based fingerprint sensor.70 
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1.9.2 Fingerprints in Security 
 
Fingerprints are well known for their uses in crime investigation but they are also 
widely used in biometric security. Fingerprints are often the first type of biometric 
systems individuals associate with security, due to being well-known for their 
uniqueness and uses in identification.75 Perhaps it is for this reason that as of 
2001 more biometric systems were available using fingerprints than any other 
method.76 More recent research has shown that fingerprints are still the most 
popular choice for biometric security systems.77 There are several reasons for 
this, one being that fingerprint sensors can be made smaller and comparatively 
cheaper than any other biometric method.77 As already stated, fingerprints are 
already being widely used in crime investigation and this has in turn increased 
their usability in biometric security due to readily available standards for matches 
and fingerprint databases.77 
 
  Aims and Objectives 
 
The following research aimed to investigate how physiological aspects and 
processes could optimise the collection, and enhance the analysis of latent 
fingermarks.  
 
Chapter 2: Dark Adaptation outlines the planning of a study performed to 
investigate the importance of dark adapting the eyes prior to looking for evidence 
in a dark environment. Alongside assessing the importance of dark adaptation for 
forensic examiners, the work completed and outlined throughout this chapter 
aimed to assess the Crime-lite Eye™ as a dark adaptation checker and evaluate 
the usefulness of a standard inkjet printer to print amino acids to give consistent 
fluorescent prints. 
 
The initial work on dark adaptation, lead to Chapter 3: Dark Adaptation and 
Docosahexaenoic Acid which explains how a relationship between 
docosahexaenoic acid (DHA) present in fish oils may have an influence on dark 
adaptation ability. The aim of the work presented in this chapter was to establish 
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if this relationship between DHA and dark adaptation does exist, and to discuss 
the possible benefits of such a relationship. The study outlined in this chapter 
utilised GCMS analysis of fingerprick blood samples to quantify the amount of 
DHA present pre- and post-supplementation.  
 
Whilst the previous chapters focused on dark adaptation of the eyes, Chapter 4: 
Fingertip Compression and Stature aimed to assess if a relationship exists 
between fingerprint size and physical stature. This chapter not only aimed to 
assess whether such a relationship exists, but also to establish if any relationship 
found was strong enough, that fingermarks found, but showing little ridge detail 
could still provide examiners with a characteristic of the individual who deposited 
it. The aim was to establish whether such a relationship could provide immediate 
support to officers, to narrow the range of suspects possibly still present near the 
scene. 
 
The final working chapter, Chapter 5: The Effect of Fingermark Development on 
Subsequent Analytical Testing continued the idea of obtaining further information 
from a fingermark. Whilst analytical testing, particularly mass spectrometry is well 
documented to ascertain compounds that the individual ingested or touched prior 
to depositing the fingermark, often the effect of classic development techniques 
on these analytical techniques is unknown. This chapter investigated the effect 
of cyanoacrylate fuming on the ability to detect drugs present on a fingermark via 
LCMS.  
 
This thesis aims to explain the research undertaken throughout this PhD, all 
utilising or investigating how physiological aspects of an individual or their 
fingermarks specifically could improve how fingermarks are found and analysed. 
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2 Dark Adaptation 
 
This initial chapter outlines the work performed assessing the importance of dark 
adaptation for crime scene officers. The effectiveness of the Crime-lite Eye as a 
dark adaptation checker was investigated alongside the use of a standard inkjet 
printer for the production of standard fluorescent marks. 
 
 Literature Review 
 
The following literature review aims to introduce the reader to dark adaptation 
variability, and the need for dark adaptation by crime scene officers. Current 
methods for monitoring dark adaptation are explained, and the process of 
obtaining standardised amino acid marks is investigated. 
 
2.1.1 Variation in Dark Adaptation Ability 
 
As outlined in Section 1.6, whilst everyone goes through the same process of 
dark adaptation, there are differences in the time taken to adapt, and the level of 
dark adaptation that is obtainable. Light adaptation is very rapid compared to dark 
adaptation, taking only minutes.48 Whilst time taken to dark adapt varies naturally 
between individuals, certain aspects can influence dark adaptation ability. Age 
has been shown to affect dark adaptation, older adults require significantly more 
time to fully dark adapt than younger adults.78 This increase in time taken to adjust 
to darkness with increasing age has been shown to occur through both stages of 
cone and rod mediated dark adaptation.78,79 However, despite previous 
contradictory evidence, M. Rowe found that gender does not affect dark 
adaptation.80 
 
Alongside physiological differences, differences in environment can affect the 
time taken to dark adapt. Hecht et al found that the intensity of light adaptation 
that precedes the dark adaptation changes the time taken to subsequently dark 
adapt.54 Specifically it was found that pre-adaptation with intensities below 200 
photons, was only followed by rod adaptation, whereas pre-adaptation intensities 
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of above 4000 photons required both cone and rod dark adaptation, slowing the 
whole process.54 It was suggested that whilst the physiological process of dark 
adaptation is the same independent of the light intensity observed prior to dark 
adapting, that it is technically a different phenomenon, as shown by the lack of 
need for cone adaptation when adapting from only dim light.54 
 
Whilst much of the literature on dark adaptation focuses on dark adapting to 
absolute threshold, the need for dark adaptation generally only requires that a 
certain level is obtained to visualise something in the dark to the best possible 
ability. This is true for particular individuals with certain professions, such as 
astronomers, and crime scene officers looking for, or analysing evidence in the 
dark. 
 
2.1.2 Dark Adaptation for Crime Scene Officers 
 
As outlined in Section 1.6.3, forensic crime scene officers are often required to 
look for evidence in the dark, using various light sources. For these investigations 
it is recommended that the investigator should be fully dark adapted,32 to avoid 
the possibility of missing evidence. Fully dark adapting also allows investigators 
to accurately judge fluorescent evidence, and determine whether it is worth 
investigating further.9,81 
 
The dark adaptation process is poorly standardised across the forensic science 
discipline, with little evidence regarding the benefits of such preparative steps.  If 
the process of dark adaptation is critical to finding all evidence available, it is 
crucial that those looking for evidence are appropriately dark adapted. However, 
with so many variables affecting the time taken for the specific individual to have 
achieved dark adaptation, it is difficult to establish when an individual has been 
in the dark long enough, without waiting too long and wasting valuable 
investigation time. It is also often the case that investigators must leave the 
darkened area, meaning they lose their current level of dark adaptation. Red 
goggles have been used previously to allow investigators to maintain some level 
of dark adaptation when leaving a darkened area, along with beginning to dark 
adapt the wearer before entering the dark.50.  
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2.1.3 Assessing Dark Adaptation 
 
Whilst there is much research into the mechanisms, and the biochemical 
processes associated with dark adaptation,49 as previously mentioned the 
process is not fully understood. It is known that percentage of rhodopsin 
increases as the eyes dark adapt.49 A method was developed by Rushton et al, 
which allowed the amount of rhodopsin to be measured in a living mammalian 
eye. This method was used to confirm that when dark adapted, the eyes absorb 
much more light, confirming a high presence of rhodopsin when eyes are dark 
adapting.49,82 Later research conducted measuring or monitoring dark adaptation 
has used various field analysers.83 Jackson et al utilised a Humphrey Field 
Analyser (HFA) to measure dark adaptation functions in relation to aging.79 Whilst 
Stordy used a Friedmann Visual Field Analyser 2 when investigating a link 
between dark adaptation and dyslexia.84 More recently the Portable Field Dark 
Adaptometer (PFDA) has been developed and tested as a method to monitor 
dark adaptation.85 Whilst the PFDA has shown to perform as a reliable tool for 
measuring dark adaptation, it still requires the user to wear a headset, bleaching 
the eyes with a retinal flash and then videoing the pupillary responses using an 
infrared camera.85 These videos then need to be analysed to gain usable 
information on dark adaptation. Whilst this device has proved useful, it would be 
far too time consuming and require too much processing to be used regularly. 
 
2.1.4 Dark Adaptation Readiness Kit  
 
The Dark Adaptation Readiness Kit (DARK) was developed by CAST whilst 
investigating the necessity for forensic investigators to dark adapt their eyes prior 
to looking for evidence in the dark.50 It offers two modes, depending on the type 
of fluorescent examination the user is currently undertaking. LEDs in the shape 
of a cross gradually grow brighter in intensity from 1 to 99 % over a 30 second 
period. The user presses start, then when they are able to visualise the cross, 
they press stop and the readout indicates the percentage intensity they were able 
to visualise. The lower the percentage intensity, the more dark adapted the 
individual is. Whilst this device is not currently available commercially, a similar 
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device developed and commercialised for forensic investigators is the Crime-lite 
Eye™. 
 
2.1.5 The Crime-lite Eye™ 
 
The Crime-lite Eye is a darkness adaptation checker developed by Foster and 
Freeman to give investigators a way to establish what level of dark adaptation 
they have reached. Whilst the DARK offers two modes, blue or red, and tells you 
the intensity of light you are able to visualise, the Crime-lite Eye offers a LED 
numerical display, where the lower the number seen, the more dark adapted the 
individual is. However, so far the effectiveness of using a dark adaptation checker 
has not been evaluated, along with other benefits, such as the ability to determine 
useful marks that should be processed for further examination. The use of the 
Crime-lite Eye is explained fully in Section 2.3.3, and this device was used 
throughout the participant study, and into further research. 
 
2.1.6 Differences in Latent Fingermark Composition  
 
As outlined in Section 1.2.3, there are many different components in fingermark 
residue, and the component mixture will vary between each fingermark, even 
from the same finger. Due to this variation, getting consistent latent fingermarks, 
even from the same donor is almost impossible due to both the variance in the 
components of a latent fingermark and the distribution of sweat deposited when 
the fingermark is left. 
 
2.1.7 Inkjet Printing Amino Acids 
 
This problem of inconsistency between fingermark residue leads to variance in 
the development of the fingermark in order to visualise and analyse. This 
inconsistency makes testing current and new fingermark development 
techniques difficult. In order to evaluate a fingermark development technique, 
tests must be repeated and then analysed statistically to ascertain the actual 
results, which can be both impractical and time consuming.29 To overcome this 
inconsistency, a procedure has been described using an inkjet printer, filled with 
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an artificial fingerprint sweat solution, to print artificial test fingermarks. The first 
artificial fingermarks printed using an inkjet printer used a solution of amino acids 
and sodium chloride.29 Since this, other researchers have attempted to optimise 
the printing method along with making the composition used closer to natural 
fingerprint sweat.86,87 This method of printing amino acids to use as artificial 
fingermarks allows development reagents that react with amino acids to be 
evaluated consistently. However the surfaces that can be printed onto are 
currently limited to paper, or similar surfaces that can fit into an inkjet printer, 
meaning reagents that work on non-porous surfaces cannot be evaluated in the 
same way. Similarly reagents that rely on a different component to amino acids 
in fingermark residue that cannot be as easily printed, would be difficult to mimic, 
such as ethyl cyanoacrylate which requires a base to initiate the polymerisation 
reaction,20 as explained in Section 1.4.2. It is acknowledged, that as useful as 
printing artificial fingerprints is, that it could never fully replace the need for real 
fingermarks and case studies. 
 
Using an inkjet printer to print amino acids, which can then be developed using 
standard fingerprinting techniques, also allows for intricate recognisable patterns 
to be printed and detected as if they were fingerprints. 
 
 Aims and Objectives 
 
Use of an inkjet printer to print amino acid solutions has been established as a 
method to obtain consistent pseudo fingerprints for research into development 
techniques. However, the following work utilised the method of printing amino 
acids to ascertain if consistent fluorescent marks that were easily identifiable to 
participants could be produced. Simultaneously, whether this method of printing 
amino acids could be performed using any available inkjet printer was tested. 
 
The study outlined below aimed to assess the importance of dark adapting prior 
to looking for fluorescent evidence in the dark. This study will also assess the 
effectiveness of the Crime-lite Eye, a darkness adaptation device developed to 
assist forensic practitioners both in the laboratory and in field. The method 
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development and route taken to reach the aims of this research are outlined 
below in Figure 16. The way this is structured reflects the order of work 
undertaken throughout this part of the research. 
 
 
 
 
 
 
 
 
 
 
Inkjet
Printing
• Adapting a standard inkjet printer to print amino acid 
solutions.
• Selecting an appropriate amino acid solution.
• Choosing a suitable fingermark development reagent.
• Optimising the process.
Fluorescence 
Spectroscopy
• Quantifying the fluroescence intensity produced by different 
concentrations of amino acid solutions.
Participant 
Study
• Using the optimal methods for inkjet printing amino acids.
• Developing a study exploring the importance of dark 
adaptation for forensic examiners.
• Integrating the Crime-lite Eye within the study in order to 
assess its effectiveness.
• Assessing the outcome of these results with regards to 
forensic examiners.
Figure 16 – A schematic outlining the route taken to fulfil the aims and objectives 
of this chapter.  
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 Experimental 
 
This section outlines the generic experimental methods that were used 
throughout this chapter. Method development and any variations in concentration 
are outlined in specific sections as necessary.  
 
2.3.1 Inkjet printing amino acids 
 
An Epson Stylus Photo R265 inkjet printer was used for all inkjet printing of amino 
acids. Prior to use printing amino acids, all ink was removed from the printer, and 
the print heads cleaned with deionised water. 4 mM solutions of L-alanine (Sigma 
Aldrich) and L-glycine (Sigma Aldrich) were prepared in deionised water. The 
4mM solution of alanine was diluted to produce 0.4 mM, 0.04 mM and 0.004 mM 
solutions of alanine in deionised water. Empty ink cartridges, shown in Figure 17, 
were purchased for an Epson Stylus Photo R265 inkjet printer and were washed 
with deionised water prior to use. The black, cyan and magenta ink cartridges 
were filled with 0.4 mM, 0.04 mM and 0.004 mM alanine solution, respectively. 
To print each respective concentration, any shapes, letters and patterns were set 
to the RGB values shown in Table 5. 
 
 
Figure 17 – The empty black, magenta and cyan ink cartridges purchased for 
use with the Epson Stylus Photo R265. 
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Table 5 – The RGB code corresponding to each coloured cartridge and 
respective alanine concentration. 
Colour seen on screen Alanine concentration (mM) R, G, B code 
Black 0.4 0, 0, 0 
Magenta 0.04 255, 0, 255 
Cyan 0.004 0, 255, 255 
 
2.3.2 Fingermark development 
 
1,8-Diazafluoren-9-one (DFO) (WA Products, 0.1 g) was added to a solution of 
petroleum ether (Sigma Aldrich, 156 ml), acetic acid (VWR, 4 ml), ethyl acetate 
(Fisher Scientific, 20 ml) and methanol (VWR, 20 ml) and stirred until all DFO had 
dissolved. To develop paper sheets containing either latent fingermarks or inkjet 
printed amino acids, a small amount of DFO solution was poured into a dipping 
tray. The paper was then dipped into the tray using tweezers for approximately 5 
sec. The paper sheet was then left to air dry, prior to drying in an oven for 20 mins 
at 100 °C. DFO developed paper samples were viewed under green light 
excitation using the Crimelite 2 (490-560 nm) through a red Schott glass filter 
(OG590, orange glass, showing wavelengths above 590 nm). 
 
Ninhydrin (Sigma Aldrich, 0.8 g) was added to a solution of petroleum ether 
(Sigma Aldrich, 180 ml), ethyl acetate (Fisher Scientific, 14 ml), acetic acid (VWR, 
2 ml) and methanol (VWR, 4 ml). This solution was optimised by Lennard and 
Mazella.88 A ‘humidity chamber’ was set up comprising a tub with fully closable 
lid (safe to 100 °C) containing a beaker with a solution of water (50 ml) with 
sodium chloride (18 g) added to saturation. This was placed within an oven at 
100 °C and left to acclimatise for at least one hour. Ninhydrin solution was 
transferred to a dipping tray and paper samples were dipped into the solution fully 
for approximately 5 seconds. The paper was then left to air dry, before being 
moved and placed within the humidity chamber within the oven for 20 mins. 
Samples were photographed under white light. 
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1,2-indanedione (1,2-ind) (BVDA, 0.05 g) was added to ethanol (Fisher Scientific, 
100 ml). 1,2-ind solution was poured into a dipping tray, and paper samples were 
dipped into the solution for approximately 5 sec. The sheets were left to air dry, 
and then moved to an oven at 100°C for 20 mins. 
 
2.3.3 The Crime-lite Eye™ 
 
The Crime-lite Eye™ uses a LED display that decreases in both numerical value 
as well as optical intensity from 20 to 1. As illustrated in Figure 18, the number 
20 appears relatively bright (when in a darkened environment with a degree of 
dark adaptation) with a gradual decrease in intensity to a very dim number 1. The 
display switches off after a few minutes of no interaction, so users are 
encouraged to continuously move up and down through the numbers to establish 
which numbers are visible to them. As each person’s eyes adapt to the dark at a 
slightly different rate and to a different endpoint, using such a device allows an 
adequate and repeatable level of dark adaptation to be achieved. 
 
Whilst it is recommended that crime scene investigators dark adapt prior to 
examination,32 there is currently no standardised way or level of dark adaptation 
that must be reached. The Crime-lite Eye has been proposed as a method to 
standardise dark adaptation along with allowing users to understand when and 
how dark adapted they are. 
 
 
Figure 18 - The Crime-lite Eye™ showing a schematic representation of the 
dimming display as would be perceived during dark adaptation. 
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 Results and Discussion 
 
2.4.1 Printing Amino Acids 
 
As outlined in Section 2.1.7, inkjet printers have been used to print amino acid 
solutions in order to obtain reproducible consistent fingerprints for research 
uses.29 To assess an individual’s dark adaptation it was decided that a similar 
consistent fluorescent mark would be needed. If participants were simply asked 
to count fingerprints in the dark, it is impossible to know whether they are simply 
counting the same fingerprint multiple times, or if they have missed one that they 
assumed they had counted. Instead clear and easily recognisable shapes were 
needed, which could be achieved using the suggested method of inkjet printing 
amino acids.  
 
A standard Epson Stylus Photo R265 inkjet printer was available, and was used, 
as outlined in Section 2.3.1, to assess whether these recognisable shapes could 
be achieved without any other equipment. 
 
5 drops of 4 mM L-alanine and 5 drops of L-glycine were placed onto a white 
piece of copier paper and standard lined paper. A control sheet of paper was also 
prepared with 5 drops of deionised water. Each sheet was developed using DFO 
solution. After this treatment, fluorescence under green light excitation (490-560 
nm) through a red filter was seen from all amino acid samples, shown in Figure 
19. The control sample, showed no fluorescence under green light excitation.  
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Whilst fluorescence could be seen from both the glycine and alanine samples, at 
both 4 mM and 0.4 mM concentrations, it was decided that alanine would be used 
in the inkjet printer. The alanine samples appeared slightly brighter, as seen in 
Figure 19, and whilst alanine is found in lower concentrations in fingermark 
residue compared to glycine, it is still found at a ratio of 22-35 % to serine as 
shown in Section 1.2.4. Also, studies have been published previously, specifically 
analysing the reaction between DFO and the particular amino acid, L-alanine.44  
 
To compare the differences in fluorescent intensity of different concentrations of 
alanine, a sheet was printed consisting of shapes and letters. The shapes and 
letters were printed using all three dilutions of alanine, 0.4, 0.04 and 0.004 mM. 
This sheet is shown in Figure 20. The black shapes appear brightest as expected 
due them being printed in the highest concentration of alanine. As little difference 
was seen between the cyan and magenta shapes, it was decided that black (0.4 
mM) and magenta (0.004 mM) would be used throughout the study. Throughout 
the study, the 0.4 mM solution was referred to as A1 solution, and 0.004 mM as 
A2 solution. 
 
 
Figure 19 – Spots of (A) alanine and (G) glycine, at (1) 4 mM concentration on 
plain paper, (2) 0.4 mM concentration on plain paper and (3) 0.4 mM 
concentration on lined paper, developed using DFO and photographed under 
green light excitation (490-560 nm) with an OG590 camera filter. 
(A1) (A2) (A3) 
(G1) (G2) (G3) 
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As fingerprints possess very fine and intricate detail, it was important to establish 
whether the inkjet printer could mimic somewhat fine detail. A sheet was printed 
using A1 solution, consisting of letters printed in font Arial, in sizes 40 down to 7. 
This sheet is shown in Figure 21. As the sheets were legible down to font size 7, 
a second sheet of letters was printed in A1 solution showing font sizes 6 -1; this 
is shown in Figure 22. 
 
 
 
B B B 
Figure 20 – The shapes and letters printed in 0.4, 0.04 and 0.004 mM alanine 
solutions corresponding to the black, cyan and magenta shapes, respectively 
and the corresponding print out developed using DFO shown photographed 
under green light excitation (490-560 nm) with an OG590 camera filter. 
Figure 21 – Letters in Arial font sizes 40 - 7 printed in 0.4 mM alanine and 
developed using DFO, shown photographed under green light excitation (490-
560 nm) with an OG590 camera filter. 
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As shown in Figure 22, the letters printed in font size 6 and 5 are legible, however,  
below this range, the letters lose definition and appear blurred together. However, 
the text shown in Figure 22 emphasises how small this font size is. The inkjet 
printer used is optimised to print ink and not amino acids; it is likely that the amino 
acid solutions used have a different viscosity to the usual ink used so the printer 
may be unable to print such fine detail in these amino acid solutions. However, 
this has shown that somewhat fine detail can be achieved using only a standard 
inkjet printer.  
 
Whilst DFO had been used to develop all tests sheets so far, 1,2-indanedione 
(1,2-ind), another amino acid reagent, similar to ninhydrin but which produces a 
fluorescent product was tested, to ascertain if this should be used alongside, or 
instead of DFO to produce the fluorescent marks. A test sheet was printed using 
A1 solution, containing two groups of patterns, shapes and letters to each fill 
approximately 1/8th of a sheet of A4, shown in Figure 23. These small test sheets 
were printed and developed using either DFO or 1,2-ind, to compare the two 
fluorescent fingerprint development techniques. This allowed the determination 
of which development reagent would offer the best and most consistent 
fluorescence over time.  
 
Figure 22 – Letters in Arial font sizes 6 - 1 (A) printed in 0.4 mM alanine and 
developed using DFO, shown photographed under green light excitation (490-
560 nm) with an OG590 camera filter and (B) shown as text. 
ABCDEFGHIJKLMNOPQRSTUVWXYZ 
 
ABCDEFGHIJKLMNOPQRSTUVWXYZ 
 
 
ABCDEFGHIJKLMNOPQRSTUVWXYZ 
 
ABCDEFGHIJKLMNOPQRSTUVWXYZ 
 
 
ABCDEFGHIJKLMNOPQRSTUVWXYZ 
 
ABCD EFGH IJKLMNOPQR STU VWXYZ  
 
(A) (B) 
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Whilst no visible pale pink colouring of the developed shapes and letters was 
visible to the naked eye, narrowband green (480-560 nm) excitation using a 
Crime-lite 2 (foster+freeman) and viewing through an orange/red interference 
filter (OG590) induced strong fluorescence. Samples were photographed 
immediately after removal from the oven, after 4 hrs, daily for 4 days and then 
once more after 7 days total.  
 
The photographs taken of the sheets printed in A1 and developed using either 
DFO or 1,2-Indanedione are shown below in Figure 24. An increase in 
fluorescence intensity can already be seen between the first photo, taken 
immediately after development with 1,2-ind, and the photograph taken 4 hrs later; 
and the difference in fluorescence intensity continues to increase through to the 
3rd day. The photographs taken of the sheets developed with DFO however, show 
better consistency as the fluorescence intensity observed immediately after 
development did not change over the seven days. This was repeated a week later 
and the same result was seen. From these results, it was decided that DFO would 
be used to develop the test sheets used in the participant study to ensure 
consistency of fluorescence between participants and between the two viewings 
by each participant. As DFO is currently a Category A process, compared to 1,2-
ind which is a Category B process15 its use also ensures that the fluorescence 
used in the study is realistic of fingerprints developed from a crime scene. 
However, as stated in Section 1.4.3, 1,2-ind has recently been evaluated for 
casework, including pseudo operational trials,42 and has shown to have benefits 
Figure 23 - Two test sheets printed in black (0.4 mM alanine) to each fill 
approximately 1/8th of a sheet of A4. 
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over both ninhydrin and DFO. The inconsistent results shown here, may be due 
to the very basic formula of 1,2-ind used, containing only ethanol, which is not 
the optimal solution for this development reagent on paper.40 However, as the 
results produced here showed a higher level of consistency in fluorescence 
intensity between samples on different days when using DFO compared to 1,2-
Ind, it was decided that DFO would be used exclusively to produce fluorescent 
marks continuing through the study.  
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2.4.2 Fluorescence Spectroscopy  
 
In order to quantify the fluorescence exhibited by two different concentrations of 
alanine used (A1 and A2), the possibility of using a fluorimeter to measure the 
fluorescence on the paper samples was investigated. 
 
A wireframe square and a solid rectangle of A1 and A2 alanine solutions were 
printed using the Epson Stylus Photo R265 printer. These shapes are shown in 
Figure 25. These printouts were developed via dipping in a tray of DFO solution, 
being left to air dry, and then moved to an oven to dry at 100 °C for 20 mins. Both 
developed squares were wrapped around a glass slide to be placed in an 
Edinburgh Instruments FLSP920 fluorescence spectrometer. Fluorescence 
emission was measured at an excitation wavelength of 375 nm. A plain section 
of the copy paper (without any printed alanine), but treated with DFO, was also 
wrapped around a slide and the fluorescence emission measured, along with an 
entirely untouched plain piece of copier paper. The fluorescence emission 
spectra for these four paper samples are shown in Figure 26.  
 
These spectra were smoothed using the Savitzky-Golay method to 10 points of 
window. The fluorescence of A1 (black) was more intense than the A2 (magenta). 
It was also noted that developing with DFO solution decreased the inherent 
fluorescence intensity of plain paper.  
 
The excitation wavelength used (375 nm) is not the usual excitation of DFO 
developed marks, DFO is known to have very close excitation and emission 
maxima at approximately 555 and 560 nm, respectively.20 This suggests that the 
fluorescence measured wasn’t purely of DFO, but of the fluorescence naturally 
associated with paper.  
 
In order to attempt to measure the fluorescence of the DFO developed alanine 
samples, filter paper was used in place of copier paper. 
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Figure 26 - Emission scan of A1 (▬) and A2 (▬) on paper developed in DFO, a 
section of paper without alanine developed in DFO (▬) and plain paper (▬). 
Using an excitation wavelength of 375 nm, the emission spectra from 400 nm to 
750 nm was obtained. 
(A) 
(B) 
A1 A2 
Figure 25 - The solid rectangle and wireframe square printed in A1 and A2 
shown (A) under green light excitation (490-560 nm) with an OG590 camera 
filter and (B) on screen before printing. 
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A1 alanine solution was pipetted onto filter paper and allowed to dry. This filter 
paper was then developed using by dipping the filter paper sample into a tray of 
DFO solution, leaving it to air dry, and then moving it to an oven to dry at 100 °C 
for 20 mins. This filter paper sample was placed in an Spex FluoroMax 
fluorescence spectrometer. Fluorescence emission was measured at an 
excitation wavelength of 466 nm. The fluorescence emission spectrum is shown 
in Figure 27. 
 
Whilst the peak emission wavelength of the DFO on filter paper (575 nm) was 
much closer to the reported emission maxima of fluorescent DFO (560 nm) the 
excitation wavelength used was 466 nm, not the 555 nm quoted as the excitation 
wavelength for DFO.20 As the fluorescence measured was not that specifically of 
DFO, it was decided that further measurements of A2 solution on filter paper 
would not be taken. 
 
 
Figure 27 – The emission spectra of A1 solution on filter paper developed in 
DFO. Using an excitation wavelength of 466 nm, the emission spectra from 500 
nm to 700 nm was obtained. 
 
As both fluorimeters used are designed to hold liquid samples within a cuvette, 
and the samples measured above were both on different types on paper, it is 
likely that the fluorescence exhibited was not optimal due to the setup of the 
0
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fluorimeter. It is also likely that whilst the filter paper didn’t affect the fluorescence 
as much as seen with the copier paper, that it still had an effect on the 
fluorescence exhibited. Whilst it would have been reassuring to ascertain the 
difference between the fluorescence of A1 and A2 solutions developed with DFO, 
specifically if the fluorescence was approximately 100 times less intense, 
matching the difference in concentration; it can be confirmed visually that the 
fluorescence of the shapes printed in A2 solution and developed using DFO is 
lesser than those printed in A1 solution. This is emphasised later in Figure 29. 
 
2.4.3 Participant Study 
 
Ethical approval was obtained from the Ethics Approvals (Human Participants) 
Sub-Committee at Loughborough University for the study ‘Using a Crime-lite Eye 
for dark adaptation’ with the reference number C16-105. 
 
Two A4 sheets of copier paper were printed using the black and magenta 
cartridges, the shapes, letters and patterns printed are shown in Figure 28. In 
addition to printing patterns in two different concentrations of alanine, the 
‘transparency’ of some shapes was also altered on screen. The change in 
transparency did not affect the concentration of alanine that was printed, as the 
concentration remained constant within each ink cartridge; it instead modified the 
amount of alanine deposited onto the paper by the printer. This was done with 
the intention to use the variable transparency printing method to mimic how 
fingermarks are deposited in ‘real-world’ scenarios, where some marks may be 
heavy and others quite light in both contact force and secretion level. The shapes 
printed at 75% transparency appear grey and pale pink on screen (depending on 
which concentration was used), compared to the ‘standard’ shapes (0% 
transparency), which appear black, as illustrated in Table 6 and Figure 28. 
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Table 6 – The differences in concentration and transparency of the printed 
shapes, letters and patterns. 
Alanine 
Solution 
Concentration Transparency Colour seen 
on screen 
A1 0.4 mM 0% ● 
A1 0.4 mM 75% ● 
A2 0.004 mM 0% ● 
A2 0.004 mM 75% ● 
 
 
Each sheet was developed using DFO, as outlined in Section 2.3.2. Whilst no 
visible pale pink colouring of the shapes and letters was visible to the naked eye, 
narrowband green (480-560 nm) excitation using a Crime-lite 2 (foster+freeman) 
and viewing through an orange/red interference filter (OG590) induced strong 
fluorescence. The brightness of the fluorescence varied between the two 
concentrations of alanine that were used and also between the 0% and 75% 
printing transparency values. 
 
The printed patterns that were developed with DFO provided good contrast 
against the substrate background. Several of the patterns printed and used within 
the study are shown in Figure 29. The fluorescence of the patterns printed in A1 
Page 1 Page 2 
Figure 28 - The patterns printed on two sheets of A4 copier paper, showing 
shapes, letters and patterns printed in A1 at 0% (●), or 75 % transparency (●) 
and A2 at 0 % (●) or 75 % transparency (●). 
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was more intense than the fluorescence of the patterns printed in A2, as shown 
below in Figure 29, comparing for example, the letters ‘S’ and ‘B’. A decrease in 
fluorescence intensity can also be seen between the shapes printed at 0% and 
75% transparency.  
 
 
   
    
    
    
Figure 29 - Several of the patterns printed using alanine, shown after 
development with DFO and on screen pre-printing. 
B 
S 
 
% 
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The shapes, letters and patterns were printed in alanine solution, whereas natural 
fingermarks are composed of a mixture of several amino acids along with other 
compounds.16 It is for this reason that previous research using a printer to print 
artificial fingerprints has focussed on perfecting the solution used.29,86,87 For this 
study however, whilst it was important that the printed patterns mimicked 
fingermarks, it was also vital that there was consistent fluorescence seen overall. 
It was for this reason that alanine solution was chosen. Alanine is known to be 
one of the most prominent amino acids present in fingermark residue,18 and, as 
shown in Figure 7, it is the amine group of the amino acid which reacts with DFO 
to produce the fluorescent compound observed. The developed fingermark 
shown above in Figure 30 shows an example of the level of fluorescence 
observed, however, this can vary between donors due to the inconsistencies 
between the composition of the donor’s sweat. Despite this, the level of 
fluorescence shown by the developed fingerprint is comparable to the 
fluorescence shown by the printed alanine which was developed using DFO and 
shown in Figure 29. 
 
50 participants (31 males, 19 females) were recruited. A participant information 
sheet, an informed consent form and a form acknowledging that the participant 
had been shown how to use the crime lite 2 were each completed before the 
study could begin, these are all shown in the appendix (pages I-L). A 
Figure 30 - An example of a fingermark developed using DFO. 
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confectionary bar and a pen were offered as incentive for participating. All 
participants were over 18 years of age and were required to complete a short 
questionnaire concerning their eyesight (appendix, page M) to ascertain if 
participants who required them would be wearing glasses during the study. 
Participants were asked to sit in a darkroom, wearing orange/red filtered goggles 
(OG590) and using a green Crime-lite 2 (480-560 nm), they were asked to speak 
out loud the letters, shapes and patterns that were visible to them on the two 
sheets of A4 paper (Figure 28). A dictaphone was placed inside the darkroom to 
record the observations from each participant. Participants were instructed to 
look over the sheets fully once. Whilst in the dark room, participants were asked 
to remain in their chair, mainly to avoid the risk of injury in the dark, however, they 
were free to lean as close to the two A4 sheets as they wished. The participants 
were also holding the Crimelite 2, so were able to move the light source as close 
to the A4 sheets as they wished. The two A4 sheets were stuck to the wall one 
on top of the other, directly in front of the participants. The dark room set-up is 
shown in Figure 31. The room contained no windows, and the underside of the 
door was blocked to avoid excess light entering the room. However, the room 
was not completely blacked out, and a very small amount of light, for example 
from the gaps at the side of doors, was able to enter. This was intentional, as a 
dark room at a laboratory, or a room converted to a dark room at a crime scene 
is unlikely to be perfectly blacked out, and this set up aimed to mimic this 
scenario. 
 
Once completed, participants were asked to leave the darkroom and let their eyes 
adapt to a fully lit environment, during which time an explanation into the use of 
the Crime-lite Eye was provided. It was ensured that all participants were out of 
the room for approximately the same length of time, however, as light adaptation 
is very quick compared to dark adaptation, participants eyes would be re-light 
adapted fully after 3 mins.48 
 
Participants were asked to re-enter the darkroom and use the Crime-lite Eye to 
reach a level of dark adaptation, which was recorded via the Dictaphone 
previously mentioned. As explained in Section 2.1.1, each person’s eyes are 
different and therefore able to reach a different level of dark adaptation, and in 
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turn a different number on the Crime-Lite Eye™; however, participants were 
encouraged to reach the lowest number they thought possible. Once the 
participant was dark adapted, they used the Crime-lite 2 (480-560 nm) and 
orange/red filtered goggles (OG590) to examine the A4 sheets again, with their 
observations being recorded via dictaphone.  
 
 
Figure 31 – The environmental set-up of the dark room, showing the position of 
the participant and the A4 sheets containing alanine printed, DFO developed 
shapes, letters and patterns. 
 
 
Participants waited an average of 10 mins to dark adapt their eyes and most 
participants reached the number 5 on the Crime-lite Eye. The full results, showing 
the time waited by each participant, and the number reached on the Crime-lite 
Eye is shown in Table 25 in the Appendix (page C). Of the 50 participants, 3 
participants saw no change in amount of shapes, letters and patterns visible pre- 
and post-dark adaptation, 1 participant saw a decrease of 2% in amount of 
shapes, letters and patterns seen post-dark adaptation, however, the other 46 
participants all saw an increase in number and clarity of fluorescent features 
visible to them. Participants could see an average of 16% more evidence 
following dark adaptation, as shown in Figure 32. The full results of each 
participant are shown in Table 26 and Table 27 in the Appendix (pages D and E). 
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Figure 32 – The overall average percentage of shapes, patterns and letters 
seen by participants, pre- and post-dark adaptation. 
 
 
The different marks visualised by the participants were analysed and it was 
noticed that whilst each participant could see a different number of patterns, some 
shapes were easy to see compared to others which very few participants saw. 
For example, the spiral motif shown in Figure 28 and Figure 29 was seen by every 
participant, this was likely due to it being a large, basic and well-recognisable 
pattern that was positioned in a reasonably central location on the printed sheets. 
The spiral was also one of the patterns printed in A1 solution, so produced a 
higher fluorescent intensity compared to the A2 solution and the shapes printed 
at 75% transparency. There were two shapes that were not seen by any 
participant: the lightning bolt and the single left facing arrow. Both of these shapes 
were printed in A2 solution at 75% transparency, suggesting that this 
concentration and transparency combination was almost too faint to visualise. 
However some participants could see other shapes printed in A2 solution at 75% 
transparency, but only when they were part of a set of concentric shapes, such 
as the concentric squares shown in Figure 28 and Figure 29. This suggests that 
the faintest marks were visible when the participant knew where to look, such as 
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when the mark was part of a concentric shape, however the weakly fluorescent 
shapes by themselves were not found as the participants didn’t know where to 
look. 
 
All letters were printed at 0% transparency, and most were visualised by the 
majority of participants. The average percentage of letters seen following dark 
adaptation was 75%, significantly higher than the percentage of overall marks 
seen following dark adaptation. Whilst several different letters were printed in A2 
solution, the letter ‘K’ was only seen by one participant. Participants generally 
saw less of the marks printed in A2 solution than the marks printed in A1 solution, 
however, the average percentage increase in marks seen following dark 
adaptation was 10% for both the marks printed in A1 solution and A2 solution. 
The average percentage of all marks seen by participants separated by solution 
concentration is shown in Figure 33. 
 
 
Figure 33 – The average percentage of shapes, patterns and letters seen by 
participants pre-and post-dark adaptation, separated by concentration of 
alanine. 
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Figure 33 illustrates that the increased number of fluorescent features observed 
by participants is consistent between those printed in A1 and A2 solutions. These 
observations suggest that the time taken by participants to dark adapt helped 
increase their ability to find and accurately record more fluorescent evidence, 
independent of the fluorescent output intensity of the subject matter. This is 
echoed by the overall increase in fluorescent shapes, patterns and letters seen 
by participants, as shown in Figure 32. This increase in ability to find not only 
more fluorescent marks, but also to find weaker marks, is of particular 
significance to forensic examiners, as it is often the weaker fluorescent evidence 
(fingermarks, body fluid stains, fibres, etc) that would be more likely missed.  
 
Concentric shapes were used in the printed design as an attempt to mimic fine 
fingerprint ridge detail, as it is these ridges and minutiae that are required for 
identification. Participants could see 16% more shapes, letters and patterns after 
dark adaptation, but separating the results found for the different fluorescent 
marks, participants were specifically able to see 21% more shapes after dark 
adaptation. This is due to an increase in not only amount of different shapes seen, 
but also in the number of concentric shapes counted. Looking specifically at an 
increase in concentric shapes seen by participants, participants on average saw 
19% more shapes within each other following dark adaptation, the equivalent of 
finding 3 further concentric shapes of the 17 visible. This indicates that 
participants could more accurately count the ‘ridges’ once dark adapted. 
 
Without dark adaptation, several participants mistook the letter ‘B’ for the number 
‘8’, but every participant that mistook this letter initially, read it as the letter ‘B’ 
when viewing it following dark adaptation. One participant initially described this 
feature as looking “like an 8” when they were not dark adapted. Following dark 
adaptation, however, the same participant described the fluorescent feature as 
“clearly a B now, not an 8”. Several other statements taken from the participant 
recordings are shown in Table 7, including when a correction was made, but also 
when participants were aware that more was visible to them compared to their 
initial viewing. This increase in accuracy, when dark adapted, is also vital to crime 
scene officers, as the ability to accurately identify evidence types is core to their 
role. The increase in accuracy also matches the conclusions already drawn 
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suggesting that participants could see more concentric shapes once dark 
adapted, as they could distinctly visualise multiple shapes, rather than blurring 
them into only one legible shape. This again indicates that fine fingerprint details 
could be more accurately seen and counted after dark adaptation. 
 
Table 7 - Statements taken from participant post-dark adaptation recordings. 
Participant 
Number 
Comments made 
4 “it’s clearly a B now, it’s not an 8” 
9 “missed lots the first time” 
18 
“that’s a H not an N” 
“definite improvement” 
20 
“that’s definitely a question mark and that’s definitely a 
pencil” 
30 “seems brighter” 
48 “significantly clearer” 
 
Only one participant said that they felt that the fluorescence was “less clear” when 
dark adapted, however, when reviewing which fluorescent features were visible 
to them before and after dark adaptation, they saw 2 % more post-dark 
adaptation, which whilst lower than the average increase across all participants, 
was not a detrimental result as may have been implied from the participant’s 
comments. 
 
2.4.4 Ruhemann Sample 
 
To test the ninhydrin development of amino acid printed shapes, alongside testing 
how well intricate patterns could be printed, a picture of Siegfried Ruhemann, the 
namesake of Ruhemann’s purple was printed using the A2 alanine solution. This 
sheet of paper was developed using ninhydrin solution, as outlined in Section 
2.3.2. The resulting picture of Siegfried Ruhemann was visible under white light, 
due to the formation of Ruhemann’s purple, the product formed from the reaction 
of amino acids with ninhydrin. This image is shown in Figure 34. This shows that 
alongside simple patterns, letters and shapes, complex and detailed patterns can 
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be printed in amino acid solutions without a specialist printer and once developed 
with a suitable fingermark development reagent, are recognisable. 
Figure 34 – An image of Siegfried Ruhemann printed in 0.4 mM alanine and 
developed using ninhydrin. 
 
 Conclusions and Future Work 
 
The use of an inkjet printer to print amino acids, whilst not a new technique, was 
shown in this study to be useful in creating shapes that could be developed using 
fluorescent fingerprint reagents, creating a standardised fluorescent pattern. 
Whilst the amino acid alanine, used in this study to mimic fingerprint sweat, was 
not a perfect example of natural fingerprint sweat, a much more complicated 
mixture, the strong fluorescent or coloured product produced when using DFO, 
ninhydrin and 1,2-ind confirms that it is the amino acids present in the fingermark 
residue that react with each reagent. Compared to work performed previously, 
the solutions printed were very simple. Previous studies have printed a complex 
mix of amino acids and sodium chloride to fully mimic fingermark residue, whilst 
other studies have inkjet printed protein mixes, utilising the precise positioning 
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achievable using this method. This shows that beyond the results presented here 
that inkjet printing of both amino acids and proteins has several uses and the 
work performed so far could be expanded via more complex mixes of amino 
acids, or to examining the other benefits of inkjet printing, such as positioning. 
 
Throughout the participant study, an average of 16 % more shapes, letters and 
patterns were visualised after dark adaptation. This increase in fluorescent marks 
visualised is quite large, particularly when considering that the marks in a crime 
scene scenario could help towards solving a crime. 
 
Only DFO marks were used throughout this study, which fluoresce red under 
green light. Further work investigating the effect of different wavelengths on the 
benefit of dark adaptation would improve the ability of forensic examination 
officers to be able to assess the appropriate level of dark adaptation necessary 
for their current examination. Additionally, repeating and expanding on the work 
done to assess the ability of red goggles to maintain dark adaptation between 
examinations would also greatly benefit forensic examiners.  
 
The Crime-lite Eye was used easily by participants and allowed them to monitor 
their individual dark adaptation. The device does offer a cheap and easy way to 
monitor dark adaptation prior to looking for evidence in the dark. It would be viable 
for crime scene officers, or any other individual needing dark adaptation for their 
profession, to use the Crime-lite Eye to find their individual threshold. This could 
then be the target number to reach, knowing that they are then as dark adapted 
as they can be. 
 
The Crime-lite Eye may have other users alongside forensic examiners, as 
monitoring dark adaptation can have other uses, as shown in Chapter 3. 
Following this study investigating the benefits of dark adaptation, the following 
chapter explores how an individual’s dark adaptation may be improved through 
supplementation with DHA from fish oils. 
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3 Dark Adaptation and Docosahexaenoic Acid 
 
During the initial dark adaptation study it was discovered that there may be a link 
between dark adaptation ability and dyslexia. Upon further reading and 
contacting Professor John Stein, an expert on dyslexia currently at Oxford 
University, it was concluded that the link between dark adaptation and dyslexia 
was actually dependent on the amount of fish oil consumed, and particularly the 
docosahexaenoic acid (DHA) component of the fish oil. This link between DHA 
consumption and dark adaptation was investigated, and reported in the following 
chapter. 
 
 Literature Review 
 
The following literature review aims to introduce the reader to the known impact 
of polyunsaturated fatty acids (PUFAs) and specifically explore eicosapentaenoic 
acid (EPA) and docosahexaenoic acid (DHA) and the impact DHA may have on 
dark adaptation ability. 
 
3.1.1 Docosahexanoic Acid and Eicosapentaenoic Acid  
 
Fatty acids are important molecules in living organisms as they are the precursors 
and building blocks for all lipids which are involved in metabolic functions.89 Many 
fatty acids, particularly those derived from n-6 and n-3 PUFAs, have biological 
activities.55  
 
Both DHA and EPA are found in fish, particularly oily fish.55 DHA cannot be 
produced in mammals and instead comes from the diet.56 The structures of both 
PUFAs are shown below in Figure 35. DHA is essential in infants for the growth 
and development of the brain.90 Both DHA and EPA have been associated with 
a decreased risk of chronic disease and dementia,91 and health benefits of 
PUFAs generally have been linked to several diseases and conditions, including 
diabetes, arthritis and some cancers.90,92,93 Whilst the effect of DHA on many 
processes, such as brain development in infants,90 has been investigated, and 
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there is considerable research investigating the links between DHA and the 
retinal process,59 any link with DHA and dark adaptation specifically is yet to be 
fully established. As outlined in Section 1.7.1, EPA converts to DHA in the body, 
so is also investigated throughout this study. 
 
 
Figure 35 – The structures of (A) cis – 4, 7, 10, 13, 16, 19 docosahexaenoic 
acid (DHA) and (B) cis – 5,8, 11, 14, 17 eicosapentaenoic acid (EPA). 
 
 
3.1.2 Docosahexaenoic Acid in the Retina 
 
DHA is known to be present in high concentrations in some tissues in humans, 
such as retinal cells.55,94 Photoreceptor cells contain more DHA than any other 
cell in the body.95 It is suggested that DHA, therefore, plays an important role 
within the retina, due to its high levels in this tissue.59 It was originally thought that 
DHA is involved in the phototransduction process,96 however, more recent 
research suggests that DHA instead has an effect on rhodopsin, which in turn is 
heavily involved in the phototransduction process.95,97 Whilst DHA accounts for 
8-20 % of retinal fatty acids, it accounts for up to 30 % of total fatty acids in the 
rods,59,60 specifically in the rod outer segments (ROS) discs.95 ROS discs are rich 
in both DHA and rhodopsin.59 
 
It is reported that synaptic membranes  are also enriched with DHA, suggesting 
again an important role for DHA in neurotransmission.60 In rats, the replacement 
of DHA with docosapentaenoic acid correlated with a reduction in visual 
signalling.94 This finding was confirmed by Litman et al who, using bovine retinas, 
found results suggesting that both visual and cognitive deficits may be the result 
of decreased efficiency in visual signalling pathways when there is an absence 
of DHA.98 An extensive study using mice established that the photoreceptor cells 
A 
B 
63 
 
are very adaptable, as all changes observed when the mice were fed a DHA-
deficient diet, were reversed when the mice were later fed a DHA-adequate diet.95 
This study also indicated that DHA-deficiency resulted in a much higher 
percentage of rhodopsin incorporated into the ROS disc membrane. However, 
this increase in rhodopsin content was not found to be a result of an increase in 
rhodopsin expression. As there is more rhodopsin per disc, but no more total 
rhodopsin; this results is fewer discs, which in turn, shortens the ROS.95 
 
3.1.3 The Effect of Docosahexaenoic Acid on Dark Adaptation 
 
As outlined in Section 1.6.2, it is the rods in the eyes that are responsible for 
vision in dim light, and these rods are rich in DHA.59 Whilst several studies have 
been reported showing this apparent link between DHA and retinal processes, no 
specific studies have been conducted to investigate a link between dark 
adaptation ability and DHA, other than those focusing on dyslexia. Stordy has 
completed small studies comparing the results of dark adaptation and movement 
skills pre and post fish oil supplementation in participants with dyslexia.60  There 
is some evidence that individuals with dyslexia have visual and processing 
deficits, and in a small study, poorer dark adaptation was found for those 
participants with dyslexia compared to the control group.84 However after 
supplementation with fish oil containing high levels of DHA, an improvement in 
dark adapted vision was observed. Whilst these small studies have been 
conducted, no larger studies, or studies observing the effects on all individuals, 
with or without dyslexia have been performed. 
 
3.1.4 Analysis of Fatty Acids 
 
In order to analyse fatty acids of biological samples, the lipids need to be 
extracted and derivitised, usually to fatty acid methyl esters (FAMEs) so that they 
are volatile, and can then be analysed using gas chromatography (GC).55 GC is 
the most common technique used for fatty acid analysis.99 Alongside GC, mass 
spectrometry (MS) is a very useful technique to differentiate compounds, which 
co-elute.89 The combination of GCMS, allows for both techniques to complement 
each other, allowing for separation and identification of fatty acids within samples. 
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3.1.5 Fragments Ions of PUFAs 
 
Several fragments are characteristic of fatty acids, m/z 74, m/z 87, m/z 81, and 
m/z 79, together can be used to determine the presence of the majority of 
FAMEs.100 The m/z 79 ion, cyclohexadienyl, specifically is most abundant in 
PUFAs; the structure of this fragment is shown below in Figure 36.100 
 
 
 
Figure 36 – The cyclohexadienyl cation (m/z 79). 
 
This cyclohexadienyl cation will be used throughout analysis to help identify DHA 
and EPA in the collected blood samples. 
 
3.1.6 Dried Blood Spot Analysis 
 
Fatty acids can be measured in blood or plasma using GC or GCMS, and this 
has been studied extensively.65–69 The time taken to perform analysis has been 
reduced using shorter GC methods, which still provides full analytical quality 
results.65,68 However, often these methods require invasive collection, which is 
unpleasant for the individual having the sample taken, and also requires a trained 
phlebotomist to do all collection. Blood samples collected via blood drop from a 
fingerprick have been investigated, and found to give identical results to whole 
venous blood samples.66 This type of collection requires minimal training and is 
far less invasive and time consuming than standard blood or plasma collection. 
This type of collection has now also been extensively used, and allowed for 
further fatty acid databases to be developed.89 Alongside removing the invasive 
nature of blood collection using this method, samples can be easily stored as 
dried blood spots, instead of as liquid whole blood. Samples can be protected 
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from degradation for up to 8 wks at room temperature using butylated 
hydroxytoluene (BHT),101 however when available samples are usually stored at 
-80 °C. Collecting blood samples using fingerprick lancets, and storing them as 
dried blood spots offers a less invasive and more easily obtainable blood sample, 
without losing clarity in the results obtainable. 
 
 Aims and Objectives 
 
The following study aimed to utilise dried blood spot collection and GCMS 
analysis to monitor each individual’s uptake and then washout of both DHA and 
EPA after taking fish oil supplementation for four weeks, and then going 6 weeks 
with no supplements. This research was designed to assess whether an increase 
in levels of DHA would affect an individual’s ability to dark adapt. The use of the 
Crime-lite Eye to monitor dark adaptation after a set time will also be assessed 
throughout this study.  
 
The method development and route taken to reach the aims of this research are 
outlined in Figure 37. The way this is structured reflects the order of work 
undertaken throughout this part of the research. 
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FAME mix
• Establishing a method to quantify the amount of DHA and 
EPA in the collected blood.
• Obtaining the relative response factors from the known 
standards.
Participant 
Study
• Developing a study in which blood samples can be taken 
alongside establishing an individuals dark adaptation.
• Using the Crime-lite Eye to assess dark adaptation after a 
set time.
• Utilisation of dried blood spot collection.
Analysis of 
Results
• Using an appropriate method to analyse the collected 
blood samples.
• Outcome of these results in relation to dark adaptation 
ability.
Figure 37 – A schematic outlining the route taken to achieve the aims and 
objectives of this chapter. 
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 Experimental 
 
3.3.1 GCMS Method 
 
All GCMS analysis was carried out using an Agilent Technologies 7820A GC 
system equipped with a HP5 column (30 m x 0.25 mm x 0.25 µm) and an Agilent 
Technologies 5977B mass spectrometer detector with an electron ionisation 
source and quadrupole ion filter. 
 
The GCMS method outlined below in Table 8 and Table 9 was adapted from 
May’s method optimised for dried blood spot analysis.102 This method was used 
to run all standards and samples throughout the study. 
 
Table 8 – GCMS conditions used for dried blood spot analysis. 
Condition Setting 
Injection volume 1 µl 
Split/splitless Splitless 
Injector temperature 230 °C 
Initial oven temperature 130 °C 
Scan/SIM Scan 
 
Table 9 – GCMS temperatures and ramp rates used for dried blood spot 
analysis. 
Ramp rate Oven start 
temperature 
Oven end 
temperature 
Hold time 
6 °C/min 130 °C 208 °C 0 minutes 
2 °C/min 208 °C 225 °C 10 minutes 
25 °C/min 225 °C 300 °C 1 minute 
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3.3.2 Blood Sampling 
 
Blood samples were collected from participants via finger prick lancets and were 
collected onto 903 Protein Saver Cards (GE Healthcare) as shown in Figure 38. 
Accu-Chek Safe-T-Pro Plus sterile single use lancing devices (Roche) were 
used. Participant’s thumbs were first wiped with an alcohol wipe, and then 
allowed to dry. A lancet was used and blood was collected onto at least 2 of the 
5 collection circles of the cards shown in Figure 38. Each card was labelled with 
the appropriate identifying number and placed within a zip-lock plastic bag. These 
bags were then stored in - 80 °C freezer until needed for analysis. 
 
3.3.3 Dried Blood Spot Derivatisation and Analysis 
 
A stock solution of 6 % K2CO3 (Sigma Aldrich) in deionised water was prepared. 
The internal standard, a 10 µg/ml solution of heptadecanoic acid (Sigma Aldrich) 
in methanol (Fisher Scientific), was also prepared. 
 
Ace pressure tubes were used as the reaction vessel. The DBS samples were 
removed from the -80 °C freezer and allowed to thaw whilst the derivatisation 
mixture was prepared. To each tube, methanol (Fisher Scientific, 3.4 ml), acetyl 
chloride (Sigma Aldrich, 200 µl) and 100 µl of the 10 µg/ml solution of 
heptadecanoic acid was added. Per reaction tube, a 30 mm2 punch was taken 
Figure 38 – A 903 Protein Saver Card (GE Healthcare) used to collect finger 
prick blood samples. 
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from each participant’s DBS and added to the reaction mixture. The tubes were 
capped and placed into a 70 °C water bath for 1 hr. 
 
After 1 hr, each tube was removed from the water bath and 5 ml of the 6% K2CO3 
solution was added to each tube to stop the reaction. The reaction mixture was 
then transferred to 15 ml centrifuge tubes and hexane was added (Fisher 
Scientific, 1.5 ml). The tubes were then centrifuged at 2500 rpm for 10 mins at 
room temperature.  
 
After 10 mins, the top hexane layer was taken and placed into a separate 5 ml 
tube. A further 1.5 ml hexane was added to each centrifuge tube and they were 
again centrifuged for 10 minutes at 2500 rpm. After this washing, the top hexane 
layer was taken and combined with the first. The combined layers were then 
evaporated to dryness using nitrogen. Once dry, 100 µl hexane was added to the 
tube and this was transferred to a GCMS autosampler vial insert and placed in 
an autosampler vial. 
 
 Results and Discussion 
 
3.4.1 Fatty Acid Methyl Ester Mix 
 
Supelco 37 Component FAME Mix (Sigma Aldrich) contains 37 fatty acid methyl 
esters (FAME). Each of the FAME’s present in the mixture, and the corresponding 
concentrations are shown in Table 10. The 37 FAME mix was analysed using the 
GCMS method outlined in Section 3.3.1. 
 
The total ion chromatogram (TIC) of the Supelco 37-FAME mix is shown in Figure 
35, highlighting the peaks showing EPA, DHA and methyl heptadecanoate, the 
internal standard (IS). These retention times, and the associated mass spectra 
were used to find EPA and DHA in the participant samples collected throughout 
the study. The relative response factor (RRF) for both DHA and EPA was 
calculated using the peak areas obtained from the DHA, EPA and IS present in 
the 37-FAME mix total ion chromatogram, these values are shown in Table 11. 
70 
 
Table 10 – The FAME’s present in the Supelco FAME mix. 
FAME 
Concentration in 
FAME mix 
(µg/ml) 
Methyl butyrate 400  
Methyl hexanoate 400  
Methyl octanoate 400  
Methyl decanoate 400  
Methyl undecanoate 200  
Methyl laurate 400  
Methyl tridecanoate 200  
Methyl myristate 400  
Methyl myristoleate 200  
Methyl pentadecanoate 200  
Methyl cis-10-pentadecenoate 200  
Methyl palmitate 600  
Methyl palmitoleate 200  
Methyl heptadecanoate 200  
cis-10-Heptadecanoic acid methyl ester 200  
Methyl stearate 400  
trans-9-Elaidic acid methyl ester 200  
cis-9-Oleic acid methyl ester 400  
Methyl linolelaidate 200  
Methyl linoleate 200  
Methyl arachidate 400  
Methyl γ-linolenate 200  
Methyl cis-11-eicosenoate 200  
Methyl linolenate 200  
Methyl heneicosanoate 200  
cis-11,14-Eicosadienoic acid methyl ester 200  
Methyl behenate 400  
cis-8,11,14-Eicosatrienoic acid methyl ester 200  
Methyl erucate 200  
cis-11,14,17-Eicosatrienoic acid methyl ester 200  
cis-5,8,11,14-Eicosatetraenoic acid methyl ester 200  
Methyl tricosanoate 200  
cis-13,16-Docosadienoic acid methyl ester 200  
Methyl lignocerate 400  
cis-5,8,11,14,17-Eicosapentaenoic acid methyl ester 200  
Methyl nervonate 200  
cis-4,7,10,13,16,19-Docosahexaenoic acid methyl 
ester 
200  
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Table 11 – The peak area and concentration of both DHA and EPA in the 37-
FAME mix TIC and the calculated RRF. 
 Concentration Peak Area RRF 
DHA 200 µg/ml 122497.72 36.54 
EPA 200 µg/ml 142561.59 45.53 
 
These RRF values were used to calculate the concentration of DHA and EPA 
present in each individual’s sample using the equation shown in Equation 1. 
 
CS = 
AS
AIS
CIS
RRF
 
 
Equation 1 – The equation used to calculate the concentration (C) of the DHA 
or EPA in the sample (S) using the area (A) of both the sample and the internal 
standard (IS), along with the calculated RRF. 
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3.4.2 Participant Study 
 
Ethical approval was obtained from the Ethics Approvals (Human Participants) 
Sub-Committee at Loughborough University for the study ‘The effect of fish oil 
capsule consumption on dark adaptation’ with the reference number R17-P169. 
An extension was granted to continue the study through to a third participant 
session. 
 
20 participants were recruited through poster and email advertisements. The 
poster used to advertise is shown in Figure 72 in the appendix (page N). 
Participants were sent the participant information sheet (appendix, pages O-S) to 
ensure they were aware of what each session would include. Participants were 
each given an initial hour slot to attend. 
 
Initially it was planned to collect full blood samples via venepuncture by a trained 
phlebotomist, however as DHA has previously been extracted from dried blood 
spots, it was decided for comfort of the participants that a simple finger prick to 
collect dried blood spots would suffice. This also meant that anyone trained to 
collect blood spots could do so, rather than requiring a trained phlebotomist. 
 
All participants attended their first session. When they arrived, they were given a 
copy of the participant information sheet, an informed consent form and a health 
questionnaire (appendix, pages T-W). Participants were able to ask any 
questions regarding the study that they had and then were asked to complete the 
informed consent form and the health questionnaire. Once the forms were 
completed participants were asked to enter the dark room with the Crime-lite Eye. 
Participants were asked to say which number they could visualise on the Crime-
lite Eye, both faintly and clearly if these were two different numbers. For the first 
4 participants, the number seen on the Crime-lite Eye by the participant was only 
recorded after the full 30 mins. After this, due to several participants being able 
to faintly see the number 1 on the Crime-lite Eye, participants were asked which 
number they could see after 15 mins in the dark and then again after a further 15 
mins, 30 mins total in the dark. A fingerprick blood sample was then taken from 
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each participant as outlined in Section 3.3.2. Participants were then given 4 
weeks supply of Omegavia Omega 3 fish oil tablets and instructed to take 4 
tablets per day.  
 
One participant dropped out of the study prior to the second session, therefore 
19 participants attended the second session. Participants were asked to bring 
with them any remaining fish oil tablets, and compliance was measured by 
checking the number of fish oil tablets remaining. The compliance level was over 
90 % for all remaining 19 participants. 
 
An explanation into the use of the Crime-lite Eye™ (Section 2.3.3) was then 
provided. Participants were then asked to enter the dark room with the Crime-lite 
Eye and after 15 minutes in the dark, participants were asked which number on 
the Crime-lite Eye they could see, both faintly and clearly. After a further 15 
minutes, 30 minutes total in the dark, participants were again asked which 
number on the Crime-lite Eye they could see. After this participants were able to 
leave the dark room. A fingerprick blood sample was then taken from each 
participant as outlined in Section 3.3.2. 
 
As participants were initially invited to attend only 2 sessions, an updated version 
of the participant information sheet (appendix, pages X-AA) was sent out to the 
remaining 19 participants, inviting them to return for a third session, with no need 
to take any further supplements. All 19 participants returned for the third session. 
Participants were asked to enter the dark room with the Crime-lite Eye. After 15 
minutes in the dark, participants were asked which number on the Crime-lite Eye 
they could see, both faintly and clearly. After a further 15 minutes, 30 minutes 
total in the dark, participants were again asked which number on the Crime-lite 
Eye they could see. After this participants were able to leave the dark room. A 
final fingerprick blood sample was then taken from each participant as outlined in 
Section 3.3.2.  
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3.4.3 DHA, EPA and Dark Adaptation 
 
To ascertain the uptake and washout of both DHA and EPA, blood samples from 
each participant were derivitised and analysed via GC-MS following the methods 
outlined in Sections 3.3.1 and 3.3.3. 
 
The RRF for both DHA and EPA was used along with the peak areas of the DHA 
or EPA and IS, with the known concentration of IS to give the concentration of 
DHA and EPA present in each blood sample. As expected, DHA and EPA levels 
in the majority of participants rose after the 4 wk supplementation period. Only 
one participant experienced a decrease in DHA levels after the 4 wks 
supplementation, suggesting a change in diet whilst taking the supplementation 
or that they were not taking their supplements as asked. EPA levels rose in every 
participant after supplementation.  
 
There were 2 participant’s samples at T2 which provided no information when 
analysed using GC-MS. Each sample was re-run to ascertain if the GC-MS 
analysis had gone wrong, however the same result was obtained, suggesting 
either an issue with the derivatisation process for those samples, or an inherent 
issue with the samples collected. As it was only these 2 samples out of the total 
57 samples that provided no information, it is unlikely that the derivatisation 
process didn’t work for these 2 samples. Similarly, all samples were stored in the 
same - 80 °C freezer, making it improbable that there was an issue that affected 
the samples during storage. This meant however, that EPA and DHA results were 
only obtained from 17 participants at T2, after the 6 week washout period. 
 
The results after the 6 week washout period were more variable than those seen 
at T1 after 4 weeks of supplementation. EPA levels in all but three participants 
dropped again after washout, this suggests that these three participants naturally 
increased their uptake of EPA through their diet. To monitor effects like this in 
future studies, it would be useful to obtain a food diary from all participants 
throughout the study. The DHA levels however were less consistent between 
participants after the washout period. DHA levels dropped again in 10 
participants; this was expected due to the reduction in intake via supplementation. 
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However, an increase in DHA levels was seen in the remaining 7 participants; 
this could be due to the conversion of EPA through to DHA in the body, following 
the synthesis pathway from ALA to DHA outlined in Section 1.7.1. The three 
participants, who saw an increase in EPA levels after the 6 week washout period, 
also saw an increase in DHA levels, correlating with the suggestion that their diet 
had altered to include a naturally high level of fatty acids. However the remaining 
4 participants with increases in DHA levels after the 6 week washout period saw 
an opposing decrease in EPA levels. Three of these remaining 4 participants 
whilst seeing a decrease in EPA levels, they did not drop as low as they had been 
at T0, prior to taking supplements. The fourth participant seems completely 
anomalous, as they are also one of only two participants whose dark adaptation 
seemed to worsen after supplementation. The second participant, whose dark 
adaptation worsened after supplementation, indicated on her documents that she 
was feeling quite unwell whilst undertaking the study at T1, and that she thought 
this may affect her results. The full DHA and EPA results are shown in Table 28 
in the appendix (page F).  
 
Of the 19 participants, 4 saw no change in dark adaptation ability after the 4 
weeks supplementation, and 13 participants were able to visualise a lower 
number on the Crime-lite Eye after 30 minutes in the dark at T1, than they could 
at T0, indicating that their eyes were more dark adapted. Of the 4 individuals who 
saw the same number on the Crime-lite Eye at T0 and T1, 2 of them were able 
to visualise the number 1 (the lowest number possible) at T0, so no improvement 
after half an hour was possible. As these participants could visualise the number 
1 pre-supplementation, it was at this point that the Crime-lite Eye number visible 
to each participant was recorded after both 15 minutes and 30 minutes in the 
dark. The full results of the numbers visualised on the Crime-lite Eye by each 
participant are shown in Table 12.  
 
Interestingly, all participants who saw no change, or whose dark adaptation ability 
improved at T1 after supplementation, saw again either no change, or a 
worsening of dark adaptation ability at T2, after a 6 week washout period. 
However, the 2 participants whose dark adaptation ability worsened at T1, both 
saw an improvement in dark adaptation ability again at T2, after the washout 
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period, suggesting an inverse reaction to that observed from the majority of 
participants. This result seems understandable for the participant who claimed to 
feel unwell at T1, as they had recovered by T2; however this result remains 
anomalous for the other participant.   
 
Table 12 – The numbers visualised on the Crime-lite Eye by each participant 
after 15 and 30 minutes in the dark, at T0, pre supplementation, T1, after 4 
weeks of supplementation with omega-3 fish oil tablets, and T2, after a 6 weeks 
washout period of no supplementation. 
Participant 
Number 
T0 T1 T2 
15 
minutes 
30 
minutes 
15 
minutes 
30 
minutes 
15 
minutes 
30 
minutes 
BMDHA001 * 7 9 2 8 3 
BMDHA002 * 2 5 1 5 1 
BMDHA003 * 1 7 1 5 1 
BMDHA004 * 1 6 1 6 1 
BMDHA005 10 2 7 1 10 3 
BMDHA006 6 3 5 2 3 3 
BMDHA008 9 7 8 4 8 6 
BMDHA009 12 9 7 1 10 9 
BMDHA010 10 8 9 4 5 4 
BMDHA011 7 5 8 6 6 5 
BMDHA012 6 4 3 1 5 4 
BMDHA013 9 7 8 6 9 8 
BMDHA014 8 5 5 1 7 2 
BMDHA015 7 2 20 7 8 4 
BMDHA016 12 7 8 7 11 8 
BMDHA017 9 5 5 1 9 2 
BMDHA018 13 8 13 6 12 8 
BMDHA019 16 9 8 8 11 9 
BMDHA020 4 2 4 2 6 3 
* No Crime-lite Eye number was recorded for participants 1-4 after 15 minutes in 
the dark. 
 
As no placebos were used in this study, there was a risk of inductive bias. As 
participants already knew how to use the Crime-lite Eye at T1, there was the 
possibility that their ability to visualise a lower number, was simply due to 
learning. However, the results from T2 suggest that this was not the case, as 
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many participants dark adaptation worsened either back to the level it was prior 
to supplementation, or worsened, but didn’t return fully to the level it was at T0. 
A placebo however, would increase the validation of results, and also remove 
response bias. There is a possibility that participants, when asked which number 
they could visualise, gave an answer they thought to be correct, as participants 
were fully aware of the aim of the study, and the number they could visualise after 
dark adaptation could not be verified. 
 
Previous papers studying effects of changes in level of DHA on various bodily 
functions have shown that any effects observed through changes in DHA level, 
positive or negative are reversible.95 The results shown here support this finding, 
as if the changes seen in dark adaptation ability are due to the changes in level 
of DHA, the dark adaptation ability increases after 4 weeks supplementation, and 
returns, in most participants, to the level seen pre-supplementation after only 6 
weeks washout. 
 
 
Figure 40 shows visually the general trend across all participants, with an 
increase in both DHA and EPA levels after 4 weeks supplementation, and this 
0
1
2
3
4
5
6
7
8
9
10
0
0.0005
0.001
0.0015
0.002
0.0025
0.003
0.0035
0.004
0.0045
1 2 3
N
u
m
b
e
r 
s
e
e
n
 o
n
 t
h
e
 C
ri
m
e
-l
it
e
E
y
e
 
a
ft
e
r 
3
0
 m
in
u
te
s
 i
n
 t
h
e
 d
a
rk
C
o
n
c
e
n
tr
a
ti
o
n
 (
µ
g
/m
l)
Average EPA
Average DHA
Average CLE
number
T0 T1 T2 
Figure 40 – The average change in concentration of both DHA and EPA and 
the average number visualised on the Crime-lite Eye by all participants at T0, 
T1 and T2. 
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corresponding with a decrease in number visualised on the Crime-lite Eye, 
indicating an improvement in dark adaptation ability. The levels of EPA and DHA 
drop again after the 6 week washout period, and the number visualised on the 
Crime-lite Eye increases, indicating a worsening of dark adaptation ability. Box 
and whisker plots showing a deeper breakdown of all EPA and DHA 
concentrations across participants is shown in Figure 70 and Figure 71 in the 
appendix (pages G-H). These figures show that despite the large differences 
seen in DHA and EPA levels between individuals, the overall trend is still 
consistent between individuals. 
 
Whilst previous research has shown that dark adaptation in individuals with 
dyslexia was improved after supplementation with DHA,84 the research presented 
here suggests that DHA supplementation could improve dark adaptation in all 
individuals regardless of whether or not they have dyslexia.  
 
 Conclusions and Future Work 
 
The dried blood spots were easy to collect from participants and caused much 
less discomfort than a full venous blood sample being collected. Once derivitised 
and analysed using GC-MS, DHA and EPA were detectable in all samples except 
two where no peaks were detected. However this occurred in only two of fifty 
seven samples.  
 
DHA levels rose in all but one participant after the 4 week supplementation 
period. EPA levels rose in all participants after 4 weeks supplementation. 13 
participants were able to visualise a lower number on the Crime-lite Eye after 
dark adaptation. Of these 13 participants, all but 1 saw a drop in dark adaptation 
ability at T2 after the 6 week washout period. After the 6 week washout period, 
participant’s DHA and EPA levels were much more variable, this result could be 
better quantified if participant’s had also kept a food dairy alongside 
supplementation. However, the general trend of the results shows that individuals 
return to the dark adaptation level they could reach prior to supplementation, this 
result correlates with the literature which suggests that any visual effects caused 
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by DHA deficiency, or in this case, an excess of DHA, are reversible when the 
DHA intake is returned to normal.95 
 
The results obtained throughout this study suggest a link between dark 
adaptation and DHA, however this is a preliminary study and future work would 
be necessary to confirm the link established. Whilst the 20 participant sample is 
larger than any participant study performed exploring a link between DHA and 
dark adaptation previously, it is still a relatively small sample group, especially 
when considering anomalous results. It would be beneficial to perform a larger 
study, and to ask participants to keep a food diary so that trends in DHA and EPA 
levels could possibly be linked to changes in diet along with the supplements. 
Similarly, when conducting a larger study, a placebo group could be used to 
assess and check the general variations in DHA and EPA levels seen. The 
addition of a placebo group would further confirm that any improvement in dark 
adaptation by participants was likely due to supplementation and not due to any 
form of bias through rising from participants or investigator.  
 
Whilst previous research has been published suggesting that DHA improves dark 
adaptation ability in individuals with dyslexia, the results of this work propose that 
DHA could improve dark adaptation in all individuals independent of whether or 
not they are dyslexic. For future studies, it would be beneficial to ask participant’s 
whether they have been diagnosed with dyslexia, as there may be a difference 
seen in the level of dark adaptation improvement seen between individuals with 
and without dyslexia. 
 
These last two chapters have utilised participant studies to assess methods to 
improve dark adaptation ability and assess how vital dark adaptation is for the 
visualisation of fluorescent fingermarks in the dark. The following chapter 
investigates whether fingermarks once found, can have further uses, beyond 
pattern matching, specifically if the size of a fingerprint can be used to give an 
initial estimate of the stature of the individual who deposited it.  
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4 Fingertip Compression and Stature  
 
The following study aimed to ascertain if there is a relationship between the 
physical characteristics of the fingertip and the corresponding latent fingermark 
to overall stature. This study was devised to establish whether a fingermark found 
at a crime scene could be used to immediately give feedback on the 
characteristics of a potential perpetrator through stature identification. It was 
hoped that this could be used by on scene officers to narrow the range of 
suspects possibly still present near the scene. The resulting chapter outlined 
below, describes the study undertaken using bespoke biometric measurement 
and the protocol used to assess and describe the relationship between fingerprint 
size and stature. The outcomes of the study and its implications for forensic 
officers are discussed. 
 
 Literature Review 
 
The following literature review was performed to give the reader an overview of 
the mechanics of the fingertips, followed by a critical assessment of any current 
literature in the areas of both fingerprinting, and physical anthropometry.  
 
4.1.1 The Fingertip 
 
The fingertip undergoes significant compression when in contact with objects.103 
MRI scans of the hand and fingertip are available but are most commonly 
performed on cadavers.104,105 Whilst these are very useful and give an in-depth 
insight into the composition of the fingertip, it is difficult to fully understand the 
fatty tissues without a living example. Research into tumours in fingertips has led 
to MRI scans of living participants being performed to ascertain its use as a 
diagnostic,106 however, no literature has been found which shows the differences, 
using images obtained from an MRI scan, between the composition of the 
fingertip when it is and is not under load. Several attempts to model the 
compression of the fingertip pulp have been made.4,107,108 Two simplified models 
have previously been proposed; these are known as the ‘Waterbed’ model and 
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the ‘Continuum’ model. The waterbed model models the fingertip as ‘a membrane 
enclosing an incompressible fluid’.107 This model was found to be accurate up to 
approximately 3 mm from the load.107 However, the waterbed model has 
limitations; it does not consider pulp mechanics and loading is restricted to line 
loads. Srinivasan et al, when proposing the waterbed model showed that the 
fingertip is stiffer than indicated by the waterbed model.109 This is due to the 
waterbed model not accounting for the membrane thickness.107 The waterbed 
model was further investigated by Serina et al, who looked at the limitations of 
the model.4 The fingertip pulp was modelled as an ellipsoidal membrane, and it 
was found that this model was highly supported by experimental data.4 This study 
concluded that the relationship between force and displacement was due to the 
different components of the fingertip and the initial tension and geometry. This 
contradicts the conclusion reached by Westling and Johansson who assumed 
that the relationship between force and displacement was due to ‘mechanical 
restraints’ imposed by the hard tissues underneath the skin and subcutaneous 
tissues.108 Whilst it is true that the hard tissues form a fixed boundary, Serina et 
al concluded that the characteristics of pulp tissues determine the force-
displacement relationship of the fingertip.4  
 
Alternatively, the continuum model was proposed by Phillips and Johnson110 and 
is based on the standard continuum mechanics theory. This model assumes that 
the skin of the distal phalange and the subcutaneous tissues that make up the 
fingertip, resemble a ‘homogenous, isotropic elastic medium’.110 The main 
purpose of the skin is to prevent unwanted materials entering the body from the 
outside world.111 The composition of each layer of skin is therefore, very complex, 
and this leads to the epidermis, the dermis and the subcutaneous tissues not 
being structurally homogenous or isotropic; suggesting that the continuum model 
will be inherently flawed. Despite the model having known flaws, it has been 
shown to give agreement with recorded primate fingertip response under a range 
of indentations.109  
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4.1.2 Physical Anthropometry 
 
Research has been performed which investigates the relationship between the 
limbs, the hands and the feet and the physical stature and build of a person.112–
115 The most significant correlations have been found between foot length, leg 
length and stature. Tharmer et al found a correlation between foot length and 
stature of between 0.829 and 0.875.114 However, this result was obtained using 
only Malays in Malaysia, meaning the sample may not be completely relevant to 
the wider population. Also, a relatively small sample size of only 107 people was 
used meaning the standard error of the results will be large. Özaslan et al used 
a larger sample size of 311 people, making the collected results, which show a 
significant correlation between leg length and stature, more reliable to a larger 
population. However, participants were selected mostly from Istanbul and were 
all considered middle class with at least 5 years of elementary education, again, 
narrowing the ability to consider the results relevant to a wider population. Both 
of these studies used the lower limbs and feet to establish the anthropometric 
relationship with the height of an individual, yet many other studies have been 
performed using the measurements of the hand. 
 
4.1.3 Fingerprint Anthropometry 
 
Zavala and Paley performed research in 1975 attempting to predict 
anthropometric measurements from fingerprints.116 Whilst they showed 
significant correlations between print and gender, they did not show a correlation 
between fingerprint details and height of a person. The study also did not show 
any correlation between the fingerprint details and weight or race of the donor. 
This study was conducted over 40 years ago, and the only research performed 
focussing specifically on the relationship between fingerprint size and 
anthropometric characteristics more recently was conducted in 2005, with a small 
sample size of 17 people.117 However, several of the studies which measured 
hand length also compared finger length and even measured individual sections 
of the fingers. Whilst the length of the entire hand showed the most significant 
correlation with stature, every other measurement of the hand was also shown to 
have a significant relationship with stature except sections of the thumb and little 
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finger.118 A person’s fingerprint is present on the volar surface of each finger, they 
begin at the tip of the finger and finish at the distal interphalangeal joint. This 
section of each finger has been measured as one part of the hand/hand print and 
the relationship between this and stature has been examined.115,118,119 Whilst all 
3 studies agree that the middle finger gives the most significant correlation when 
compared with stature, the correlation coefficients found between studies varies. 
Both Jasuja and Singh and Paulis found the correlation coefficient between the 
middle distal phalange print length and stature to be between 0.610-0.681,115,118 
Jee and Yun only found a correlation coefficient of 0.279.119 There are significant 
differences between all of the studies, as each was done on a small population 
in India, Egypt or Korea respectively. Also, the study by Jee and Yun uses only 
physical measurements, whilst Jasuja and Singh used both physical 
measurements and measurements taken from a hand print, and Paulis used only 
measurements from a scanned hand print. Also, both the studies by Paulis and 
Jee and Yun were performed recently (2015) whilst the third study was performed 
over 10 years ago (2004). 
 
4.1.4 Anthropometry Methodology 
 
The majority of the studies comparing stature and anthropometric dimensions 
use physical measurements of the hand to establish a relationship between 
stature and hand length,113,119–121 however, other methods to measure the hand 
can, and have been used. Alongside physical measurements, Jasuja and Singh 
took an ink print of the hand of their participants;115 they showed no significant 
difference between the printed measurements and the physical measurements. 
Furthermore, Paulis did not take any physical measurements of the hand to 
compare to stature,118 instead a scanned palm print was taken and computer 
software was used to take various measurements from the print. Whilst physical 
measurements are the simplest and least time consuming option when 
measuring the hand, the inked and scanned palm prints would give a more 
accurate depiction of what would be deposited and collected as a fingermark from 
a crime scene. However, when taking a print or scanned image of the hand and 
fingers, it can be difficult to ensure that the amount of pressure each participant 
uses to leave a print is as uniform as possible. It is important to control this 
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variable as the pressure exerted into the placement of the print could alter the 
size and the observable ridges of the fingerprint. 
 
4.1.5 Standardisation of Fingerprinting  
 
It can be difficult, when using fingerprints in research, to ensure that differences 
in the prints are not simply due to variation in the deposition of the print. The 
appearance of the ridges of a fingermark can be affected by the force applied 
during deposition, the duration of the finger contact and the angle of the 
contact.122 
 
There has been a lot of research conducted into making the collection of 
fingerprints more standardised. Theofanos et al. found that the instruction given 
on how to deposit a fingerprint along with gender and age of the donor, affected 
the pressure a participant used when depositing a fingerprint.123 Whilst recent 
guidelines are available for the collection of fingerprints and on how to examine 
them,26 variability between deposition of fingerprints can still give results that may 
be unreliable. The Reed-Stanton press rig27 was established around the same 
time that S. Fieldhouse published an article describing the fingerprint sampler.28 
Both sets of equipment were established for the collection of standardised 
fingerprints. Fieldhouse found that using different amounts of force during 
fingerprint deposition significantly affected the length and width of a print up to 5 
N.28 Maceo also described how an increase in force increases the size of the 
latent print deposited.124 In certain cases the investigator may welcome this 
variation, if they are examining the natural variation in fingerprints and their 
deposition; but in other cases for example, where the size of the fingerprint is 
important to the research, this variation may need to be controlled. 
 
 Aims and Objectives 
 
Throughout the following studies the overall aim was to identify if a correlation 
exists between fingerprint size and anthropometric measurements and to 
establish the significance of any correlation found. The usability of such a 
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correlation will also be investigated, and if/how it will be possible to use any 
correlation as an additional identifier from fingerprints. For this to be established 
the differences between the sizes of photographed fingerprints and developed 
fingermarks will be investigated, and any differences in correlation this creates. 
The timeline of the studies performed in order to obtain results to investigate this 
aim are shown in Figure 41. The way this is structured reflects the order of work 
undertaken throughout this part of the research. 
 
 
  
Pilot Study
• Establishing a standard participant study.
• Assessing its ability to collect usable results.
• Analysing the collected results to confirm the continuation 
fo the study.
Fingerprint 
Temperature
• Ascertaining whether a variable measured, but not 
controlled from the pilot study will affect results.
Full study
• Performing a full scale study using the optimised protocol 
from the pilot.
• Assessing the outcome of these results with regards to 
fingerprint examination, and with regards to physical 
anthropometry generally.
Figure 41 – A schematic outlining the route taken to fulfil the aims and 
objectives of this chapter. 
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 Experimental 
 
This section outlines all generic experimental methods, along with any 
anthropometric measurement standards that were used throughout this chapter.  
 
4.3.1 Finger Compliance Meter 
 
A bespoke finger compliance meter was used to compress and collect 
photographs of participant’s fingertips. The configuration of this equipment is 
shown in Figure 42. The equipment comprises a camera unit able to collect 
photos of whatever is placed above it and a compression arm which applies a set 
pressure to whatever is placed below it. 
 
Participants were asked to rest their arm along the arm rest with their hand palm 
down resting on the camera unit. The participant’s middle fingertip was then 
aligned over the camera unit as shown in Figure 43, ensuring their DIP joint was 
not under the compression arm. If participants were depositing a fingerprint onto 
Figure 42 – The setup of the finger compliance meter showing (A) the power 
unit (B) the arm rest (C) the participant accessible remote control (arranged 
for a left-handed participant) (D) the camera unit (E) the compression arm (F) 
the control computer and (G) the visualisation computer showing the camera 
output. 
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a specific surface, the surface was placed on top of the camera unit and 
participants were asked to keep their middle finger hovering above the surface 
until the compression arm came into contact with their finger. However, if a 
photograph was being collected, participants could rest their finger on the screen 
throughout compression. 
 
 
Figure 43 – The position of participant’s hand above the camera unit and below 
the compression arm before (A) and during (B) compression. 
 
Once the participant’s fingertip was aligned and the participant was ready, they 
were asked to press the white ‘start’ button on the remote control. Participants 
were also informed of the large stop button available on the same remote control 
which could be used by them at any point if they felt uncomfortable. Once the 
participant pressed ‘start’ the compression arm delivered the programmable force 
of 10 Newtons (N) for a pre-set time of 5 sec. 10 N of force was chosen based on 
the work performed by Edwards117 and this chosen force of 10 N was also above 
the 5 N threshold where fingerprint size no longer changes with additional force, 
as described by Fieldhouse.28  
 
The force was continuously measured and determined by an interposed 
cantilever strain gauge sensor. The target force was kept at 10 N by a 
conventional error correcting negative feedback loop, and held irrespective of the 
inherent spring factor of the finger and the corresponding compression or 
deformation under load.  The system also compensates for any elasticity in the 
intervening material at the zone of contact above the finger. The compression 
arm moved slowly down until it came into contact with the participant’s finger. 
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After 5 seconds of contact, the compression arm released and the participant was 
free to move their arm. 
 
Two light sources are used in the camera unit, light source 1 injects light parallel 
to the surface and light source 2 injects at a shallow angle into the lower face of 
the surface as shown in Figure 44. The image of the fingerprint can be seen due 
to FTIR, however, as ridge detail from the fingerprints was not required, the lights 
were set up so that the image collected would show contrast between the 
fingerprint surface and the background.  
 
 
 
Figure 44 – A simplified figure showing the light sources inside of the camera 
unit. 
 
4.3.2 Measuring Temperature 
 
A Type K Thermocouple, with a range between -120 and +550 °C was used to 
measure participant’s skin temperature. Participants were asked to pinch 
together the middle finger and thumb of their dominant hand. The wire was then 
placed between the participant’s thumb and middle finger and temperature was 
recorded in degrees Celsius to the nearest degree.  
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4.3.3 Measuring Height and Weight 
 
To measure participant height, participants were asked to remove their shoes 
and stand on the bottom plate of the stadiometer with their heels, buttocks, back, 
and the back of their head against the wall, whilst looking straight ahead. Height 
was recorded using a stadiometer in centimetres, to the nearest centimetre, three 
times and an average was calculated from these three measurements. To 
measure participant weight, with shoes still removed, participants were asked to 
stand on weighing scales whilst their weight was recorded. Weight was recorded 
three times and participants were asked to step off of the scales and back on 
between measurements. Participant weight was recorded in kilograms to the 
nearest kilogram and the average of the three measurements was calculated. 
 
4.3.4 Fingermark Development 
 
1,8-Diazafluoren-9-one (DFO) (WA Products, 0.1 g) was added to a solution of 
petroleum ether (Sigma Aldrich, 156 ml), acetic acid (VWR, 4 ml), ethyl acetate 
(Fisher Scientific, 20 ml) and methanol (VWR, 20 ml) and stirred until all DFO had 
dissolved. To develop paper sheets containing either latent fingermarks or inkjet 
printed amino acids, a small amount of DFO solution was poured into a dipping 
tray. The paper was then dipped into the tray using tweezers for approximately 5 
seconds. The paper sheet was then left to air dry, prior to drying in an oven for 
20 minutes at 100 °C. DFO developed paper samples were viewed under green 
light excitation (490-560 nm) through a red filter (OG590). 
 
Ninhydrin (Sigma Aldrich, 0.8 g) was added to a solution of petroleum ether 
(Sigma Aldrich, 180 ml), ethyl acetate (Fisher Scientific, 14 ml), acetic acid (VWR, 
2 ml) and methanol (VWR, 4 ml). This solution was optimised by Lennard and 
Mazella.32 A ‘humidity chamber’ was set up comprising a tub with fully closable 
lid (safe to 100 °C) containing a beaker with a solution of water (50 ml) with 
sodium chloride (18 g) added to saturation. This was placed within an oven at 
100 °C and left to acclimatise for at least one hour. Ninhydrin solution was 
transferred to a dipping tray and paper samples were dipped into the solution fully 
for approximately 5 seconds. The paper was then left to air dry, before being 
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moved and placed within the humidity chamber within the oven for 20 minutes. 
Samples were photographed under white light. 
 
1,2-indanedione (1,2-ind) (BVDA, 0.05 g) was added to ethanol (Fisher Scientific, 
100 ml). 1,2-ind solution was poured into a dipping tray, and paper samples were 
dipped into the solution for approximately 5 seconds. The sheets were left to air 
dry, and then moved to an oven at 100°C for 20 minutes. 
 
A Foster and Freeman MVC 1000/D2 cyanoacrylate fuming chamber was used 
for all cyanoacrylate fuming. The water heater was filled to within the maximum 
and minimum lines with deionised water. Polycyano UV (Foster and Freeman, 
~0.6 g) was added to a foil dish and this was placed underneath the weighted 
ring on the glue heater. The 230 automatic cycle was used. This automatic cycle 
consists of a humidify stage which takes 10 minutes to raise the humidity to 80 
RH, followed by a 30 minute glue stage, in which the glue is heated to 230 °C, 
followed finally by a purge stage lasting 10 minutes. Non-porous samples were 
placed within the cabinet and an automatic cycle was run. Samples could either 
be hung using the clips in the cabinet, or placed onto the middle shelf as shown 
in Figure 45. Samples were viewed and photographed under both white light and 
also under UV light (350-380 nm). 
 
Aluminium powder (WA Products) was also used to develop fingermarks on non-
porous surfaces. The powder was dusted onto samples using a Zephyr fibreglass 
filament dusting brush. These were photographed over black paper to improve 
contrast under white light. 
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 Results and Discussion 
 
4.4.1 Finger Compression Pilot Study 
 
50 participants (26 male, 24 female) were recruited through opportunity sampling 
to participate in the finger compression pilot study. Participants were given the 
opportunity to read the full participant information sheet (appendix, pages BB-
CC) before taking part in the study. A confectionary bar was offered as incentive 
for participating. Each participant had to complete the informed consent form and 
a health questionnaire (appendix, pages DD-FF) before taking part in the study. 
 
Figure 45 – A Foster + Freeman MVC 1000 cyanoacrylate fuming cabinet. 
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Each participant’s height and weight were recorded, and fingertip temperature 
was taken. A fingerprint photograph of the middle finger of the dominant hand 
was collected from each participant using the finger compliance equipment as 
outlined in Section 4.3.1. Examples of the fingerprint photographs collected are 
shown in Figure 46. As explained in Section 4.3.1, the image of the fingerprint 
can be seen due to FTIR, however, as ridge detail from the fingerprints was not 
required, the lights were set up so that the image collected would show contrast 
between the fingerprint surface and the background, giving an easy to measure 
contact outline. 
 
Four different image measuring programs were trialled using the first collected 
fingerprint photographs. Analysing Digital Images (ADI), Klonk, Inkscape and IC 
Measure were all tested. The aim was to find software that would allow several 
measurements of the fingerprint to be taken. Ideally the software would also allow 
the measurements to be recorded to scale, in mm, and to allow the scale to be 
saved to avoid calibration error between measurements and to speed up the 
measuring process. A photograph was taken, using the finger compliance 
equipment, of a ruler to allow this calibration scale to be set. Table 13 shows the 
comparison of the software tried. 
 
 
 
 
Figure 46 – Examples of fingerprint photographs collected using the finger 
compliance equipment. 
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Table 13 – The criteria investigated when trialling image measurement 
software. 
Software 
Free to 
use? 
Allows Pixel - mm 
Calibration 
Measures: 
Can the 
Processed 
Image be 
Saved? 
ADI Yes 
Yes, but cannot be 
saved 
Length and 
Width 
No 
Inkscape Yes 
No, but 
measurements found 
can be converted 
Length, Width 
and Area 
Yes 
Klonk 
Free 
Trial 
Yes, and the 
calibration can be 
saved 
Length, Width 
and Area and 
Circumference 
Yes 
IC Measure Yes 
Yes, and the 
calibration can be 
saved 
Length, Width, 
Area and 
Circumference 
Yes 
 
IC Measure was chosen to measure all of the collected fingerprints, as the length, 
width, area and circumference of each fingerprint could be measured, and the 
pixel calibration could be saved. It was chosen over Klonk, which also performed 
similarly, due to being completely free to use, and easier to navigate. 
 
Using linear regression, correlation coefficients between height and the various 
measurements of the fingerprint were established using SPSS. Correlation 
coefficients between weight and the fingerprint measurements were also 
established also using SPSS. The correlation results are shown in Table 14.  
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Table 14 – The correlation coefficient (R) and the coefficient of determination 
(R2) found between the height/weight of an individual and the length, width, 
circumference or area of the individuals fingerprint. 
 
 
  Participant's: 
 
  Height Weight 
    R R2 R R2 
Fingerprint: 
Length 0.72 0.51 0.67 0.45 
Width 0.56 0.32 0.59 0.35 
Area 0.70 0.49 0.67 0.45 
Circumference 0.72 0.52 0.67 0.45 
 
The R squared value is a measure of how close the data sits to the regression 
line and represents the percentage of the variation in height that can be 
accounted for by fingerprint size.  
 
The correlation coefficients between weight and fingerprint size whilst all positive, 
were not as strong as the correlation coefficients between height and fingerprint 
size. The R2 values found with weight were all very similar, except width which 
showed a weaker correlation.  All of the correlation coefficients between height 
and fingerprint size were larger than the correlation coefficients found between 
weight and fingerprint size, again with width giving the weakest R2 value. The 
highest correlation coefficient was found between the circumference of the 
fingerprint and height (0.72), with a corresponding R2 value of 0.52. The results 
of the regression analysis between height and fingerprint circumference are 
shown below in Table 15 and Figure 47. 
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Table 15 – The Model Summary (A), ANOVA (B) and Coefficients (C) for the 
Linear Regression between height and fingerprint circumference of 50 
participants, showing the correlation coefficient (R), the coefficient of 
determination (R2), the p-value (sig) and the values needed to predict height 
from fingerprint circumference. 
 
(A) Model Summaryb 
Model R R Square 
Adjusted R 
Square 
Std. Error of 
the Estimate 
1 0.719a 0.517 0.507 7.2000 
a. Predictors: (Constant), Fingerprint Circumference 
b. Dependent Variable: Height (cm) 
 
(B) ANOVAa 
Model 
Sum of 
Squares 
df 
Mean 
Square 
F Sig. 
1 
Regression 2666.912 1 2666.912 51.445 0.000b 
Residual 2488.323 48 51.840   
Total 5155.236 49    
a. Dependent Variable: Height (cm) 
b. Predictors: (Constant), Fingerprint Circumference 
 
(C) Coefficientsa 
Model 
Unstandardized 
Coefficients 
Standardized 
Coefficients t Sig. 
B Std. Error Beta 
1 
(Constant) 104.820 9.849  10.643 0.000 
Fingerprint 
Circumference 
1.235 .172 0.719 7.173 0.000 
a. Dependent Variable: Height (cm) 
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Figure 47 – The correlation between Height and Fingerprint Circumference of 
50 participants. 
 
The regression equation (Equation 2) is the equation of the line in Figure 47. This 
could be used to estimate height of an individual from their fingerprint 
measurements. The standard error of the estimate is 7.2, as shown in Table 15. 
This in a more usable sense indicates that each estimate of height calculated 
from fingerprint size would be accurate to within ± 14.4 cm for 95 % of results.  
 
Equation 2 – The regression equation calculated using the initial 50 participants 
used to estimate height (Y) from the measured circumference of a fingerprint 
(C). 
 
Y = 104.8 + 1.24 × C       ±14.4 cm 
 
The results from 50 participants gave a positive, significant correlation for each 
measurement of the fingerprint, however, also gave a large standard error of the 
estimate (7.2). It was decided that the study would be progressed, in order to 
obtain a larger sample size to reduce random error, and to establish if with a 
larger sample size, the correlation and responding standard error would change. 
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4.4.2 Effect of Fingertip Temperature 
 
To establish if a difference in temperature affects the size of the fingerprint 
collected, a smaller study using a single participant and the finger compliance 
equipment was completed. 
 
The participant’s skin temperature was measured and the temperature recorded 
was 27 °C. A photograph of the middle fingertip of the participant’s dominant hand 
was collected using the finger compliance meter as described in Section4.3.1. 
Once the photograph was collected, the participant cooled their dominant hand 
down by holding it under cold water for approximately 5 mins. The temperature 
of the skin on the participant’s fingertip was recorded again, this time the 
temperature recorded was 22 °C. A second photograph of the middle fingertip of 
the participant’s dominant hand was collected using the finger compliance meter. 
The participant then waited at room temperature for their hand to warm up, whilst 
frequently measuring the temperature of the skin on their middle fingertip. When 
the temperature reached 24 °C, a third photograph of the middle fingertip of the 
participant’s dominant hand was collected using the finger compliance meter. The 
participant’s hand was then warmed using a sodium acetate hand warmer. The 
temperature of the skin on the participant’s fingertip was recorded again, this time 
the temperature recorded was 35 °C. A fourth photograph of the middle fingertip 
of the participant’s dominant hand was collected using the finger compliance 
meter. The participant then waited at room temperature for their hand to cool 
down, again, frequently measuring the temperature of the skin on their middle 
fingertip. When the temperature reached 30 °C, a fifth and final photograph of the 
middle fingertip of the participant’s dominant hand was collected using the finger 
compliance meter. 
 
To measure the size of the collected fingerprint photographs, the software IC 
Measure was used. The length, width, circumference and area of each fingerprint 
was measured in millimetres and recorded to the nearest 0.1 mm. The outline 
was redrawn for each fingerprint due to the prints being collected from the same 
person. It was found that the outline would often fit without any alterations, 
causing bias in the measurements. The collected data was analysed using IBM 
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SPSS statistics, version 22. This was used to analyse the results using a one-
way ANOVA. The results of the one-way ANOVA are shown in Table 16. 
 
Table 16 – The output of the one-way ANOVA, showing the significance level 
(Sig.) which indicates whether a statistically significant difference in fingerprint 
size is seen at different temperatures. 
 
 
Sum of 
Squares 
df 
Mean 
Square 
F Sig. 
Between Groups 10.975 
92130.535 
92141.510 
4 
15 
19 
2.744 
6142.036 
0.000 1.000 
Within Groups 
Total 
 
 
As shown in Table 16, the significance level is 1 (p = 1). If the significance level 
had been lower than 1 (p < 1) the null hypothesis (that there is no significant 
difference in fingerprint size) would have been rejected, indicating that 
temperature significantly changed the size of fingerprints. However as p > 1, we 
accept the null hypothesis, meaning there is no statistically significant difference 
in fingerprint size at different temperatures.  
 
It was found that changing the temperature of the fingertip did not significantly 
change the size of the fingerprint. Unintentionally deposited prints could be 
deposited anywhere, and would not be temperature controlled. This result shows 
that, in terms of temperature, the correlation is relatable from controlled 
conditions to less controlled natural fingermarks. However, there are still many 
variables that have been controlled throughout this study that natural fingerprints 
may not conform to. 
 
4.4.3 Finger Compression Full Study 
 
200 total participants (117 male, 83 female) including those used in the pilot study 
were recruited through opportunity sampling to participate in the full finger 
compression study. Participants were given the opportunity to read the full 
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participant information sheet (appendix, pages BB-CC) before taking part in the 
study. A confectionary bar was offered as incentive for participating. Each 
participant had to complete the informed consent form and a health questionnaire 
(appendix, pages DD-FF) before taking part in the study. A more equal split of 
male and female participants was hoped for, but it was found that more males 
volunteered. All participants were aged 18-56. The average height for both the 
male and female participant’s is shown in Table 17 along with the standard 
deviation.  
 
Each participant’s height and weight were measured and their fingertip 
temperature was taken. A fingerprint photograph of the middle finger of the 
dominant hand was collected from each participant using the finger compliance 
equipment as outlined in Section 4.3.1.  
 
Table 17 – The mean height (cm) and standard deviation of both the male and 
female participant’s. 
 
Gender Mean N Std. Deviation 
Female 165.827 83 7.4859 
Male 178.379 117 7.0090 
Total 173.170 200 9.4957 
 
 
The average height of participants in this study, is slightly higher for both male 
and female participants than the average found by the 2012 Health Survey for 
England (HSE) (175.3cm for men, and 161.9cm for women),125 however, this is 
likely due to the age of the average participant, as the same survey showed that 
average height decreased with age. The majority of participants (92 %) recruited 
for this study were between 18-24 years old as shown in Table 18.  
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Table 18 – Participants grouped by age. 
Age Group Frequency Percent 
 
18-24 184 92.0 
25-40 13 6.5 
40-60 3 1.5 
Total 200 100.0 
 
Using linear regression, correlation coefficients between height and the various 
measurements of the fingerprint were established using SPSS. Correlation 
coefficients between weight and the fingerprint measurements were also 
established also using SPSS. The correlation results are shown in Table 19.  
 
Table 19 – The correlation coefficient (R) and the coefficient of determination 
(R2) found between the height/weight of an individual and the length, width, 
circumference or area of the individuals fingerprint. 
 
 
  Participant's: 
 
  Height Weight 
    R R2 R R2 
Fingerprint: 
Length 0.57 0.33 0.36 0.13 
Width 0.50 0.25 0.50 0.25 
Circumference 0.61 0.37 0.43 0.18 
Area 0.59 0.35 0.46 0.21 
 
The correlations found between weight and fingerprint size whilst all positive, 
were not very strong, the highest R2 value for weight was found with the width of 
the fingerprint, however this was only 0.25. One explanation for this is that weight 
fluctuates more in a person than their height, and unless a significant amount of 
weight was gained or lost, it would be unlikely to see a change in the size of the 
hand, and therefore also the size of the fingers and fingerprints. Height however, 
is more constant and this may be the reason that a better correlation was found 
between height and fingerprint size. 
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All of the correlation coefficients between height and fingerprint size were larger 
than the correlation coefficients found between weight and fingerprint size, and 
each result was found to be significant (p < 0.001). The highest correlation 
coefficient was found between the circumference of the fingerprint and height 
(0.61), with a corresponding R2 value of 0.37. The results of the regression 
analysis between height and fingerprint circumference are shown below in Table 
20 and Figure 48. 
 
Table 20 – The Model Summary (A), ANOVA (B) and Coefficients (C) for the 
Linear Regression between height and fingerprint circumference of 200 
participant’s showing the correlation coefficient (R), the coefficient of 
determination (R2), the p-value (sig) and the values needed to predict height 
from fingerprint circumference. 
(A) Model Summary 
Model R 
R 
Square 
Adjusted R 
Square 
Std. Error of 
the Estimate 
1 0.610a 0.372 0.369 7.5446 
a. Predictors: (Constant), Fingerprint Circumference 
 
(B) ANOVAa 
Model 
Sum of 
Squares 
df Mean Square F Sig. 
1 
Regression 6672.959 1 6672.959 117.232 0.000
b 
Residual 11270.372 198 56.921   
Total 17943.331 199    
a. Dependent Variable: Height (cm) 
b. Predictors: (Constant), Fingerprint Circumference 
 
(C) Coefficientsa 
Model 
Unstandardized 
Coefficients 
Standardized 
Coefficients t Sig. 
B Std. Error Beta 
1 
(Constant) 111.512 5.720  19.497 0.000 
Fingerprint 
Circumference 
1.090 0.101 0.610 10.827 0.000 
a. Dependent Variable: Height (cm) 
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Figure 48 – The correlation between Height and Fingerprint Circumference of 
200 participants. 
 
The equation of the regression line (Equation 3) can again, be used to predict 
height measurements from fingerprint size.  
 
y = 111.2 + 1.09 × C     ± 15 cm 
Equation 3 – The regression equation calculated used to estimate height (Y) 
from the measured circumference of their fingerprint (C). 
 
Whilst fingerprint circumference gave the best correlation of any single fingerprint 
measurement, a multiple regression analysis was also attempted to assess if 
using all of the fingerprint measurements, circumference, area, length and width, 
would improve the correlation. The results of the regression analysis between 
height and all fingerprint measurements are shown below in Table 13 and the 
regression equation using all measurements is shown in Equation 4. 
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Table 21 – The Model Summary (A), ANOVA (B) and Coefficients (C) for the 
Linear Multiple Regression between height and fingerprint circumference, area, 
width and length of 200 participant’s showing the correlation coefficient (R), the 
coefficient of determination (R2), the p-value (sig) and the values needed to 
predict height using all fingerprint values. 
 
(A) Model Summary 
Model R R Square 
Adjusted 
R Square 
Std. Error of the 
Estimate 
1 0.617a 0.381 0.368 7.5460 
a. Predictors: (Constant), Fingerprint Height (mm), Fingerprint 
Width (mm), Fingerprint Area, Fingerprint Circumference 
 
(B) ANOVAa 
Model 
Sum of 
Squares 
df 
Mean 
Square 
F Sig. 
1 Regression 6839.668 4 1709.917 30.029 0.000b 
Residual 11103.663 195 56.942   
Total 17943.331 199    
a. Dependent Variable: Height (cm) 
b. Predictors: (Constant), Fingerprint Height (mm), Fingerprint Width (mm), 
Fingerprint Area, Fingerprint Circumference 
 
(C) Coefficientsa 
Model 
Unstandardized 
Coefficients 
Standardized 
Coefficients t Sig. 
B Std. Error Beta 
1 
(Constant) 
Fingerprint 
Circumference 
Fingerprint Area 
Fingerprint Width 
(mm) 
Fingerprint Height 
(mm) 
78.477 
1.911 
-0.143 
1.106 
0.252 
21.734  3.611 0.000 
0.765 
0.092 
0.756 
0.921 
1.069 
-0.658 
0.182 
0.054 
2.498 
-1.557 
1.462 
0.273 
0.013 
0.121 
0.145 
0.785 
a. Dependent Variable: Height (cm) 
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y = 78.48 + (1.91C) – (0.14A) + (0.25L) + (1.11W)     ± 15 cm 
 
Equation 4 – The stepwise regression equation used to estimate height (Y) from 
(C) Circumference, (A) area, (L) length and (W) width of a fingerprint. 
 
Whilst the multiple regression analysis provided correlations of equal strength to 
using only the fingerprint circumference, as there was no increase in correlation 
strength, it was decided that using one measurement instead of four would keep 
the error associated with measuring the fingerprint low. 
 
The results collected with 200 participants show the same relationship between 
height and fingerprint size as shown with 50 participants, however, the correlation 
is less strong. The addition of more participants will have lowered the random 
error, but has shown that there is reasonable variance between people. 
 
Many studies already performed correlating body measurements with height 
have separated male and female measurements prior to establishing the 
correlation coefficients.115,118–121 Whilst this method when applied to fingerprints 
would possibly lower the usability of such a correlation, as it would not 
immediately be possible to establish if a fingerprint was deposited by a male or 
female donor, it was important to assess any differences this method would show. 
To establish if separating male and female participants gave a better correlation 
than grouping them together, scatter graphs, shown below in  
Figure 49, were created to see the difference this would make. 
 
The coefficient of determination (R2 value) for female participants was 0.070 and 
for male participants was 0.127; both of these values are significantly lower than 
the R2 value found for all of the data (0.37). This is thought to be due to the larger 
spread of heights obtained when combining the male and female participants. 
This suggests that separately, the data is not linear enough to perform an 
accurate linear regression. For these reasons, the data was kept together and 
was analysed this way from this point. 
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Only the studies outlined in Table 22 were compared with the results from this 
research, as they were the only ones that specifically included measurements 
and correlations found from the middle fingertip. The only study that found higher 
R and R2 values than 0.61 and 0.37, respectively was performed by Jasuja and 
Singh,115 however, this study only used 60 participants and additionally, the 
correlation found during this finger compression research from a smaller 
participant group was stronger. The only study which used a larger number of 
participants, found a much weaker correlation. This study by Jee and Yun also 
only used physical measurements of the hand.119 Conversely, all of the 
correlations found in the literature list the male and female results separated, so 
it is unknown if combined they would have found a stronger correlation. 
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Figure 49 – The correlation between Height and Fingerprint Circumference for 
(A) Male and (B) Female participants showing a regression line, the equation of 
this line and the R2 value. 
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The results collected from the 200 participants show a positive, significant 
correlation between fingerprint size and height. However, the strength of the 
correlation is reasonably low, meaning the standard error of the estimate is ± 7.5 
as shown in Table 13. This, in a more usable sense, indicates that each estimate 
of height calculated from fingerprint size will be accurate within ± 15 cm for 95 % 
of results. Whilst a total of 30 cm is not a large percentage of a person’s height, 
it is still a reasonable percentage of error, assuming the person falls within the 95 
%. However, when a fingerprint cannot be matched to an individual, this would 
give an estimate of the stature of the individual, similar to a witness recalling the 
approximate height of a perpetrator. In order to compare this result with a witness’ 
description of an individual, an ex-police officer was contacted to simply ask if a 
general margin of error was used for any estimate given. His answer shown 
quoted below was simply that they used what they were given.  
 
“If you are talking about suspect descriptions given by witnesses, there is no set 
parameter for the estimate of height. If a witness says ‘they were 6’2”’, that is 
what the police officer would record. If they were described as ‘between 5’4” and 
5’10”’, again, that is what they would put in a description.” 
- Geoff Feavyour 2016 
 
However it is not only the error of the estimate that affects the usability of the 
correlation. The collection of controlled and photographed fingerprints up to this 
point has allowed for ‘perfect’ fingerprints to be collected.  
 
Whilst no correlation exists between fingerprint size and weight, a statistically 
significant correlation exists between fingerprint size and height. This correlation 
has been found to be consistent between a relatively small group (50 participants) 
and a larger, more significant group (200 participants). The standard error of the 
estimate was found to be ± 15 cm, which whilst small when compared with 
someone’s total height, becomes significant when you consider it simply as the 
difference between average height. However, an error of this size would still be 
able to rule out some people, particularly if the individual was not of average 
height. 
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The results so far have all been established using photographed prints. To 
continue with the aims of this study and investigate the usability of this correlation 
as another form of identification from fingerprints, it is important to assess 
whether fingermarks developed using common fingerprint development 
techniques can be used with the established correlation to effectively estimate 
height. 
 
4.4.4 Finger Compression Development Study 
 
To establish if the correlation found, despite having a large standard error, could 
be used when fingerprints are found at a crime scene and developed, rather than 
photographed, the following study was performed. 
 
37 participants (29 male, 8 female) were recruited through opportunity sampling 
to participate in the finger compression development study. Participants were 
given the opportunity to read the full participant information sheet (appendix, 
pages GG-HH) before taking part in the study. A confectionary bar was offered 
as incentive for participating. Each participant had to complete the informed 
consent form and a health questionnaire (appendix, pages II-MM) before taking 
part in the study. 
 
Participant’s height was recorded using a stadiometer in centimetres, to the 
nearest centimetre, three times and an average was calculated from these three 
measurements. 
 
Five fingerprints were collected from each participant using the finger compliance 
equipment as outlined in Section 4.3.1. All fingerprints were collected using the 
same middle finger of the dominant hand. The first two fingerprints were collected 
onto two individual glass slides, one after the other. The second two fingerprints 
were collected onto two small pieces of paper, but prior to giving each of these 
fingerprints participants were asked to touch their face and neck to provide 
artificially high sebaceous fingerprints. The final fingerprint was collected as a 
photograph using the camera unit on the finger compliance equipment. Once all 
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fingerprints were collected, participant’s fingertip temperature was also 
measured. 
The four fingerprints collected onto glass and paper were developed using four 
of the most commonly used and recommended fingerprinting techniques for 
porous and non-porous surfaces. Superglue fuming and aluminium powder were 
used to develop the prints on glass, whilst ninhydrin and DFO were used to 
develop the prints on paper. 
 
To measure the size of the collected photographs from the finger compliance 
meter and of the developed fingermarks, the software IC Measure was used. IC 
Measure allows the length, width, area and circumference of each fingerprint to 
be measured. The software also allows pixel to mm calibrations to be saved, 
keeping the measurements consistent and allowing ease between measuring the 
fingerprints on different surfaces and using different development processes. 
Fingerprint size was measured to the nearest 0.1 mm. 
 
Both prints from each participant deposited onto glass gave a high-quality print 
when developed using superglue fuming or aluminium powder, shown in Figure 
50 A and B. However, the prints developed on paper using DFO and ninhydrin 
showed more inconsistency, some prints were developed but lacked full detail, 
or a print simply did not develop. Figure 50 C and D show a well-developed 
ninhydrin print and a print that showed some detail but was only partially 
developed respectively. Whilst Figure 50 E and F respectively show both a well-
developed DFO print and a print which has developed but shows no intricate 
detail, possibly because of smudging upon deposition. Whilst this smudging has 
removed the detail usually used to identify a person from their fingerprint, it was 
hoped that providing the option to measure these fingerprints and obtain an 
approximation of the height of the donor would make these prints usable in an 
investigation. 
 
Unfortunately, the examples shown in Figure 50 C and F also show how natural 
unintentional marks could vary significantly, through smudging, overlapping or 
simple partial prints, all of which would lead to an inaccurate measurement, and 
therefore an incorrect estimate of height.  
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Using the regression equation (Equation 3) established from the 200 participant 
study completed and detailed in Section 4.4.3, the fingerprint circumferences 
measured from the developed prints and the prints photographed using the finger 
compliance meter were used to calculate an estimation of height for each 
participant. A height estimation was also calculated using each of the fingerprint 
measurements using the multiple regression equation (Equation 4) also 
established from the 200 participant study. Using the measured height of each 
participant, the estimation of height from fingerprint circumference, and the 
estimation of height from multiple fingerprint measurements, Microsoft Excel 
2016 was used to perform a one-way ANOVA to establish if the differences in 
height were significant. 
 
The results of the one-way ANOVA showed that of the 37 participants, 17 
participant’s measurements gave estimations of height that were significantly 
different to their actual heights. This result suggests that the measurements of 
the developed fingerprints do not give accurate sizes that can be used to estimate 
height. However, due to this method of analysis comparing averages, this does 
not give an overall image of how each individual development technique 
compares to each other, or to the measured height. Figure 51 shows the 
A B C D E F 
Figure 50 – Images of (A) Fingerprint on glass developed using superglue 
fuming, (B) fingerprint on glass dusted with aluminium powder, (C) and (D) 
fingerprints on paper developed using ninhydrin all photographed under white 
light and (E) and (F) fingerprints on paper developed using DFO, photographed 
under narrowband green (480-560 nm) excitation using a Crime-lite 82S 
(foster+freeman) and through an orange/red interference filter (OG590). 
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measured height of each participant and the height calculated using the 
circumference of each of the 5 prints taken. 
 
 
 
 
 
 
 
The ± 15 cm error that exists with the regression equations, affects the usability 
of the correlation itself, as if a person was average height, this 15 cm would 
encompass a large proportion of the population, however, this study was simply 
to establish if developed prints could be measured and still fall within this error. 
Figure 52 shows three participants pulled from the full set of 37, showing that 
whilst a few participant’s fingerprints fell well within the ± 15 cm error, shown by 
participant 23, other participants fingerprints did not even fall within the already 
large error, and most participants fell somewhere between these two extremes 
shown in Figure 51; with no single technique proving more accurate than any 
other. 
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Figure 51 – The measured height of each participant (●) with error bars showing 
± 15 cm, the height predicted from the circumference of the fingerprints 
collected as a photo (●), developed using ninhydrin (●), DFO (●), dusted with 
aluminium powder (●) and fumed using superglue (●). 
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This finger compression development study was performed to see if developed 
fingerprints would give consistent measurements that could be used to estimate 
height. Despite the collection of the fingerprints being standardised, many of the 
fingerprints developed gave measurements which in turn gave estimations of 
height which were significantly different to the measured height of the individual, 
even falling outside of the already large ± 15 cm error. It was important to attempt 
to establish the usability of the correlation found between fingerprint size and 
height, as the correlation itself is significant, however these further results 
suggest that the correlation may not be suitable for use with developed 
fingermarks. 
 
 
The results of the 37 participants finger compression development study shows 
that developing fingerprints causes a difference in size such that the height 
estimated using the regression equation was found to be different from the 
measured height of many participants. Whilst some participants estimated height 
fell within the ± 15 cm error, which the regression equation is accurate to, several 
participants did not fall even within this already large error. Though the correlation 
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Figure 52 – The measured height of 3 participants (●) with error bars showing ± 
15 cm, the height predicted from the circumference of the fingerprints collected 
as a photo (●), developed using ninhydrin (●), DFO (●), dusted with aluminium 
powder (●) and fumed using superglue (●). 
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between fingerprint size and height exists, this study aimed to establish the 
usability of this correlation; the results suggest that due to the differences in 
fingerprint size that occur when developing a fingerprint with various techniques, 
the usability of this correlation is quite limited. This is likely due to the lack of 
control in where fingerprint deposition occurs from the fingerprint pad. Based on 
what an individual has touched, eaten and drunk, fingerprint composition will vary, 
and it is various compounds within this composition that causes the reaction with 
development reagents, e.g. amino acids with DFO and ninhydrin. Unlike a 
photograph, a fingermark on a surface may be smaller than the actual fingertip if 
a small amount of residue is deposited, or larger is smudging occurs, and these 
changes would impact and change the size of the developed fingerprint. 
 
 Conclusions and Future Work 
 
It was found that no significant correlation exists between any measurements of 
fingerprint size and weight, however, the combined results from the finger 
compression studies show that a statistically significant correlation does exist 
between height and fingerprint size. Fingerprint circumference gives the highest 
correlation of any single measurement with participant height (0.61), and using 
multiple measurements also gives an equally high correlation (0.62). To be 
reliably used, the correlation would ideally need to be 0.9 or above. 
 
The addition of the temperature study shows that temperature doesn’t affect the 
fingertip enough to significantly change the size of the fingerprints. However, as 
this temperature study was only performed with one participant, this would need 
to be repeated to ensure it does not change with different participants. As the 
result of the finger compression study with 50 participants, gave very similar 
results to the 200 participant study, it is unlikely that simply the addition of more 
participants would change the correlation result. However, as the majority of 
participants were aged 18-24, it would be beneficial to include more participants 
from a larger age range, as this may affect the result.  
Whilst it may be possible to improve the correlation found between fingerprint 
size and height by further controlling fingerprint deposition variables and other 
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environmental factors, it would reduce the usability of any correlation found, 
meaning that whilst statistically more viable, it would reduce its capability to 
provide any extra information from a fingerprint. 
 
The standard error associated with the correlation established was found to be ± 
15 cm, which whilst small when compared with someone’s total height, becomes 
significant when you consider it simply as the difference between average height. 
Using developed fingermarks, some participants were found to not even fall within 
this already large error range. 
 
The 4 fingermark development techniques used to develop the latent fingerprints 
deposited onto glass and paper showed good ridge detail and some showed even 
finer fingerprint detail such as pores, however, as shown by the number of 
measured fingermarks which fell outside of the standard error of the estimate, 
they were not consistent enough to reliably use as a measure for individual 
height.  
 
These collective studies around fingerprint size and anthropometry have 
established that a correlation that was previously undefined exists and has 
statistical significance; however, the large error associated with the correlation 
suggests it would not be immediately useful in a forensic application. The use of 
fingermark development reagents throughout this chapter increased the 
variability of the fingermark size enough that the correlation found using 
photographed marks was not usable on these developed fingermarks.  
 
Several analytical techniques, which help gain extra information from a latent 
fingermark are also hindered by the development of the print prior to analytical 
testing, which is often necessary to visualise the fingermark in the first place. The 
following chapter explores whether development of fingermarks using 
cyanoacrylate fuming hinders the ability to detect drugs present in the latent 
fingermark residue using liquid chromatography mass spectrometry. 
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5 The Effect of Fingermark Development on Subsequent 
Analytical Testing 
 
This chapter outlines the work done to investigate the effect of cyanoacrylate 
fuming on subsequent analysis using liquid chromatography mass spectrometry. 
 
 Literature Review 
 
The following literature review was performed to give the reader an insight into 
the currently utilised methods of analytical testing used on latent fingermarks, and 
the associated advantages and disadvantages. 
 
5.1.1 Mass Spectrometry of Fingermarks 
 
Mass spectrometry (MS) analysis of fingermarks has been heavily investigated 
as a method of gaining further insight from a fingermark. There are many 
chemical components that make up the residue of a latent fingermark, and certain 
constituents will be present due to substances that have been touched, or 
ingested. Identifying these compounds can give an insight into the individual who 
deposited the mark, alongside the identification possible from the fingermark 
pattern. Whilst using fingermarks for identification is one of the most used forensic 
evidence types, there are several scenarios where fingerprinting cannot provide 
an adequate mark to use for identification.126 
 
Use of Matrix Assisted Laser Desorption Ionisation (MALDI) MS for fingermark 
examination has been researched heavily, as it can provide not only a method of 
finding specific substances present in the fingermark, but can also provide an 
image of the fingermark.64,127–129 MALDI MS has been shown to accurately 
distinguish between condom brands whilst confirming the presence of condom 
lubricant on a fingermark,130 allowing forensic evidence to still be viable when no 
DNA is present. Though being investigated heavily and indicating that a practical 
work-flow is likely to be tested operationally soon, it is often that the development 
of latent fingermarks with various development techniques hinders the technique 
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such as MALDI MS from performing, as well as, on an undeveloped latent 
fingermark. MALDI MS has been shown to detect heroin, cocaine, THC and 
cholesterol in latent fingermarks after development with vacuum metal deposition 
(VMD) and cyanoacrylate fuming.64 Moreover, whilst the detection of bloodied 
fingermarks via MALDI has been conducted,131,132 recent studies have used this 
method to map the haem species present on bloodied fingermarks and allowed 
the determination between human, bovine and equine sources.128 Despite the 
many benefits of using MS, and specifically MALDI MS on latent fingermarks, the 
technique is still undergoing operational trials prior to its inclusion in the 
fingermark visualisation manual.  
 
MALDI MS is undoubtedly a powerful tool to gain insight into a fingermark, and 
the individual who deposited it, however, the technique is expensive and requires 
specialist equipment and individuals, and would only be viable to use in high 
profile cases, rather than volume crimes.126 However, other MS techniques, such 
as LCMS and GCMS, are considerably cheaper and more accessible, and it was 
the aim of this part of the research to ascertain whether development techniques, 
such as cyanoacrylate fuming, would affect the ability to detect certain molecules 
within a latent, developed fingermark. 
 
LCMS analysis has been shown to work well with latent fingermarks, with amino 
acids being detected,17 alongside exogenous compounds, such as 
methamphetamine, lorazepam and their respective metabolites.133,134 However 
these studies have each investigated latent fingermarks with no development 
techniques used to visualise the fingermark to the naked eye. This is of particular 
importance to MS, and LCMS specifically, as the process is destructive, and 
require the fingermark to be removed from the surface it is deposited on.20 For 
this reason, the development of a fingermark prior to LCMS analysis would not 
only allow the visualisation and collection of the fingermark initially, but also mean 
that the fingermark could be photographed and properly visualised prior to being 
removed to analyse via LCMS. 
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5.1.2 Other Instrumental Analysis of Fingermarks 
 
ATR-FTIR spectroscopy and Raman spectroscopy are both techniques, which 
allow analysis of fingermarks on the surface they were deposited, or can be used 
to analyse fingermark lifts.20 FTIR microspectrospcopy can also be used, to 
obtain both visual and chemical information from a fingermark.135 This method is 
advantageous as it is non-destructive; however, the information gathered cannot 
be separated in the same way that it can through MS. Raman spectroscopy has 
been used to detect drugs of abuse (codeine phosphate, cocaine hydrochloride, 
amphetamine sulphate, barbital and nitrazepam) alongside several non-
controlled substances, which are often mistaken for or mixed with controlled 
substances (caffeine, aspirin, paracetamol, starch and talc). Each of the 
substances could be detected using Raman spectroscopy, after the fingermark 
had been developed using cyanoacrylate fuming.136 However, it was found to be 
difficult to find areas of each substance to detect within the polycyanoacrylate 
layer on top of the fingermark.136 
 
5.1.3 Compounds within Fingermark Residue 
 
Compounds of interest within fingermark residue vary depending on the context 
of the fingermark. For research, the analysis of amino acids and other 
components of fingermark residue is of great interest, allowing fingermark 
development techniques to be targeted at specific compounds within the 
fingermark residue. However, outside of classifying gender by the difference 
observed in amino acid concentration,22 it is more likely to be specific substances 
that have been touched or ingested that will be helpful to a forensic examiner. 
The presence of drugs can be vital in some cases, either illegal drugs, or 
substances such as alcohol and caffeine. The following research focussed on 
four non-controlled drugs, ibuprofen, paracetamol, caffeine and aspirin, initially, 
with the aim to moving to other compounds later in the work. 
 
Ibuprofen is a chiral nonsteroidal anti-inflammatory drug (NSAID).137 It is a 
painkiller that can be purchased without a prescription in both Great Britain and 
the US.137 The structure of ibuprofen is shown in Figure 53. When administered 
120 
 
as a drug, ibuprofen is provided as a racemic mixture of both the R and S-
enantiomers, however it is the S-enantiomer that is the more pharmacologically 
active compound.138 The R-enantiomer is epimerised to the active S species in 
the body.138 
 
 
 
Figure 53 – The structure of ibuprofen, showing the R and S enantiomers. 
 
 
Paracetamol is one of the most widely used drugs worldwide. It is a mild painkiller, 
but does not classify as a NSAID as it does not possess anti-inflammatory 
properties.139 The structure of paracetamol is shown in Figure 54.  
 
 
 
Figure 54 – The structure of paracetamol. 
 
 
Caffeine has been consumed for centuries, likely due to its occurrence in a variety 
of plants.140 Caffeine was chemically isolated in 1820, and since has been used 
therapeutically as a stimulant, for skin disorders and also for migraine 
headaches.140 The structure of caffeine is shown in Figure 55. 
 
 
(R) (S) 
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Figure 55 – The structure of caffeine. 
 
Aspirin is otherwise known as acetylsalicylic acid, it is also classed as a NSAID,141 
similar to ibuprofen with both compounds having anti-inflammatory properties. 
The structure of aspirin is shown in Figure 56. Paracetamol, aspirin and ibuprofen 
are all classed as essential medicines by the World Health Organisation 
(WHO).142 
 
 
 
Figure 56 – The structure of aspirin. 
 
Ibuprofen, paracetamol, caffeine and aspirin have all been frequently detected 
using MS, and have also been detected in fingermark residue.129,143 However, 
the interactions of cyanoacrylate with these compounds on a fingermark surface 
has not been investigated, specifically via LCMS. 
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5.1.4 Aims and Objectives 
 
This chapter aimed to investigate the effect of cyanoacrylate fuming on the ability 
to detect drugs present on a fingermark via LCMS. Whether the process 
cyanoacrylate fuming and the formation of polycyanoacrylate on the latent 
fingermark will hinder the process of LCMS to detect various compounds will be 
investigated. 
 
Initially, the ability to detect ibuprofen, paracetamol, caffeine and aspirin within 
extracted fingermarks will be explored, and once detectable, the limit of detection 
will be assessed. The performed in order to obtain results to investigate this aim 
are shown in Figure 57. The way this is structured reflects the order of work 
undertaken throughout this part of the research. 
 
 
  
 
  
Method 
Development
• Establishing a standard method for collecting 
cyanoacrylate developed fingermarks.
• Establishing methods to deposit fingermarks containing 
drug contaminants.
Doped 
Fingermarks
• Assessing the results of the initial doped fingermarks.
• Confirming the reproducability of the results obtained.
Limit of 
Detection
• Attempting to establish the concentration of drug present 
on a doped fingermark.
• Confirming the reproducibility of results obtained.
Figure 57 – A schematic outlining the route taken to fulfil the aims and 
objectives for this chapter. 
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 Experimental 
 
5.2.1 Cyanoacrylate Fuming 
 
Fingermarks throughout this study were collected onto glass slides and fumed 
with cyanoacrylate in a Foster and Freeman MVC 1000/D2 cyanoacrylate fuming 
chamber. The water heater was filled to within the maximum and minimum lines 
with deionised water. Cyanobloom (Foster and Freeman, 4 drops, ~0.1 g) was 
added to a foil dish and this was placed underneath the weighted ring on the glue 
heater. A fingerprint, collected on glass, was placed within the cabinet and an 
automatic cycle was run. The automatic cycle consists of a humidify stage which 
takes 10 mins to raise the humidity to 80 RH, followed by a 30 min glue stage, in 
which the glue is heated to 120 °C, followed finally by a purge stage lasting 10 
mins. Samples can be hung in the chamber or placed on the middle shelf shown 
in Figure 45. 
 
5.2.2 LCMS Method 
 
All LCMS analysis was carried out using a Waters Acquity UPLC system 
equipped with an Acquity UPLC BEH HILIC column 1.7 µm, 2.1 mm x 150 mm 
and a Synapt G2-Si mass spectrometer detector with an electrospray ionisation 
source and quadrupole ion filter. 
 
The injection volume was set as 5 µl, and the samples were run in positive ion 
mode. Two solvents were prepared, solvent A was made using HPLC grade 
methanol (Fisher Scientific) and 0.1 % formic acid (Sigma Aldrich) and solvent B 
was comprised of HPLC grade water (Fisher Scientific) and 0.1 % formic acid 
(Sigma Aldrich). The gradient used for each run is shown in Table 23. An 
autosampler was used to load each sample throughout the study. 
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Table 23 – LCMS gradient used. 
Time (min) Flow Rate % Solvent A % Solvent B 
0 0.2 90 10 
2 0.2 70 30 
4 0.2 60 40 
6 0.2 40 60 
9 0.2 20 80 
15 0.2 10 90 
18 0.2 90 10 
19 0.2 100 0 
  
An aliquot of HPLC grade acetonitrile was placed in an autosampler vial and run 
as a blank prior and post all fingermark samples on the LCMS, using the method 
outlined in Section 5.2.2. 
 
5.2.3 Fingermark Extraction 
 
Acetonitrile was used for all fingermark extraction. Fingermarks were collected 
onto clean glass slides and either fumed using the method outlined in Section 
5.2.1, or left as latent fingermarks. The fingermark was then extracted using 
acetonitrile. 1 ml of acetonitrile was placed in a collection tube and a cotton bud 
was dipped into this. This cotton bud was used to rub off the visible fingermark 
and then cut and the bud placed within the collection tube. A further 2 ml of 
acetonitrile was then added to the collection tube and mixed. A 1 ml aliquot of 
this extracted fingermark was then transferred to an autosampler vial. 
 
5.2.4 Preparation of Natural Fingermarks 
 
Throughout this study, one donor was used. This donor placed fingermarks onto 
cleaned glass slides. A fresh finger was used for each slide when multiple prints 
were needed. Natural fingermarks were used, ensuring that hands had not been 
washed for at least 15 minutes prior to deposition. Some prints were left at this 
stage, to allow the difference in latent prints, and cyanoacrylate developed prints 
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to be investigated. The glass slides that were being developed were then hung 
in the MVC 1000/D2 cyanoacrylate fuming chamber and fumed following the 
method in Section 5.2.1. Once the fuming cycle was complete, the glass slides 
were removed from the fuming cabinet and the now developed fingermark was 
extracted, following the method outlined in Section 5.2.3. 
 
5.2.5 Preparation of Doped Fingermarks – Method One 
 
Aspirin (300 mg tablets, Almus), paracetamol (500 mg capsules, Wockhardt), 
ibuprofen (200 mg tablets, Wockhardt) and Energy Extra tablets containing 
50 mg caffeine (Tesco) were each ground to powder using a pestle and mortar. 
The donor placed a clean finger into the chosen powder and then brushed off any 
excess using another clean finger. The finger was then not touched for 30 
minutes, allowing natural sweat to accumulate. After 15 minutes a fingermark was 
deposited using this ‘doped’ finger. Whilst some powder was still visible on the 
finger when the fingermark was deposited, little to no powder was visible on the 
latent fingermark present on the glass slide. These glass slides were then fumed 
using cyanoacrylate as outlined in Section 5.2.1. The glass slides were removed 
from the fuming cabinet once the cycle was complete and the developed 
fingermark was extracted, following the method outlined in Section 5.2.3. These 
fingermarks were produced to mimic handling of a drug. 
 
5.2.6 Preparation of Doped Fingermarks – Method Two 
 
Ibuprofen (200 mg tablets, Wockhardt), paracetamol (500 mg capsules, 
Wockhardt) and Energy Extra tablets containing 50 mg caffeine (Tesco) were 
each weighed prior to being ground to powder using a pestle and mortar. As the 
concentration of active drug in each tablet was known, solutions containing 
100 µg/ml of paracetamol or caffeine were produced using HPLC grade water 
(Fisher Scientific). Paracetamol and caffeine are both soluble in water, whilst 
ibuprofen is not.144 A solution containing 100 µg/ml of ibuprofen was prepared 
using ethanol (Fisher Scientific). It was found that there was often a small amount 
of precipitation left when dissolving the tablets. As the tablets used contained 
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other chemicals alongside the active drug, it was assumed that some of these 
were insoluble in the chosen solvents. 
 
A 50 µl aliquot of ibuprofen, paracetamol or caffeine 100 µg/ml samples was 
dropped onto a clean glass slide. This was left until all solvent had evaporated. A 
finger was then rubbed liberally across the same glass slide and a ‘doped’ 
fingermark then placed onto a new cleaned glass slide. This fingermark was then 
developed using cyanoacrylate fuming, following the method outlined in Section 
5.2.1. The glass slides were removed from the fuming cabinet once the cycle was 
complete and the developed fingermark was extracted, following the method 
outlined in Section 5.2.3. These fingermarks were prepared in an attempt to 
control the concentration of drug present on the fingermark. 
 
5.2.7 Preparation of Doped Fingermarks – Method Three 
 
The 100 µg/ml solutions of ibuprofen, paracetamol and caffeine prepared for 
Method Two (Section 5.2.6) were also used for Method Three. 
 
A natural fingermark was placed onto a clean glass slide. A 25 µl aliquot of 
ibuprofen, paracetamol or caffeine (100 µg/ml samples) was dropped on top of 
the latent fingermark and the solvent was allowed to evaporate. Once fully 
evaporated, the fingermarks were developed using cyanoacrylate fuming 
following the method outlined in Section 5.2.1. The glass slides were removed 
from the fuming cabinet once the cycle was complete and the developed 
fingermark was extracted, following the method outlined in Section 5.2.3. These 
fingermarks were prepared as an alternative method to attempt to control the 
concentration of drug present on the fingermark. 
 
5.2.8 Split Prints 
 
As explained in Section 1.3.2, using split prints is common practise in fingermark 
research to compare multiple fingermark enhancement methods. This technique 
was utilised to compare the differences in the spectrums obtained from a 
fingermark with and without cyanoacrylate fuming. A fingermark, doped following 
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Method One (Section 5.2.5) was placed across two separate slides positioned 
next to each other. One glass slide containing half of the fingermark was then 
developed using cyanoacrylate as outlined in 5.2.1. Both glass slides were then 
extracted separately following the method outlined in Section 5.2.3. 
 
 Results and Discussion 
 
5.3.1 Cyanoacrylate solvent 
 
A solvent was needed to extract the fingermark from the glass slides they were 
deposited on, in order to run the samples using LCMS. As the fingermarks 
developed during this study would have a layer of polycyanoacrylate coating them 
from the fuming process, and making them visible to the naked eye, this solvent 
needed to adequately dissolve the polycyanoacrylate, as well as, the constituents 
of the fingermark. 
 
One fingermark was deposited onto each of six separate glass slides. These 
glass slides were placed inside the superglue cabinet and developed via 
cyanoacrylate fuming following the method outlined in Section 6.2.1. Once 
fumed, all slides were removed and each slide was used to test a different 
solvent. The six solvents used were methanol, ethanol, propan-2-ol (IPA), water, 
acetonitrile and acetone. Each slide was washed with ~ 3 ml of the respective 
solvent, this first wash was collected. Each slide was then left to sit in the same 
solvent for ~ 1 hr, and this second wash was then collected. Any remaining 
fingermark was then rubbed off using a cotton bud dipped into the same solvent, 
and this third wash was collected. Both acetone and acetonitrile removed all 
visible fingermark from the slide during the first wash. However water had no 
effect on the visible fingermark until the cotton bud was used to rub it off. Ethanol, 
methanol and IPA all appeared to remove the visible fingermark whilst the slide 
was wet, but when left to dry, the fingermark was clearly visible again, suggesting 
that little to no fingermark or polycyanoacrylate was collected. The differences in 
the remnants of glue left after washing with different solvents are shown in Table 
24. 
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Table 24 – The cyanoacrylate fumed marks shown pre-washing and post-
washing whilst still wet and once left to dry. 
Solvent used Fumed mark 
After 1st washing 
(wet) 
After 1st washing 
(dry) 
Acetonitrile 
   
Ethanol 
   
Water 
   
 
Whilst the fingermark was fully removed with all solvents when the slide was 
rubbed with a cotton bud, it was still decided that from these results, acetonitrile 
would be used throughout the study to extract the fingermarks from the glass 
slides. The method was developed and the final extraction method is outlined in 
5.2.3. As well as using acetonitrile to extract the fingermark, it was also used to 
clean all glass slides prior to fingermark deposition. 
 
5.3.2 Doped Fingermarks (Method One) 
 
Using Method One (Section 5.2.5) to dope the fingermarks, ibuprofen (Figure 58), 
caffeine (Figure 59) and paracetamol (Figure 60) were all detected in the latent 
fingermark extraction using the LCMS method outlined in Section 5.2.2. Aspirin 
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was not identified using LCMS. Both paracetamol and caffeine were detected via 
the [M+H]+ ion, corresponding to m/z 152 and 195 respectively. Ibuprofen was 
detected via the fragment shown in Figure 58 corresponding to m/z 161. As 
several of the drugs could be detected using the LCMS method outlined in 
Section 5.2.2, this method was used for all analysis during this study. 
 
Figure 58 – The mass spectra of ibuprofen (m/z 161) extracted from a doped 
fingermark sample. 
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[M+H]
+
 
Figure 60 – The mass spectra of paracetamol (m/z 110, 152) extracted from a 
doped fingermark sample. 
[M+H]
+
 
Figure 59 – The mass spectra of caffeine (m/z 195) extracted from a doped 
fingermark sample. 
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To ascertain if cyanoacrylate fuming affected the ability to detect these 
compounds within the latent fingermark, fingermarks doped with the various 
drugs and then developed via cyanoacrylate fuming were analysed. 
 
Fingermarks were doped using Method One (Section 5.2.5) and developed via 
cyanoacrylate fuming following the method outlined in Section 5.2.1. Ibuprofen 
(Figure 61), caffeine (Figure 62) and paracetamol (Figure 63) were again all 
detected in the latent fingermark extraction using the LCMS method outlined in 
Section 5.2.2. Aspirin was not identified using LCMS. The same m/z ions found 
on the undeveloped fingermarks were found in the samples that had been subject 
to cyanoacrylate fuming. 
 
 
 
 
 
Figure 61 – The mass spectra of ibuprofen (m/z 161) extracted from a doped 
fingermark developed using cyanoacrylate fuming. 
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Figure 62 – The mass spectra of caffeine (m/z 195) extracted from a doped 
fingermark developed using cyanoacrylate fuming. 
Figure 63 – The mass spectra of paracetamol (m/z 110, 152) extracted from a 
doped fingermark developed using cyanoacrylate fuming. 
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5.3.3 Split Fingermarks 
 
Whilst caffeine, ibuprofen and paracetamol were all detectable in the latent 
fingermarks via LCMS, with and without cyanoacrylate fuming, the fingermarks 
could not be directly compared. Split fingermarks were utilised to assess if 
compounds specific to the cyanoacrylate could be determined. Fingerprints were 
doped using Method One (Section 5.2.5) and this print was placed across two 
glass slides, providing a split print. One half of the fingermark was fumed using 
cyanoacrylate as outlined in Section 5.2.1. Both halves, one developed using 
cyanoacrylate, the other containing only the doped latent fingermark, were 
extracted using acetonitrile, and 1 ml aliquots of each half was placed into 
autosampler vials, ready for LCMS analysis. Following the LCMS method 
outlined in Section 5.2.2, ibuprofen, caffeine and paracetamol were all detected 
in both halves of each fingermark.  
 
The total ion chromatograms for the fingermarks doped with ibuprofen, 
paracetamol and caffeine are each shown in Figure 64, Figure 65 and Figure 66. 
In each of these chromatograms, the peak present at 7 mins 48 secs is present 
only in the half of the fingermark that was developed using cyanoacrylate, and 
cannot be seen in any of the other halves that were not fumed. The extracted ion 
chromatograms and corresponding mass spectra for ibuprofen, caffeine and 
paracetamol (Figure 67, Figure 68 and Figure 69 respectively) show very little 
difference between the half fingermark that was developed via cyanoacrylate 
fuming and the half that was exposed to no development technique. 
 
  
134 
 
 
  (A
) 
(B
) 
F
ig
u
re
 6
4
 –
 T
h
e
 to
ta
l io
n
 c
h
ro
m
a
to
g
ra
m
s
 o
f a
n
 ib
u
p
ro
fe
n
 d
o
p
e
d
 fin
g
e
rm
a
rk
 s
p
lit a
n
d
 e
x
tra
c
te
d
 a
fte
r (A
) n
o
 
d
e
v
e
lo
p
m
e
n
t a
n
d
 (B
) d
e
v
e
lo
p
e
d
 u
s
in
g
 c
y
a
n
o
a
c
ry
la
te
 fu
m
in
g
. 
135 
 
 
  (A
) 
(B
) 
F
ig
u
re
 6
5
 –
 C
h
ro
m
a
to
g
ra
m
s
 o
f a
 c
a
ffe
in
e
 d
o
p
e
d
 fin
g
e
rm
a
rk
 s
p
lit a
n
d
 e
x
tra
c
te
d
 a
fte
r (A
) 
n
o
 d
e
v
e
lo
p
m
e
n
t a
n
d
 (B
) d
e
v
e
lo
p
e
d
 u
s
in
g
 c
y
a
n
o
a
c
ry
la
te
 fu
m
in
g
. 
136 
 
 
  (A
) 
(B
) 
F
ig
u
re
 6
6
 –
 C
h
ro
m
a
to
g
ra
m
s
 o
f a
 p
a
ra
c
e
ta
m
o
l d
o
p
e
d
 fin
g
e
rm
a
rk
 s
p
lit a
n
d
 e
x
tra
c
te
d
 a
fte
r (A
) n
o
 
d
e
v
e
lo
p
m
e
n
t a
n
d
 (B
) d
e
v
e
lo
p
e
d
 u
s
in
g
 c
y
a
n
o
a
c
ry
la
te
 fu
m
in
g
. 
137 
 
 
 
(A) 
(B) 
Figure 67 – The mass spectra of ibuprofen (m/z 161) extracted from a doped 
fingermark, split with half (A) not developed and the other half (B) developed 
using cyanoacrylate fuming. 
Figure 68 – The mass spectra of paracetamol (m/z 110, 158) extracted from a 
doped fingermark, split with half (A) not developed and the other half (B) 
developed using cyanoacrylate fuming. 
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The m/z peaks were not as prominent as seen previously, however, this was the 
same between both halves of the fingermark suggesting that this was likely an 
issue with the methodology and not the cyanoacrylate fuming. It can be seen 
throughout all of the mass spectra that a contaminant with m/z ions at 77, 141 
and 158 is present. Looking back at the mass spectra obtained previously 
(Figures 50-55), these m/z ions are often present, but at a much lower 
percentage. These peaks are consistent with N-butyl benzenesulfonamide, 
suggesting contamination from a plastic source.145 The blank acetonitrile samples 
were checked to see if any contaminant was present in these samples. No peaks 
were seen corresponding to ibuprofen, caffeine or paracetamol, and the peak 
seen at 7.48 minutes seemingly corresponding to a compound present post 
cyanoacrylate fuming was also not seen in any of the blank acetonitrile samples. 
However, when mass spectra were visualised from various sections of the 
chromatogram, the m/z ions, 77, 141 and 158 were again prominent, suggesting 
that the contamination was not due to the fingermark extraction method, but 
instead a contamination from the solvents or the column. Nevertheless, these 
(A) 
(B) 
Figure 69 – The mass spectra of caffeine (m/z 195) extracted from a doped 
fingermark, split with half (A) not developed and the other half (B) developed 
using cyanoacrylate fuming. 
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peaks did not affect our ability to visualise the ibuprofen; paracetamol and 
caffeine present in the fingermark residues. 
 
The cyanoacrylate did not appear to affect the ability to detect the drugs present 
on the latent fingermarks. However, as the amount of drug present on the finger 
was not measured; it was not possible from these first results to ascertain the 
amount of each drug that was detectable. 
 
5.3.4 Doped Fingermarks (Method’s Two and Three)  
 
Method Two and Three were utilised, in an attempt to quantify the limit of 
detection of drug present on the fingermark. Method Two (Section 5.2.6) was 
used to obtain doped fingermarks, which were then analysed using LCMS. None 
of the drugs used to dope the fingermarks could be detected. To ascertain if this 
was due to the small amount of drug present in the sample, Method Two was 
used to obtain more doped fingermarks and the analysis was repeated, however 
alongside the Method Two doped fingermarks, a control print, doped using 
Method One was also analysed.  Again, no drugs could be detected in the 
fingermarks doped via Method Two, however, no drugs could be detected on the 
fingermarks doped using Method One either. As fingermarks doped using Method 
One had previously given consistent repeatable results, this suggested that 
something else was affecting the ability to detect the drugs in the fingermarks.  
 
Doped fingermarks were prepared using Method Three, alongside a control print 
doped using Method One. These fingermarks were extracted and analysed. None 
of the drugs were detectable in the prints doped using Method Three, and again, 
no drugs were detectable in the fingermarks doped using Method One.  
 
As no parameters had been changed within the LCMS method used, and the 
ibuprofen, caffeine and paracetamol tablets used were consistent throughout all 
experiments, it was unclear why the once repeatable detection of ibuprofen, 
caffeine and paracetamol was no longer working.  
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 Conclusions and Future Work 
 
The initial results show that cyanoacrylate fuming does not affect the ability of 
certain compounds to be detected within a latent fingermark. Confirming that 
identifying the fingermarks that may otherwise be invisible would not affect the 
ability to perform MS analysis on the print after visualisation. However, this study 
requires a significant amount of future work in order to offer a more complete 
understanding of the effect any interaction of development reagents, specifically 
cyanoacrylate, will have on future analysis of the fingermark.  
 
The slides used throughout this work were cleaned prior to use, however, latent 
fingermarks could be deposited onto any surface that may have several 
contaminants present that in turn could affect the analysis using MS, specifically 
LCMS where the fingermark needs extracting using a solvent. It would be 
important to check how natural surfaces affect the results.  
 
Only four easily accessible and non-controlled drugs were used throughout this 
study, and only three of the four were detected, more compounds which would 
likely offer an insight to forensic examiners should be tested, such as drugs of 
abuse. Similarly for future work, pure samples of the compounds should be 
tested, rather than crushed tablets, which contain impurities. Or to ascertain 
whether someone had ingested a compound rather than merely touched it, 
metabolites of the compounds could be investigated. 
 
Whilst the initial results shown here provided repeatable detection of ibuprofen, 
caffeine and paracetamol in latent fingermarks, when an attempt to control the 
amount of each compound present in the fingermark was made, the results were 
no longer repeatable, and this shows that further LCMS method optimisation is 
necessary to continue obtaining consistent results and to determine the detection 
limit. 
 
Although this work provided some insight into the ability to use methods such as 
LCMS after development techniques, such as cyanoacrylate fuming, there is lots 
of future work necessary to fully understand and optimise the process. 
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6 Overall Conclusions and Future Work 
 
The research documented in this thesis aimed to investigate how physiological 
aspects and processes could optimise the collection, and enhance the analysis 
of latent fingermarks. Several studies involving participants were undertaken to 
meet this aim, along with the optimisation and use of bespoke and standard 
equipment and methods.  
 
The need for forensic examiners to dark adapt their eyes prior to looking for 
fluorescent evidence in the dark had previously been suggested by the UK Home 
Office, however, any improvement in evidence discovered had never been 
quantified. Similarly, it was unknown whether the time needed to wait for the eyes 
to dark adapt would negate any improvement in evidence discovered. The study 
performed involving 50 participants showed that an average dark adaptation time 
of 10 mins improved the number of fluorescent marks discovered by 16 %, a large 
increase for a short amount of time. To perform this study, an inkjet printer was 
utilised and filled with amino acid solutions to create pseudo fingermarks, which 
could be developed using standard amino acid development reagents. Whilst 
inkjet printers had previously been used to create pseudo fingermarks which 
could be used to test fingermark reagents, this study instead utilised the amino 
acid printing to develop a standardised fluorescent test, which used recognisable 
letters, shapes and patterns to ascertain what participants were able to visualise 
in the dark.  
 
The dark adaptation study successfully used the Crime-lite Eye to monitor 
participant’s dark adaptation, the dark adaptation level reached for each 
participant could be easily recorded, and participants were able to use the device 
with minimal training. Participant’s chose how long they took to dark adapt during 
this study, however in later research assessing the effect of DHA on dark 
adaptation, the time participants were given to dark adapt was controlled. The 
Crime-lite Eye was instead used to ascertain the level of dark adaptation that 
participants could reach after this set time. This showed that the Crime-lite Eye 
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has further uses outside of forensic examinations, such as monitoring uptake of 
supplements. 
 
This work assessing the effect of DHA levels on dark adaptation did show that 
the majority of participants saw an increase in dark adaptation ability. This was 
indicated by a lower number being visible to them on the Crime-lite Eye after the 
same length of time in the dark, after supplementation with fish oils for 4 weeks. 
This study, however, requires expanding on, a future study could utilise a placebo 
group to further validate the results, alongside a larger sample size, and the 
addition of groups supplemented with specific compounds found in fish oils. The 
initial results from this study do nevertheless suggest a link between DHA levels 
and dark adaptation, in all individuals, not simply those with dyslexia. The reversal 
in dark adaptation seen after a washout also conforms to results published 
previously stating that all effects seen due to a lack or excess of DHA are fully 
and easily reversible. These two chapters focussed on the eye and how dark 
adaptation itself affects the ability of forensic examiners to accurately identify the 
most evidence, specifically fingerprints. The remaining two chapters instead 
focussed on gaining further information from a fingermark once it had been 
identified. 
 
Whilst ergonomic and physical anthropometry literature has shown to have 
investigated the relationship between the length of various body parts and overall 
stature, similar research has never been conducted investigating anything as 
small as fingerprint size, especially with a forensic focus. The results presented 
in this thesis show that when using standardised photographs of fingerprints that 
a significant correlation exists between fingerprint size and height. No significant 
relationship between fingerprint size and weight was found. The fingerprint 
photographs were collected using bespoke finger compliance equipment which 
allowed the pressure exerted onto an individual’s fingertip whilst collecting the 
photograph to be standardised. The collective results of 200 participants were 
used to create an equation which could be used to ascertain height of an 
individual from their fingerprint circumference to within ± 15 cm. When latent 
fingermarks were collected and developed using standard fingermark 
development techniques, rather than fingerprint photographs, it was found that 
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many individuals fingermarks no longer fit to the correlation established using the 
photographs. This was likely due to a combination of latent fingermark secretion 
areas and development variations which cannot be controlled. This study was 
able to show that a significant correlation does exist between fingerprint size and 
stature, adding to the physical anthropometric data already reported. However, 
this study also showed that the results are limited in regards to being used by 
officers, due to variations in fingermark size that cannot be controlled. 
 
Continuing with the theme of investigating further uses of fingermarks, the various 
analytical tests that can be performed on latent fingermark residues were 
investigated throughout the final chapter of this thesis. Mass spectrometry 
specifically has shown to be a very beneficial technique to not only quantify 
compounds present in latent fingermark residue, but it can also be used to 
‘develop’ an image of a fingermark via mapping of a compound present in the 
residue. These techniques can be expensive and are often tested on fingermarks, 
which have not yet been visualised via any development technique, so this 
chapter investigated whether cyanoacrylate fuming would affect detection of 
drugs via LCMS. This chapter would benefit most from future work, as whilst the 
initial results from the study were positive, suggesting that cyanoacrylate fuming 
does not affect the ability to detect caffeine, paracetamol or ibuprofen in 
fingermark residue, the later results were inconclusive, when the drugs were no 
longer detectable, even without the addition of cyanoacrylate to the fingermarks. 
 
This thesis as a whole has explained the methodology and studies performed in 
order to investigate the physiological processes involved in analysis of 
fingerprints, and the process used by the eyes when looking for fluorescent 
evidence in the dark. The findings presented here indicate that these processes 
can be enhanced to aid in the detection, and analysis of forensic evidence. 
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 Results 
 
8.3.1 Dark Adaptation 
 
Table 25 – The results from all 50 participants in the dark adaptation study, 
showing the number reached on the Crime-lite Eye and the time waited in the 
dark prior to being able to visualise this number. 
Participant 
Number 
Number 
Reached 
Time 
Taken 
Participant 
Number 
Number 
Reached 
Time 
Taken 
1 8 00:10:50 27 5 00:06:20 
2 4 00:13:50 28 3 00:10:40 
3 2 00:14:00 29 4 00:18:20 
4 5 00:03:30 30 4 00:16:00 
5 5 00:19:40 31 8 00:06:50 
6 4 00:15:00 32 7 00:10:20 
7 5 00:25:00 33 10 00:10:40 
8 4 00:12:30 34 5 00:05:30 
9 6 00:11:00 35 5 00:12:40 
10 5 00:07:00 36 4 00:07:00 
11 7 00:03:40 37 5 00:08:00 
12 13 00:03:30 38 5 00:06:30 
13 5 00:18:40 39 7 00:09:40 
14 2 00:09:10 40 8 00:04:00 
15 5 00:07:40 41 3 00:12:20 
16 5 00:08:30 42 4 00:08:20 
17 8 00:03:30 43 6 00:08:20 
18 6 00:06:00 44 11 00:06:00 
19 5 00:08:00 45 1 00:06:30 
20 5 00:12:20 46 14 00:08:20 
21 1 00:12:50 47 20 00:07:30 
22 2 00:13:30 48 5 00:05:20 
23 12 00:09:40 49 6 00:18:00 
24 8 00:06:30 50 4 00:11:20 
25 8 00:04:30 Mean 5.92 00:10:00 
26 2 00:15:00 Mode 5  
 
 
 
 
 
 
 
D 
 
Table 26 – The percentage of shapes letters and patterns seen pre- and post-
dark adaptation by participants 1-30. 
Participant 
Number 
Pre/post 
dark 
adaptation 
Percentage 
Seen 
(total) 
Participant 
Number 
Pre/post 
dark 
adaptation 
Percentage 
Seen 
(total) 
1 
Pre 73.91% 
16 
Pre  71.74% 
Post 82.61% Post 82.61% 
2 
Pre 67.39% 
17 
Pre  36.96% 
Post 78.26% Post 63.04% 
3 
Pre 36.96% 
18 
Pre  15.22% 
Post 63.04% Post 36.96% 
4 
Pre 65.22% 
19 
Pre  4.35% 
Post 82.61% Post 6.52% 
5 
Pre 58.70% 
20 
Pre  13.04% 
Post 67.39% Post 28.26% 
6 
Pre 60.87% 
21 
Pre  10.87% 
Post 71.74% Post 71.74% 
7 
Pre 39.13% 
22 
Pre  73.91% 
Post 47.83% Post 84.78% 
8 
Pre 26.09% 
23 
Pre  13.04% 
Post 52.17% Post 17.39% 
9 
Pre 13.04% 
24 
Pre  28.26% 
Post 41.30% Post 56.52% 
10 
Pre 54.35% 
25 
Pre  41.30% 
Post 56.52% Post 43.48% 
11 
Pre 45.65% 
26 
Pre  76.09% 
Post 56.52% Post 86.96% 
12 
Pre 45.65% 
27 
Pre  73.91% 
Post 47.83% Post 82.61% 
13 
Pre 28.26% 
28 
Pre  73.91% 
Post 50.00% Post 86.96% 
14 
Pre  32.61% 
29 
Pre  45.65% 
Post 69.57% Post 78.26% 
15 
Pre  43.48% 
30 
Pre  58.70% 
Post 76.09% Post 82.61% 
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Table 27 – The percentage of shapes letters and patterns seen pre- and post-
dark adaptation by participants 31-50. 
Participant 
Number 
Pre/post 
dark 
adaptation 
Percentage 
Seen 
(total) 
Participant 
Number 
Pre/post 
dark 
adaptation 
Percentage 
Seen 
(total) 
31 
Pre  45.65% 
41 
Pre  84.78% 
Post 69.57% Post 84.78% 
32 
Pre  45.65% 
42 
Pre  80.43% 
Post 60.87% Post 91.30% 
33 
Pre  23.91% 
43 
Pre  50.00% 
Post 28.26% Post 69.57% 
34 
Pre  56.52% 
44 
Pre  56.52% 
Post 73.91% Post 54.35% 
35 
Pre  86.96% 
45 
Pre  26.09% 
Post 86.96% Post 73.91% 
36 
Pre  47.83% 
46 
Pre  80.43% 
Post 80.43% Post 91.30% 
37 
Pre  86.96% 
47 
Pre  54.35% 
Post 89.13% Post 65.22% 
38 
Pre  82.61% 
48 
Pre  60.87% 
Post 89.13% Post 71.74% 
39 
Pre  56.52% 
49 
Pre  73.91% 
Post 80.43% Post 91.30% 
40 
Pre  56.52% 
50 
Pre  47.83% 
Post 56.52% Post 80.43% 
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8.3.2 Dark Adaptation and Docosahexaenoic Acid 
 
 
Table 28 – The concentration of DHA and EPA for each participant at T0, T1 
and T2. 
Participant 
number 
Concentration µg/ml 
DHA T0 EPA T0 DHA T1 EPA T1 DHA T2 EPA T2 
1 0.0012 0.0000 0.0009 0.0024 0.0012 0.0007 
2 0.0040 0.0012 0.0044 0.0067 0.0046 0.0017 
3 0.0021 0.0031 0.0027 0.0036 0.0023 0.0012 
4 0.0015 0.0000 0.0039 0.0069 0.0039 0.0079 
5 0.0016 0.0008 0.0028 0.0037 0.0027 0.0012 
6 0.0033 0.0013 0.0042 0.0032 0.0043 0.0174 
8 0.0021 0.0008 0.0039 0.0136 0.0021 0.0000 
9 0.0005 0.0014 0.0028 0.0016 0.0009 0.0001 
10 0.0015 0.0010 0.0015 0.0028    
11 0.0013 0.0008 0.0018 0.0015 0.0004 0.0000 
12 0.0006 0.0000 0.0013 0.0014 0.0016 0.0007 
13 0.0010 0.0000 0.0013 0.0020 0.0005 0.0005 
14 0.0014 0.0000 0.0019 0.0018 0.0045 0.0043 
15 0.0009 0.0000 0.0015 0.0035 0.0020 0.0000 
16 0.0004 0.0004 0.0010 0.0013    
17 0.0009 0.0000 0.0034 0.0050 0.0015 0.0000 
18 0.0007 0.0000 0.0023 0.0049 0.0015 0.0000 
19 0.0017 0.0004 0.0034 0.0062 0.0018 0.0007 
20 0.0006 0.0000 0.0051 0.0076 0.0015 0.0007 
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Figure 70 – Box and whisker plot showing the DHA concentration data for all 
participants at T0, T1 and T2. 
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Figure 71 – Box and whisker plot showing the EPA concentration data for all 
participants at T0, T1 and T2. 
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 Ethics Documents 
8.4.1 Dark Adaptation 
 
Dark Adaptation – The Crime Lite Eye 
Participant Information Sheet 
Dear Participant, 
 
Thank you very much for agreeing to take part in this research at Loughborough 
University. This research is attempting to establish whether more evidence is found 
when the person looking has achieved full dark adaptation using the Crime-lite Eye. 
 
This study is part of a student research project supported by Loughborough University. 
You will be rewarded with a confectionary bar and a pen for your assistance with this 
research and to thank you for your time. It is recommended that you do not take part in 
this study if you are very frightened of the dark. 
 
You will be required to attend a session which will take approximately 45 minutes. You 
will be sat in a dark room and using forensic light sources, and wearing filtered goggles, 
you will be asked to speak out loud the letters, shapes and patterns that are visible to 
you. Once you have completed this first part of the study, you will leave the dark room 
and the Crime-lite Eye (shown below) will be explained to you.  
 
Once this explanation is complete, you will be asked to re-enter the dark room and use 
the Crime-lite Eye to establish when your eyes are dark adapted. You will be asked to 
speak aloud again during this time, simply to establish the speed at which your eyes 
become dark adapted. Once you believe you are dark adapted, you will once again use 
the forensic light sources and filtered goggles and be asked to speak out loud the letters 
and patterns that are visible to you.  
 
J 
 
During your time using the Crime-lite Eye and waiting to be fully dark adapted, you are 
welcome to listen to music if you have your own device with you, however you will not 
be able to look at the device screen during this time as it will affect your dark adaptation. 
It is also requested that you keep the volume low/ keep one ear bud removed so that 
you can hear for any instructions. When you are fully dark adapted, you should remove 
any headphones to ensure you are giving your full attention to the research task. 
 
After you have read this information and asked any questions you may have we will ask 
you to complete an Informed Consent Form, however if at any time, before, during or 
after the session you wish to withdraw from the study please contact the main 
investigator.  If you are uncomfortable during your time in the dark, you are welcome to 
leave the dark room and end your involvement in the study, it will be explained to you 
how to do this safely, ensuring that all forensic light sources are switched off before 
removing your filter goggles. 
 
You can withdraw at any time, for any reason and you will not be asked to explain your 
reasons for withdrawing. However, once the results of the study are published 
(expected to be by 2019), it will not be possible to withdraw your individual data from 
the research. Please be aware that any personal information you provide, will be treated 
in strict confidence and will be kept anonymous and confidential unless (under the 
statutory obligations of the agencies which the researchers are working with), it is 
judged that confidentiality will have to be breached for the safety of the participant or 
others or for audit by regulatory authorities.  
 
If you are not happy with how the research was conducted, please contact Ms Jackie 
Green, the Secretary for the University’s Ethics Approvals (Human Participants) Sub-
Committee: 
 
Ms J Green, Research Office, Hazlerigg Building, Loughborough University, Epinal Way, 
Loughborough, LE11 3TU.  Tel: 01509 222423.  Email: J.A.Green@lboro.ac.uk 
 
The University also has a policy relating to Research Misconduct and Whistle Blowing 
which is available online at http://www.lboro.ac.uk/committees/ethics-approvals-
human-participants/additionalinformation/codesofpractice/.   
 
Once again, thank you for your participation. If you have any questions, please feel 
free to contact me using the email address below. 
 
Yours sincerely, 
Beth McMurchie 
b.mcmurchie@lboro.ac.uk 
Dark Adaptation and the Crime Lite Eye 
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Informed Consent Form 
(to be completed after Participant Information Sheet has been read) 
 
Taking Part  
 
The purpose and details of this study have been explained to me.  I understand 
that this study is designed to further scientific knowledge and that all 
procedures have been approved by the Loughborough University Ethics 
Approvals (Human Participants) Sub-Committee. 
  
I have read and understood the information sheet, the information regarding 
the use of forensic light sources and this consent form. 
  
I have had an opportunity to ask questions about my participation.  
  
I understand that I am under no obligation to take part in the study, have the 
right to withdraw from this study at any stage for any reason, and will not be 
required to explain my reasons for withdrawing. 
  
I agree to take part in this study.  
 
Use of Information 
 
I understand that all the personal information I provide will be treated in strict 
confidence and will be kept anonymous and confidential unless (under the 
statutory obligations of the agencies which the researchers are working with), 
it is judged that confidentiality will have to be breached for the safety of the 
participant or others or for audit by regulatory authorities.  
   
I agree for the data I provide to be securely archived at the end of the project.  
 
  
I agree that the results obtained during this study can be used for the write up 
of a report. 
 
 
________________________ _____________________ ________  
Name of participant [printed] Signature                 Date 
 
 
__________________________  _______________________ _________  
Researcher  [printed] Signature                    Date 
 
Dark Adaptation and the Crime Lite Eye 
L 
 
Using the Forensic Light Source 
 
 
How to use the forensic light source (Crime Lite 2) has been explained to me. 
  
I understand that I should not turn the light sources on unless I am wearing the 
correct protective goggles, and should not remove these goggles until the light 
sources have been switched off. 
 
I understand that I should not look directly at the light source, or point the 
light source towards another person even when wearing protective goggles. 
 
I have had an opportunity to ask any questions I have. 
 
 
 
________________________ _____________________ ________  
Name of participant [printed] Signature                 Date 
 
 
__________________________  _______________________ _________  
Researcher  [printed] Signature                    Date 
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Dark Adaptation and the Crime Lite Eye 
Additional Questions 
 
 
1. Do you currently wear glasses or contact lenses? (if no, please proceed to Q5) 
 
……………………………………………………………………………………… 
 
2. Do you wear your glasses/contact lenses for specific things (driving, reading etc 
(please specify)) or all of the time?  
 
……………………………………………………………………………………… 
 
3. Would you describe yourself as long or short sighted? 
 
……………………………………………………………………………………… 
 
4. Will you be wearing contact lenses or glasses during the study? (if yes, please 
specify which) 
 
……………………………………………………………………………………… 
 
5. Are you colour blind? 
 
……………………………………………………………………………………… 
 
6. Do you have any other issues with your vision? (e.g. recent injuries) 
 
……………………………………………………………………………………… 
 
7. Do you have any phobias that may affect you during this study? (e.g. 
claustrophobia or fear of the dark, please see below for details) 
 
……………………………………………………………………………………… 
 
……………………………………………………………………………………… 
 
As outlined in the participant information sheet, you will be required to sit in a dark 
room for this study. You will have a chair to sit on, and will not be required to move 
once the study has begun.  
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8.4.2 Dark Adaptation and Docosahexaenoic Acid 
 
 
 
Figure 72 – The poster used to advertise the dark adaptation and DHA study. 
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The effect of fish oil capsule consumption on dark adaptation 
Adult Participant Information Sheet 
 
Investigators Details: 
Paul Kelly,a 01509 222578, p.f.kelly@lboro.ac.uk 
Beth McMurchie,a 01509 564113,  b.mcmurchie@lboro.ac.uk 
Martin Lindley,b 01509 226349, m.r.lindley@lboro.ac.uk 
Lynsey Wilson,b 01509 228779, l.wilson2@lboro.ac.uk 
Jim Reynolds,a 01509 222590, j.c.reynolds@lboro.ac.uk 
 
aChemistry Department, Loughborough University, LE11 3TU 
bSchool of Sport, Exercise and Health Sciences, Loughborough 
University, LE11 3TU 
 
Thank you for considering participating in this study. Before you decide we would 
like you to understand why the research is being done and what it would involve 
for you. One of our team will go through the information sheet with you and 
answer any questions you have. Talk to others about the study before making a 
decision if you wish. 
 
What is the purpose of the study? 
 
This study aims to establish if taking fish oil supplements affects an individual’s 
dark adaptation. 
 
Who is doing this research and why? 
 
This study is part of a student research project supported by Loughborough 
University. It will be led by the investigators above based in Chemistry and the 
School of Sport, Exercise and Health Science. This study will form part of Beth 
McMurchie and Lynsey Wilson’s PhD research. 
 
Are there any exclusion criteria? 
 
You will unfortunately be unable to take part in this study if: 
- You have a blood borne disease 
- You have a history of coagulation/bleeding disorder 
- You are already taking dietary supplements or have in the last 6 months 
- You are already able to reach the lowest level using our Crime-lite Eye 
which assesses your dark adaptation level. 
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What will I be asked to do? 
 
As a participant, you will be asked to attend two sessions, one in week 1, 
semester 2 and the second in week 5, semester 2.You will be required to take 
fish oil supplements for 4 weeks in between these two sessions. The sessions 
will involve assessing your dark adaptation level using the Crime-lite Eye (shown 
in Figure 1). 
 
Figure 1 – The Crime-lite Eye, used to assess your dark adaptation. 
 
You will be asked to sit in a dark room for 30 minutes and using the Crime-lite 
Eye, find the lowest number that you can read on the device. As your eyes adapt 
to the dark you will be able to see lower numbers and we will record which number 
you can reach after 30 minutes. You can have music or an audio book playing 
during this time if you wish, however you will be unable to look at any devices 
(e.g. phones etc) that will affect the dark adaptation process. During your first 
session a blood sample will also be taken, this will be performed by a certified 
phlebotomist. 
 
After this first session you will be given your fish oil supplements (Omegavia 
Omega 3) and will be asked to take four capsules a day over the next four weeks. 
If you have any adverse side effects whilst taking the supplements you should 
contact an investigator and stop taking the supplements immediately. 
 
After you have taken the four weeks of supplements you will return for your 
second session. This will run almost identically to your first. You will again sit in 
a dark room for 30 minutes and we will record the number you are able to reach 
on the Crime-lite Eye. A second blood sample will be taken by a certified 
phlebotomist. Once this session is complete you have completed the study.  
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Once I take part, can I change my mind? 
 
Yes.  After you have read this information and asked any questions you may 
have, if you are happy to participate we will ask you to complete an Informed 
Consent Form, however if at any time, before, during or after the sessions you 
wish to withdraw from the study please just contact the main investigator.  You 
can withdraw at any time, for any reason and you will not be asked to explain 
your reasons for withdrawing. 
 
However, once the results of the study are published or the data has been 
included and submitted as part of a report (expected to be by 09/2018), it will not 
be possible to withdraw your individual data from the research. 
 
Will I be required to attend any sessions and where will these be? 
 
You will be required to attend 2 sessions, one initial session where we will collect 
a blood sample and measure your dark adaptation level at 30 minutes, and a 
second session after 4 weeks of fish oil supplements where again a blood sample 
will be taken and your dark adaptation level at 30 minutes measured. These 
sessions will be completed in the Chemistry building or in Clyde Williams, both 
on Loughborough University Campus this will be decided at the time based on 
both the investigators and your, as the participant, needs. 
 
How long will it take? 
 
Each session should take approximately one hour, so the total time taken for 
this study will be 2 hours. 
 
What personal information will be required from me? 
 
All information provided by you will be stored anonymously. You will be required 
to complete a health questionnaire and give a blood sample. 
 
Are there any disadvantages or risks in participating? 
 
An appropriate risk assessment has been performed, but the following risks exist 
when taking part in this study: 
- Some people feel light headed when giving a blood sample, the 
phlebotomist taking your sample will be fully first aid trained and will ensure 
you are as comfortable as possible. 
- Taking dietary supplements can lead to side effects in some participants, 
such as gastro-intestinal problems, if this happens contact an investigator 
immediately and stop taking the supplementation. 
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- You will be sat in a dark room for 30 minutes, if you are uneasy in the dark, 
or begin to feel uneasy once you have started, there will be a light available 
to you and the safest way to leave the room will be outlined to you. 
 
Will my taking part in this study be kept confidential? 
 
You will be given a code that we will use for data storage so that all data is stored 
anonymously. This code will be used to label any blood samples stored in 
freezers and any personal data about the participants. Investigators will ensure 
that no information is published that would allow individuals to be identified. 
 
Paper copies of consent forms, participant questionnaires and data recording 
sheets will be kept in a locked secure office. All electronic data will be stored 
anonymously on password protected University computers. All information will be 
securely locked away for 5 years, following this it will be securely destroyed. 
 
Blood samples will be stored in -80°C freezers and logged and tracked using 
Procuro, enabling an audit trail as per Human Tissue Act Regulations. Samples 
will be destroyed as Biohazard waste, and logged on Procuro, after a period of 5 
years. 
 
I have some more questions; who should I contact? 
 
If you have any questions please contact Beth McMurchie 
(b.mcmurchie@lboro.ac.uk) or any of the other investigators listed at the start of 
this sheet. 
 
What will happen to the results of the study? 
 
The results of this study will be used as part of a thesis for PhD submission, and 
may also be published. Investigators will ensure that no information is published 
that would allow individuals to be identified. 
 
What if I am not happy with how the research was conducted? 
 
If you are not happy with how the research was conducted, please contact the 
Secretary of the Ethics Approvals (Human Participants) Sub-Committee, 
Research Office, Hazlerigg Building, Loughborough University, Epinal Way, 
Loughborough, LE11 3TU.  Tel: 01509 222423.  Email: 
researchpolicy@lboro.ac.uk 
 
The University also has policies relating to Research Misconduct and Whistle 
Blowing which are available online at http://www.lboro.ac.uk/committees/ethics-
approvals-human-participants/additionalinformation/codesofpractice/ . 
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Is there anything I need to bring with me? 
 
You may wish to bring your own music devices, particularly those which are 
Bluetooth enabled, as you will then be able to listen to music/ an audio book of 
your own choice whilst dark adapting for 30 minutes. 
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The effect of DHA consumption on dark adaptation 
 
INFORMED CONSENT FORM 
(to be completed after Participant Information Sheet has been read) 
 
Taking Part                                                                                                                         Please initial box 
 
The purpose and details of this study have been explained to me.  I understand 
that this study is designed to further scientific knowledge and that all 
procedures have been approved by the Loughborough University Ethics 
Approvals (Human Participants) Sub-Committee. 
  
I have read and understood the information sheet and this consent form 
 
  
I have had an opportunity to ask questions about my participation.  
  
I understand that I am under no obligation to take part in the study, have the 
right to withdraw from this study at any stage for any reason, and will not be 
required to explain my reasons for withdrawing. 
  
I agree to take part in this study.  
 
Use of Information 
 
I understand that all the personal information I provide will be treated in strict 
confidence and will be kept anonymous and confidential to the researchers 
unless (under the statutory obligations of the agencies which the researchers 
are working with), it is judged that confidentiality will have to be breached for 
the safety of the participant or others or for audit by regulatory authorities. 
   
 
Bodily Samples  
  
I agree that the bodily samples taken during this study can only be used for 
this study and will be disposed of upon completion of the research. 
 
I understand that any bodily samples taken will be disposed of after 5 years. 
 
  
________________________ _____________________ ________  
Name of participant [printed] Signature              Date 
 
 
 
__________________________ _______________________ _________  
Researcher  [printed] Signature                 Date 
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Name/Number ...............…….. 
Male/Female  ...............……… 
Date of Birth ...............……….. 
 
Health Screen Questionnaire for Study Volunteers 
 
As a volunteer participating in a research study, it is important that you are currently in 
good health and have had no significant medical problems in the past. This is (i) to 
ensure your own continuing well-being and (ii) to avoid the possibility of individual 
health issues confounding study outcomes. 
If you have a blood-borne virus, or think that you may have one, please do not take 
part in this research. 
 
Please complete this brief questionnaire to confirm your fitness to participate: 
 
1. At present, do you have any health problem for which you are: 
(a) on medication, prescribed or otherwise .......  Yes  No  
(b) attending your general practitioner ..............  Yes  No  
(c) on a hospital waiting list ...............................  Yes  No  
 
2. In the past two years, have you had any illness or injury which required you to: 
(a) consult your GP ............................................ Yes  No  
(b) attend a hospital outpatient department ........ Yes  No  
(c) be admitted to hospital  ................................ Yes  No  
 
3. Have you ever had any of the following: 
(a) Convulsions/epilepsy  ................................... Yes  No  
(b) Asthma  ........................................................ Yes  No  
(c) Eczema  ....................................................... Yes  No  
(d) Diabetes  ...................................................... Yes  No  
(e) A blood disorder  .......................................... Yes  No  
(f) Head injury  .................................................. Yes  No  
(g) Digestive problems  ...................................... Yes  No  
(h) Heart problems/chest pains  
.…………………… 
Yes  No  
(i) Problems with muscles, bones or joints     .... Yes  No  
(j) Disturbance of balance/coordination  ............ Yes  No  
(k) Numbness in hands or feet  .......................... Yes  No  
(l) Disturbance of vision  ................................... Yes  No  
(m) Ear/hearing problems  .................................. Yes  No  
(n) Thyroid problems  ......................................... Yes  No  
(o) Kidney or liver problems  .............................. Yes  No  
(p) Problems with blood pressure  ..................... Yes  No  
V 
 
 
If YES to any question, please describe briefly if you wish (eg to confirm problem 
was/is short-lived, insignificant or well controlled.) 
 
........................................................................................................................................... 
 
4. Allergy Information 
(a) Are you allergic to any food products? Yes  No  
(b) Are you allergic to any medicines? Yes  No  
(c) Are you allergic to plasters? Yes  No  
(d)   Are you allergic to latex? Yes  No  
 
If YES to any of the above, please provide additional information on the allergy 
 
……………………………………………………………………………………………………………… 
 
5. Additional questions for female participants 
(a) Are your periods normal/regular?  ................. Yes  No  
(b) Are you on “the pill”?  .................................... Yes  No  
(c) Could you be pregnant?    ............................. Yes  No  
(d) Are you taking hormone replacement 
therapy (HRT)? 
Yes  No  
 
6. Are you currently involved in any other research studies at the University 
or elsewhere? 
 Yes  No  
If yes, please provide details.  
 
………………………………………………………………………………………………… 
 
7. Have you recently given blood or been involved with research involving 
blood samples? 
 Yes  No  
If yes, please provide details.  
 
………………………………………………………………………………………………… 
 
8. Are you currently taking any dietary supplements or have you in the last 6 
months? 
 
 Yes  No  
If yes, please provide details.  
 
………………………………………………………………………………………………… 
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9. Do you have any phobias that may affect you during this study? (e.g. fear 
of the dark or small spaces?) 
 Yes  No  
If yes, please provide details.  
 
………………………………………………………………………………………………… 
 
 
10. Please provide contact details of a suitable person for us to contact in the 
event of any incident or emergency. 
 
Name  
 
………………………………………………………………………………………………… 
 
Telephone Number  
 
………………………………………………………………………………………. 
 
 Work  Home  Mobile  
 
Relationship to Participant  
 
………………………………………………………………….................... 
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The effect of fish oil capsule consumption on dark adaptation 
Adult Participant Information Sheet - Extension 
 
Investigators Details: 
Paul Kelly,a 01509 222578, p.f.kelly@lboro.ac.uk 
Beth McMurchie,a 01509 564113,  b.mcmurchie@lboro.ac.uk 
Martin Lindley,b 01509 226349, m.r.lindley@lboro.ac.uk 
Lynsey Wilson,b 01509 228779, l.wilson2@lboro.ac.uk 
Jim Reynolds,a 01509 222590, j.c.reynolds@lboro.ac.uk 
 
aChemistry Department, Loughborough University, LE11 3TU 
bSchool of Sport, Exercise and Health Sciences, Loughborough 
University, LE11 3TU 
 
Thank you for participating in this study, and for considering continuing with the 
proposed extension. Before you decide we would like you to understand why the 
research is being done and what it would involve for you. One of our team will go 
through the information sheet with you and answer any questions you have. Talk 
to others about the study before making a decision if you wish. 
 
What is the purpose of the extension of the study? 
 
This study aims to establish if taking fish oil supplements affects an individual’s 
dark adaptation and if any changes found revert when not taking fish oil 
supplements. 
 
Who is doing this research and why? 
 
This study is part of a student research project supported by Loughborough 
University. It will be led by the investigators above based in Chemistry and the 
School of Sport, Exercise and Health Science. This study will form part of Beth 
McMurchie and Lynsey Wilson’s PhD research. 
 
Are there any exclusion criteria? 
 
Only participants who took part in the full study can continue with the extension. 
 
What will I be asked to do? 
 
As a participant, you will be asked to attend one further session, during the week 
commencing 16th April. The session will be identical to those that you have 
attended previously. It will involve assessing your dark adaptation level using the 
Crime-lite Eye (shown in Figure 1). 
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Figure 1 – The Crime-lite Eye, used to assess your dark adaptation. 
 
You will be asked to sit in a dark room for 30 minutes and using the Crime-lite 
Eye, find the lowest number that you can read on the device. As your eyes 
adapt to the dark you will be able to see lower numbers and we will record 
which number you can reach after 30 minutes. You can have music or an audio 
book playing during this time if you wish, however you will be unable to look at 
any devices (e.g. phones etc) that will affect the dark adaptation process. 
During your first session a fingerprick blood sample will also be taken. 
 
No further supplements will be needed. 
 
Once I take part, can I change my mind? 
 
Yes.  After you have read this information and asked any questions you may 
have, if you are happy to participate we will ask you to complete an Informed 
Consent Form, however if at any time, before, during or after the sessions you 
wish to withdraw from the study please just contact the main investigator.  You 
can withdraw at any time, for any reason and you will not be asked to explain 
your reasons for withdrawing. 
 
However, once the results of the study are published or the data has been 
included and submitted as part of a report (expected to be by 09/2018), it will 
not be possible to withdraw your individual data from the research. 
 
Will I be required to attend any sessions and where will these be? 
 
You will be required to attend 1 session, where your dark adaptation will be 
measured and a fingerprick blood sample will be taken. These sessions will be 
completed in the Chemistry building or in Clyde Williams, both on 
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Loughborough University Campus this will be decided at the time based on both 
the investigators and your, as the participant, needs. 
 
How long will it take? 
 
The session will take under one hour. 
 
What personal information will be required from me? 
 
All information provided by you will be stored anonymously. You will be required 
to give a blood sample. 
 
Are there any disadvantages or risks in participating? 
 
An appropriate risk assessment has been performed, but the following risks exist 
when taking part in this study: 
- Some people feel light headed when giving a blood sample, we will ensure 
you are as comfortable as possible and first aiders will be available if 
needed. 
- You will be sat in a dark room for 30 minutes, if you are uneasy in the dark, 
or begin to feel uneasy once you have started, there will be a light available 
to you and the safest way to leave the room will be outlined to you. 
 
Will my taking part in this study be kept confidential? 
 
You will be given a code that we will use for data storage so that all data is 
stored anonymously. This code will be used to label any blood samples stored 
in freezers and any personal data about the participants. Investigators will 
ensure that no information is published that would allow individuals to be 
identified. 
 
Paper copies of consent forms, participant questionnaires and data recording 
sheets will be kept in a locked secure office. All electronic data will be stored 
anonymously on password protected University computers. All information will 
be securely locked away for 5 years, following this it will be securely destroyed. 
 
Blood samples will be stored in -80°C freezers and logged and tracked using 
Procuro, enabling an audit trail as per Human Tissue Act Regulations. Samples 
will be destroyed as Biohazard waste, and logged on Procuro, after a period of 
5 years. 
 
 
 
 
I have some more questions; who should I contact? 
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If you have any questions please contact Beth McMurchie 
(b.mcmurchie@lboro.ac.uk) or any of the other investigators listed at the start of 
this sheet. 
 
What will happen to the results of the study? 
 
The results of this study will be used as part of a thesis for PhD submission, and 
may also be published. Investigators will ensure that no information is published 
that would allow individuals to be identified. 
 
What if I am not happy with how the research was conducted? 
 
If you are not happy with how the research was conducted, please contact the 
Secretary of the Ethics Approvals (Human Participants) Sub-Committee, 
Research Office, Hazlerigg Building, Loughborough University, Epinal Way, 
Loughborough, LE11 3TU.  Tel: 01509 222423.  Email: 
researchpolicy@lboro.ac.uk 
 
The University also has policies relating to Research Misconduct and Whistle 
Blowing which are available online at http://www.lboro.ac.uk/committees/ethics-
approvals-human-participants/additionalinformation/codesofpractice/ . 
 
 
Is there anything I need to bring with me? 
 
You may wish to bring your own music devices, particularly those which are 
Bluetooth enabled, as you will then be able to listen to music/ an audio book of 
your own choice whilst dark adapting for 30 minutes. 
  
BB 
 
8.4.3 Fingertip Compression and Stature 
 
Anthropometry and Fingerprints 
Participant Information Sheet 
Dear Participant, 
 
Thank you very much for agreeing to take part in this research with the Design 
School at Loughborough University. This study is attempting to establish 
whether there is a relationship between your physical characteristics and your 
fingerprint. 
 
This study is part of a Student research project supported by Loughborough 
University. You will be rewarded with a confectionary bar for your assistance 
with this research and to thank you for your time. 
 
Before arriving at the session you are simply asked to wash your hands. You 
will be asked to fill in a short questionnaire pertaining to your health, this is 
simply to confirm that you are able to take part in this study without any risk of 
harm so if you answer yes to certain questions, you will unfortunately be unable 
to take part in the study. 
 
You will be required to attend a short session which will take approximately 
fifteen minutes where you will complete the previously mentioned health 
questionnaire and then some physical characteristics measurements will be 
taken, such as your height and weight. The middle fingertip of your dominant 
hand will then be compressed for 5 seconds with a small force of 10 N, this is 
roughly the equivalent of a 1 kg bag of sugar. This force will be distributed 
across the back of the tip of your finger using a soft pad, so should not cause 
any discomfort. Please see the diagrams below. Whilst the force is not enough 
to cause any discomfort, we will demonstrate how it will feel before using the 
equipment. There is also an emergency stop button that will be accessible to 
you throughout the compression if you do feel uncomfortable. 
Compression 
Arm with 
padding 
Arm rest 
Fingerprint 
Camera  
Emergency 
stop button 
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This is the setup of the compression equipment. You will place your arm across 
the arm rest with your hand resting over the camera. The arm will then lower 
slowly until it comes into contact with your finger, and it will then apply 10 N of 
force. Please see the diagrams below. After 5 seconds, the arm will release. 
The camera will capture a photo of the outline of your fingerprint, so will not 
contain any ridge detail therefore these photos cannot be used to identify you. 
 
After you have read this information and asked any questions you may have we 
will ask you to complete an Informed Consent Form, however if at any time, 
before, during or after the session you wish to withdraw from the study please 
contact the main investigator.  You can withdraw at any time, for any reason 
and you will not be asked to explain your reasons for withdrawing. However, 
once the results of the study are published (expected to be by 2019), it will not 
be possible to withdraw your individual data from the research.  
 
Please be aware that any personal information you provide will be treated in 
strict confidence and will be kept anonymous and confidential unless (under the 
statutory obligations of the agencies which the researchers are working with), it 
is judged that confidentiality will have to be breached for the safety of the 
participant or others or for audit by regulatory authorities.  
 
If you are not happy with how the research was conducted, please contact Ms 
Jackie Green, the Secretary for the University’s Ethics Approvals (Human 
Participants) Sub-Committee: Ms J Green, Research Office, Hazlerigg Building, 
Loughborough University, Epinal Way, Loughborough, LE11 3TU.  Tel: 01509 
222423.  Email: J.A.Green@lboro.ac.uk The University also has a policy 
relating to Research Misconduct and Whistle Blowing which is available online 
at http://www.lboro.ac.uk/committees/ethics-approvals-human-
participants/additionalinformation/codesofpractice/ .   
 
Once again, thank you for your participation. If you have any questions, please 
feel free to contact me using the email address below. 
 
Yours Sincerely, 
Beth McMurchie 
b.mcmurchie@lboro.ac.uk 
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Anthropometry and Fingerprints 
INFORMED CONSENT FORM 
(to be completed after Participant Information Sheet has been read) 
 
Taking Part
 Ple
ase initial box 
 
The purpose and details of this study have been explained to me.  I 
understand that this study is designed to further scientific knowledge 
and that all procedures have been approved by the Loughborough 
University Ethics Approvals (Human Participants) Sub-Committee. 
  
I have read and understood the information sheet and this consent 
form. 
  
I have had an opportunity to ask questions about my participation.  
  
I understand that I am under no obligation to take part in the study, 
have the right to withdraw from this study at any stage for any reason, 
and will not be required to explain my reasons for withdrawing. 
  
I agree to take part in this study.  
 
Use of Information 
 
I understand that all the personal information I provide will be treated in 
strict confidence and will be kept anonymous and confidential unless 
(under the statutory obligations of the agencies which the researchers 
are working with), it is judged that confidentiality will have to be 
breached for the safety of the participant or others or for audit by 
regulatory authorities.  
  
I agree for the data I provide to be securely archived at the end of the 
project.  
  
I agree that the results obtained during this study can be used for the 
write up of a report. 
  
________________________ _____________________ ________  
Name of participant [printed] Signature              Date 
 
 
 
__________________________ _______________________ _________  
Researcher  [printed] Signature                 Date 
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Health Questionnaire  
 
Dear Participant, 
Please complete the following questionnaire pertaining to your current health. 
This is simply to ensure your current wellbeing is maintained and no part of the 
study could cause you any harm. 
 
1. Have you ever suffered from any of the following? Please tick as 
appropriate: 
 Yes No 
Arthritis    
Haemophilia    
Brittle Bone Disease   
Leukaemia    
Any other blood disorder: 
 
  
 
2. Do you currently have any cuts or abrasions on your dominant hand? 
Yes  No  
If yes, please explain briefly: 
………………………………………………………………………………………
………………………………………….……………………………………………
……………………………………………………………………………………… 
 
3. Do you have any problems with movement of your arm or hand? 
Yes  No  
If yes, please explain briefly: 
………………………………………………………………………………………
………………………………………….……………………………………………
……………………………………………………………………………………… 
 
4. Do you have any skin conditions (e.g. eczema etc.?) 
Yes  No  
If yes, please explain briefly: 
………………………………………………………………………………………
………………………………………….……………………………………………
……………………………………………………………………………………… 
If you have answered yes to any of the above questions, unfortunately you may 
be unable to take part in the study. 
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5. Are you currently taking any regular medication? 
Yes  No  
If yes, please explain briefly: 
………………………………………………………………………………………
………………………………………….……………………………………………
……………………………………………………………………………………… 
 
6. Is there anything else that you would like us to be aware of in regards to 
your health? 
………………………………………………………………………………………
…………………………………………………………................ 
Thank you again for your participation, this information will remain 
completely confidential. Please feel free to ask any questions you might 
have. 
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Anthropometry and Fingerprints 2 
Participant Information Sheet 
Dear Participant, 
 
Thank you very much for agreeing to take part in this research at Loughborough 
University. This research is attempting to establish whether there is a relationship 
between your physical characteristics and your fingerprint. 
 
This study is part of a Student research project supported by Loughborough University. 
You will be rewarded with a confectionary bar for your assistance with this research 
and to thank you for your time. 
 
Before you begin you will be asked to fill in a short questionnaire pertaining to your 
health, this is simply to confirm that you are able to take part in this study without any 
risk of harm so if you answer yes to certain questions, you will unfortunately be unable 
to take part in the study. 
 
You will be required to attend a short session which will take approximately fifteen 
minutes where you will complete the previously mentioned health questionnaire and 
then your height will be measured. The middle fingertip of your dominant hand will 
then be compressed for 5 seconds with a small force of 10 N, this is the equivalent of 1 
kg. This force will be distributed across the back of the tip of your finger using a soft 
pad, so will not cause any discomfort, however, there is an emergency stop button 
that will be accessible to you throughout the compression if you do feel 
uncomfortable. 
 
This is the setup of the compression equipment. You will place your arm across the 
arm rest with your hand resting over the camera. The arm will then lower slowly until 
it comes into contact with your finger, and it will then apply 10 N of force. Please see 
the diagrams below. 
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After 5 seconds, the arm will release. During this initial compression, a photograph of 
your fingerprint will be taken. This will be repeated 4 times, however paper and glass 
slides will be placed underneath your finger allowing a natural fingerprint to be 
collected onto these surfaces. 
After you have read this information and asked any questions you may have we will 
ask you to complete an Informed Consent Form, however if at any time, before, during 
or after the session you wish to withdraw from the study please contact the main 
investigator.  You can withdraw at any time, for any reason and you will not be asked 
to explain your reasons for withdrawing. However, once the results of the study are 
published (expected to be by 2019), it will not be possible to withdraw your individual 
data from the research.  
 
Please be aware that any personal information you provide, including your 
fingerprints, will be treated in strict confidence and will be kept anonymous and 
confidential unless (under the statutory obligations of the agencies which the 
researchers are working with), it is judged that confidentiality will have to be breached 
for the safety of the participant or others or for audit by regulatory authorities.  
 
If you are not happy with how the research was conducted, please contact Ms Jackie 
Green, the Secretary for the University’s Ethics Approvals (Human Participants) Sub-
Committee:Ms J Green, Research Office, Hazlerigg Building, Loughborough University, 
Epinal Way, Loughborough, LE11 3TU.  Tel: 01509 222423.  Email: 
J.A.Green@lboro.ac.uk The University also has a policy relating to Research 
Misconduct and Whistle Blowing which is available online at 
http://www.lboro.ac.uk/committees/ethics-approvals-human-
participants/additionalinformation/codesofpractice/ .   
 
Once again, thank you for your participation. If you have any questions, please feel 
free to contact me using the email address below. 
 
Yours Sincerely, 
 
Beth McMurchie 
b.mcmurchie@lboro.ac.uk 
Health Questionnaire  
II 
 
Dear Participant, 
Please complete the following questionnaire pertaining to your current health. This is simply to 
ensure your current wellbeing is maintained and no part of the study could cause you any 
harm. 
 
7. Have you ever suffered from any of the following? Please tick as appropriate: 
 Yes No 
Arthritis    
Haemophilia    
Brittle Bone Disease   
Leukaemia    
Any other blood disorder: 
 
  
 
8. Do you currently have any cuts or abrasions on your dominant hand? 
Yes  No  
 
If yes, please explain briefly: 
…………………………………………………………………………………………………………………………………. 
…………………………………………………………………………………………………………………………………………… 
 
9. Do you have any problems with movement of your arm or hand? 
Yes  No  
 
If yes, please explain briefly: 
…………………………………………………………………………………………………………………………………. 
……………………………………………………………………………………………………………………………………………
………………………………… 
 
10. Do you have any skin conditions (e.g. eczema etc.?) 
Yes  No  
 
If yes, please explain briefly: 
…………………………………………………………………………………………………………………………………. 
…………………………………………………………………………………………………………………………………………… 
 
 
 
If you have answered yes to any of the above questions, unfortunately you may be unable to 
take part in the study. 
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11. Are you currently taking any regular medication? 
Yes  No  
 
If yes, please explain briefly: 
…………………………………………………………………………………………………………………………………. 
…………………………………………………………………………………………………………………………………………… 
 
12. Is there anything else that you would like us to be aware of in regards to your health? 
 
…………………………………………………………………………………………………………………………………………… 
Thank you again for your participation, this information will remain completely 
confidential. Please feel free to ask any questions you might have. 
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Anthropometry and Fingerprints 2 
INFORMED CONSENT FORM 
(to be completed after Participant Information Sheet has been read) 
 
Taking Part  
 
The purpose and details of this study have been explained to me.  I understand 
that this study is designed to further scientific knowledge and that all 
procedures have been approved by the Loughborough University Ethics 
Approvals (Human Participants) Sub-Committee. 
  
I have read and understood the information sheet and this consent form. 
  
I have had an opportunity to ask questions about my participation.  
  
I understand that I am under no obligation to take part in the study, have the 
right to withdraw from this study at any stage for any reason, and will not be 
required to explain my reasons for withdrawing. 
  
I agree to take part in this study.  
 
Use of Information 
 
I understand that all the personal information I provide will be treated in strict 
confidence and will be kept anonymous and confidential unless (under the 
statutory obligations of the agencies which the researchers are working with), 
it is judged that confidentiality will have to be breached for the safety of the 
participant or others or for audit by regulatory authorities.  
  
  
I agree for the data I provide to be securely archived at the end of the project.  
 
  
I agree that the results obtained during this study can be used for the write up 
of a report. 
  
________________________ _____________________ ________  
Name of participant [printed] Signature              Date 
 
 
 
__________________________ _______________________ _________  
Researcher  [printed] Signature                 Date 
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Health Questionnaire 
  
Dear Participant, 
Please complete the following questionnaire pertaining to your current health. 
This is simply to ensure your current wellbeing is maintained and no part of the 
study could cause you any harm. 
 
1. Have you ever suffered from any of the following? Please tick as 
appropriate: 
 Yes No 
Arthritis    
Haemophilia    
Brittle Bone Disease   
Leukaemia    
Any other blood disorder: 
 
  
 
2. Do you currently have any cuts or abrasions on your dominant hand? 
Yes  No  
 
If yes, please explain briefly: 
……………………………………………………………………………………… 
………………………………………………………………………………………
………………………………………………………………………………………. 
 
3. Do you have any problems with movement of your arm or hand? 
Yes  No  
 
If yes, please explain briefly: 
……………………………………………………………………………………… 
………………………………………………………………………………………
………………………………………………………………………………………. 
 
4. Do you have any skin conditions (e.g. eczema etc.?) 
Yes  No  
 
If yes, please explain briefly: 
……………………………………………………………………………………… 
………………………………………………………………………………………
………………………………………………………………………………………. 
 
If you have answered yes to any of the above questions, unfortunately you may 
be unable to take part in the study. 
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5. Are you currently taking any regular medication? 
Yes  No  
 
If yes, please explain briefly: 
……………………………………………………………………………………… 
………………………………………………………………………………………
………………………………………………………………………………………. 
 
6. Is there anything else that you would like us to be aware of in regards to 
your health? 
 
………………………………………………………………………………………
…………………………………………………………............................... 
 
Thank you again for your participation, this information will remain 
completely confidential. Please feel free to ask any questions you might 
have. 
 
 
